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Executive Summary
1.1—Rationale
A Public Health Evaluation (PHE) was commissioned 
to examine PEPFAR-funded care and support. Phase 2 
of this PHE aimed to evaluate how PEPFAR care and 
support programme components and costs are related 
to health outcomes.
1.2—Methods
Phase 2 was completed using three methods: a longi-
tudinal quantitative observational study of patient care 
and self-reported health outcomes over three months; 
qualitative interviews with patients, informal carers and 
staff; and a costing study to estimate facility-level costs 
of providing care and support. Six facilities receiving 
PEPFAR Care and Support funding were selected to 
participate in Phase 2 from those which had completed 
Phase 1. In the longitudinal study, health outcomes 
were measured using the MOS-HIV and the APCA 
African POS (Palliative Outcomes Scale, and patient 
care using a modified Client Services Receipt Inventory 
(CSRI).
1.3—Main Findings of Longitudinal Quantitative 
Study
1.3.1—Facility Characteristics
The facilities (numbered 252, 255, 256, 258, 259, and 
260, as in Phase 1) all provided outpatient care to 
people with HIV. They were a mission hospital, two 
research centres, a testing and care centre, two hospital 
HIV clinics and a community care organisation.
1.3.2—Participant Characteristics
Six hundred forty-one people were recruited to the 
study and interviewed at a mean of 32.6 day intervals 
for four months. During this time 538 (83.9%) partici-
pants completed all four interviews; of those who did 
not complete all four interviews, seven died, 22 were 
unable to continue, one refused, one left the study and 
72 gave no reason. Participants were aged 18 to 70 
with a mean age of 35, 32% were male, and they had a 
median of four dependants. Median time from HIV di-
agnosis to study recruitment was 196 days and 31% had 
been diagnosed within 14 days of recruitment. For the 
63% who had a recent CD4 count, the median count 
was 297. At the first appointment 25% were accompa-
nied by an informal carer; this proportion later dropped 
to 17%. The wealth of patients was indicated by their 
reported living conditions. Over a quarter (26%) of 
participants used a shared or public latrine, which is 
considered inadequate sanitation, and 12% sourced 
drinking water from a unsafe supply. Almost half (46%) 
used firewood or straw for fuel, which is associated 
with increased risk of tuberculosis (TB) and respiratory 
infections. 
1.3.3—Care Delivery
Of 52 components of care and support included in the 
questionnaire, participants received a mean of 13 com-
ponents per month and 22 during the study. Over 90% 
of participants received daily cotrimoxazole (CTX), 
adherence counselling and prevention with positives. 
Of the five categories of PEPFAR Care and Sup-
port (clinical, psychological, spiritual, social and preven-
tive), 100% of participants received clinical care and 
98% prevention. Social care was, by some distance, the 
least commonly received (35%).
During the study, 61% of participants received 
ART at least once, making it the seventh most com-
mon component of care. Monthly receipt of CTX 
increased over time from 70% at baseline to 93% by the 
end of the study. 
Newly diagnosed participants received a mean of 
eight components of care at baseline, rising to 12 after 
three months. 19% of this group received all five ele-
ments of the Preventive Care Package during the study 
period and 36% received four. The least commonly 
received element was family VCT information (49%).
1
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1.3.4—Physical and Mental Health and 
Multidimensional Problems
At baseline, participants had a mean physical health 
score of 43.5 and mean mental health score of 44.2 as 
measured by self-report using the MOS-HIV (with 
100 being the best possible health), indicating substan-
tially impaired quality of life. Their biggest problems as 
recorded on the APCA African POS multidimensional 
care scale were not being able to share their feelings 
with anyone, not having help and advice to help the 
family to cope, and not feeling at peace.
1.3.5—Differences Between Facilities
Participants at Facility 252 were poorer, with worse 
physical function and lower CD4 count, compared to 
participants at other facilities. Facilities 255 and 256 
had the highest mean CD4 count and best physical 
function scores. Care provided was also not the same 
across facilities. Clinical and preventive care had almost 
100% coverage but social care and nursing provision 
were received by varying proportions of patients at fa-
cilities. Participants at Facilities 252, 255, and 259 were 
more likely to receive additional care components from 
elsewhere. 
1.3.6—Participant Characteristics and Self-
Reported Health
Older people had lower physical health at baseline, 
and relatively wealthier people had better physical and 
mental health. Participants with a lower CD4 count 
had worse physical and mental health, although after 
controlling for physical health, the association between 
mental health and CD4 disappeared. Participants who 
received ART or TB treatment in the month before T0 
had lower physical and mental health than those who 
did not. There was no difference in physical or mental 
health between men and women.
1.3.7—Changes in Health Over Time
Over time, self-reported physical and mental health 
improved and all multidimensional care problems 
decreased, after accounting for the bias that those with 
poor health were more likely to drop out of the study. 
Outcomes also improved for the people with the worst 
health at baseline. Age, gender, education and wealth 
were not associated with change in physical or mental 
health over time. Participants at Facilities 252 and 
259 showed a greater improvement in physical (both) 
and mental (Facility 259 only) health than the other 
facilities.
Over three months, participants receiving ART 
showed less improvement in self-reported physical or 
mental health than those not taking ART, after ac-
counting for illness severity using CD4 count. 
1.4—Main Findings of Qualitative Interviews
Patients reported experiencing pain, physical symptoms, 
and psychological problems such as anxiety. These were 
exacerbated by poverty and lack of resources which 
were a recurring theme. Patients valued the services 
they received, particularly ART and other drugs, and 
the positive attitude of staff. 
Some of the causes of psychological problems were 
worry over finances, stress due to keeping the diagnosis 
secret, and inability to talk about feelings. Stigma and 
rejection were common problems, as was social isolation 
to pre-empt and avoid these reactions. Psychological 
problems had many sequelae including symptoms such 
as sleeplessness, inhibited access to care, reduced adher-
ence, increased burden for carers, and severe disruption 
to normal life. Patients derived emotional support from 
each other and from staff. 
Lack of money and lack of food were closely equat-
ed. Hunger was a threat to ART adherence, and fatigue, 
caused by both HIV and hunger, limited patients’ abil-
ity to work, which reduced income and food availability 
in a vicious cycle. 
There were many burdens to caring including the 
need to financially support the patient, health costs 
from the work of caring, and feelings of guilt over not 
doing enough. Carers found it difficult to access sup-
port services, and staff expressed the wish to reach them 
with home care services.
1.5—Main Findings of Costing Study
There was a very wide variation in costs per patient 
per year, from $41 at Facility 256 (by far the cheapest, 
probably because it did not provide ARVs directly) to 
$719 at Facility 252. The largest cost driver differed 
between facilities, and included building rental and 
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utilities at one facility, ARVs at two facilities and other 
drugs at another. Patient load for clinical staff varied 
from 1400:1 at Facility 259 to 165:1 at Facility 258. 
There were economies of scale, so that facilities with 
more patients had lower costs per patient per year.
1.6—Recommendations
1.6.1—For Health Professionals
 » People with HIV have physical and mental health 
needs throughout the trajectory of illness, and 
mental health in particular is not related to HIV 
progression but can be a problem at any stage. Care 
and support should be available to all patients ir-
respective of HIV disease severity.
 » Care must respond to non-virological dimensions 
of HIV infection. All patients referred with HIV 
should be assessed for multidimensional need on a 
regular basis.
 » Participants taking ART experienced worse self-
reported physical and mental health at baseline and 
they made less improvement over time, even after 
accounting for CD4 count. Health staff should be 
aware of the needs of this group, and all patients 
taking ART should have regular monitoring, to 
include assessment and management of emotional 
and physical wellbeing as core clinical activities.
 » Counselling services should include the opportuni-
ty for patients to raise concerns and discuss prob-
lems, rather than focusing solely on educational 
intervention
 » The needs of carers should be included in the 
patient care encounter. Including carers early in the 
disease trajectory would improve social care for pa-
tients and could help to identify patient needs that 
are not acknowledged by the patients themselves. 
 » All patients should be assessed for pain, which 
should be managed according to the WHO Pain 
Ladder.
1.6.2—For Health Facility Managers
 » Home-based care should be encouraged, so that 
family carers can receive support and services such 
as VCT, and to reduce the costs to patients. 
 » There should be sufficient numbers of non-clinical 
staff to ensure a manageable patient load for coun-
sellors, nutritionists, social workers and community 
health workers, and high quality patient care. The 
areas addressed by these professions were identified 
as areas of high need for people in this study. 
1.6.3—For Policymakers
 » No problems were reported with the supply of 
ARVs but supplies of other drugs were frequently 
unreliable, causing expense to patients and delays 
to care. Supply chain systems should adopt the best 
practices of the ART delivery system. 
 » Chronic hunger is not adequately managed by 
short-term interventions. Food shortage caused 
by poverty is a significant problem which inhibits 
delivery of HIV care. Health facilities should work 
towards sustainable, adequate food supply for all 
patients to help maintain health and adherence.
 » Patients reported living in an atmosphere of stigma 
and discrimination which adversely affected their 
mental health. They recommended increased VCT 
promotion, in order to change public perceptions 
of HIV, make it easier for patients to disclose their 
status, and relieve the stress of secrecy. Increased 
prevention services would benefit HIV care and 
support. 
 » To achieve the best possible physical and mental 
health outcomes, HIV care and support should 
include:
•	 helping family members care for patients, 
through training and health care for carers;
•	 services to allow families to achieve adequate 
nutrition, ventilation and sanitation for basic 
health;
•	 a programme of psychological care, including 
“talking therapies” and medication, with referral 
for those with psychiatric problems; and
•	 support for patients whose financial situation 
inhibits their adherence, either directly through 
inability to pay or indirectly through worry.
1.6.4—For Researchers
 » Facility staff who had hosted research projects for 
years expressed a wish to learn skills and conduct 
their own research. Future research programmes 
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should include continued building of knowledge 
and capacity in host settings.
 » A study of care and outcomes for children should 
be undertaken to explore the multidimensional 
problems of this important population, particularly 
the expanding group of HIV positive older children 
for whom optimal care is still being developed
 » Shortage of drugs delayed patient care and was a 
common complaint, but the cause of these short-
ages is unclear. Examination of the barriers to drug 
delivery and a more detailed investigation of how 
drugs are supplied would be beneficial in terms of 
care delivery and patient satisfaction. 
 » A longer follow-up period would be beneficial to 
explore whether care and outcomes are maintained 
over a period greater than three months.
 » A study of how different staff working in care and 
support of HIV patients spend their working hours 
would enable an examination of how care costs 
relate to patient outcomes.
 » Further study of referral networks from individual 
facilities would help understand where, as well as 
why, patients obtain care that is not provided at the 
principal facility of study.
 » The evaluation model used here could be replicated 
in other countries.
 » Interventions to meet these recommendations 
should be developed, implemented and robustly 
evaluated in a sample of sites using experimental 
designs.
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In 2003 the United States government (USG) funded 
a five-year, $15 billion initiative to combat the global 
HIV/AIDS epidemic: the President’s Emergency Plan 
for AIDS Relief (PEPFAR). The funds were allocated 
approximately as follows: treatment (55%), prevention 
(20%), assisting orphans and vulnerable children (10%) 
and palliative care of individuals with HIV/AIDS 
(15%). PEPFAR has commissioned PHEs in these ar-
eas to evaluate funded programmes. Palliative care was 
subsequently redefined as care and support by OGAC.
2.1—Aim
The aims of the evaluation were (a) to describe the 
nature and scope of HIV care and support provi-
sion supported by PEPFAR in two African countries, 
including the types of facilities available, clients seen, 
and availability of specific components of care (Phase 
1); and (b) to evaluate how PEPFAR care and support 
programme components and costs are related to health 
outcomes (Phase 2). 
By meeting these aims, this study was designed to 
provide detailed descriptions of the care and support 
services that have been delivered through PEPFAR 
funding and identify the effective components and 
costs of the services, to improve the health of people 
with HIV. Dissemination of the findings is planned, 
in conjunction with country teams, to inform effective 
care and support provision within the two PHE target 
countries and beyond, where lessons can be transferred 
to other PEPFAR countries.
2.2—Objectives
In order to address these aims the study objectives 
were (a) to undertake a cross-sectional survey of service 
configuration and activity by visiting 10% of the facili-
ties being funded by PEPFAR to provide HIV care and 
support in Kenya and Uganda (Phase 1); (b) to under-
take a longitudinal prospective study of 600 patients 
who were newly diagnosed with HIV or patients with 
HIV who presented with a new problem attending 
PEPFAR care and support services. Data collected 
included self-reported quality of life, core palliative out-
comes and components of care received (Phase 2); (c) 
to conduct qualitative interviews with staff, patients and 
carers in order to explore and understand service issues 
and care provision in more depth (Phase 2); and (d) to 
undertake a cost comparison of care provided, including 
staff, overhead and laboratory costs (Phase 2).
2.3—Study Overview
The evaluation design was an observational study in 
Kenya and Uganda using mixed methods. The design 
comprised two sequential periods of data collection us-
ing mixed methodologies.  
Phase 1 (2007) was a cross-sectional survey of 
facility configuration and activity using quantitative and 
qualitative descriptive data. Phase 1 reports for Kenya 
(1) and Uganda (2) have been published separately.  
Phase 2 (2008) was a longitudinal evaluation of 
existing care, focusing on patient outcomes of PEP-
FAR care and support using validated outcome tools. 
Supplementary interviews with staff, patients and 
carers provided in-depth understanding of key issues. 
An additional cost analysis component in this phase 
compared patient/family outcomes with their associ-
ated costs. Patient data collection took place between 
January and September 2008, with data collection for 
the costing component being completed in January 
2009.  This report focuses on Phase 2 of the evaluation 
in Uganda. 
This evaluation of PEPFAR-funded care and sup-
port for HIV was led by King’s College London (KCL, 
Principal Investigator) in collaboration with MEA-
SURE Evaluation at the University of North Carolina 
(UNC) and the African Palliative Care Association 
(APCA). The aims, methods and implementation of 
the evaluation were planned and agreed in consultation 
with the members of USG Care and Support Technical 
Working Group, USG Country Teams, and representa-
tives of the Ministries of Health in Kenya and Uganda.
Introduction2
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3.1—Study Design 
Phase 2 of the care and support PHE was a mixed 
method prospective evaluation of PEPFAR-funded 
care and support services. The main component was a 
longitudinal study of how care components potentially 
related to HIV patient palliative and general health 
outcomes over time. In-depth interviews with staff, 
patients and carers explored in-depth service issues. 
Descriptive cost data were collected to compare patient 
outcomes with cost of providing services. There were 
three parts to Phase 2 of this evaluation, including (a) 
a quantitative longitudinal study; (b) patient and staff 
interviews; and (c) a costing survey.
3.2—Rationale for the Study Design
The aim of the study was to evaluate how PEPFAR 
Care and Support programme components and costs 
are related to health outcomes. The PEPFAR pro-
gramme was country-wide and had been implemented 
for several years before the evaluation was commis-
sioned. Therefore it was not possible to conduct a 
‘before and after’ study. One option was to compare 
outcomes at facilities receiving PEPFAR funding with 
those which did not, but this design would have been 
difficult as there are few large facilities in the target 
countries which have never received PEPFAR funding, 
and they would have little motivation to participate. 
Little information exists regarding the quality of life of 
Ugandan populations, which could have been used as a 
comparison sample. Facilities did not have stated targets 
against which their performance could be compared.
A cross-sectional study would only be able to 
identify differences between facilities, which might be 
caused by population factors as well as variations in 
care and support delivery. A longitudinal cohort study 
design was selected to allow the effect of care over time 
to be examined. This design offered the best option for 
evaluation of outcomes, although it was not possible to 
remove the effects of previous contact with PEPFAR 
Care and Support (C&S). 
Patient self-reported health was selected as the out-
come of interest because care and support aims to im-
prove quality of life, and could not be properly assessed 
without measuring this outcome. A mixed-methods 
design incorporating both quantitative and qualitative 
methods allowed triangulation and greater understand-
ing of the data and its context.
3.3—Protocol development
The protocol was developed by a multidisciplinary 
team, including medical professionals, HIV specialists 
and clinical and academic researchers, with review and 
comment from the USG Care and Support Techni-
cal Working Group and the country teams in Kenya 
and Uganda. All tools were piloted in one facility in 
Uganda. Following piloting, the wording and structure 
of the tools were modified and clarified. The tools are 
presented in Appendices A–D, and described below.
3.3.1—Longitudinal Quantitative Study
The data collection tools for the longitudinal study 
were four questionnaires, one of them (demography) 
used only once per person and the others used four 
times at monthly intervals. The time points, each one 
month apart, were designated T0 (entry to the study), 
T1, T2 and T3. A “patient pack” was created for data 
collection, consisting of all the tools bound in the order 
they should be used, with the pages colour coded by 
time point, and preceded by a log page to complete the 
dates of interviews and a front cover with the patient’s 
ID number. For each facility, questionnaire packs were 
prepared in two languages; English and a common local 
language. All the documents were translated into local 
languages from the English versions twice, indepen-
dently, by two local researchers. Each of these versions 
was translated back to English by a third researcher, 
with any discrepancies discussed amongst the group 
and an agreed translation decided.
Demographic and medical questionnaire (Appendix A): 
Basic demographic and medical details were collected 
3 Phase 2 Methods
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using a brief questionnaire administered at T0 (recruit-
ment to study). Four clinical questions were asked at 
T1: World Health Organization (WHO) stage, date 
and result of most recent CD4 test, and date of begin-
ning ART. These were moved from T0 to T1 because in 
piloting, health staff pointed out that the information 
would not be available to new participants at T0 and the 
response rate to these questions would be higher at T1.
The African APCA Palliative Outcome Scale (POS) + 
Eastern Co-operative Global Performance Scale (ECOG) 
(Appendix B): The APCA African POS is an adapted 
version of the original POS, which was developed at 
KCL to address the multidimensional problems of 
patients with incurable progressive disease and subse-
quently adapted around the world (3, 4). The African 
APCA POS was validated in ten centres in six Sub-
Saharan African countries in 2006 (5). Its ten items 
address the primary physical, emotional and spiritual 
concerns of patients and families and employs scoring 
methods appropriate for a range of literacy skills. It 
was administered at each of the four time points. The 
validation study demonstrated its properties included 
sensitivity to change, and it has high levels of patient 
and clinician acceptability. 
The ECOG is a clinician-rated single item measure 
of performance, with no psychosocial indices of qual-
ity of life, also at administered at all four time points 
(6). Scores range from 0 (normal activity) to 4 (unable 
to get out of bed). The ECOG is the most widely used 
performance measure (7).
Medical Outcome Scale-HIV (MOS-HIV) (Appen-
dix C):The MOS-HIV is a very widely used quality 
of life measure and has been culturally adapted to the 
Ugandan HIV setting (8, 9). The 35 items, asked at 
all four time points, address the domains of role func-
tion, pain, physical functioning, cognitive functioning, 
overall health perception, mental health, and vitality. 
The weighted subscores in these domains are then 
combined to produce two summary scores measuring 
physical health and mental health.
Client Service Receipt Inventory (Appendix D): 
This tool was a version of the Client Services Receipt 
Inventory (CSRI) (10) adapted for the aims of this 
study and the HIV setting in Africa in order to collect 
information about services received by patients in the 
study. Every month the CSRI recorded receipt of 52 
components of physical, psychological, spiritual, social 
and preventive care, and whether they were received at 
the facility or from elsewhere. 
3.3.2—Qualitative Interviews
Interview schedules (Appendices E, F, and G) were de-
signed to gain greater understanding of service use and 
provision from the views of the patients, their carers 
and the staff. The principal themes for patients and car-
ers were experience of facility care, choice of facility, the 
nature and content of clinical encounters, and principal 
needs. Interviews addressed medical, psychological, 
spiritual and social domains. Initial interview tran-
scripts were reviewed and question wording amended 
where needed to improve clarity of questions and fully 
explore key issues. The interview schedules, information 
sheets and consent forms were translated into local lan-
guages from the English versions twice, independently, 
by two local researchers. Each of these versions was 
translated back to English by a third researcher, with 
any discrepancies discussed amongst the group and an 
agreed translation decided.
3.3.3—Costing Study
Because the provision of care is a complex area there 
are potentially a number of cost components that 
could be accounted for. Due to the constraints of this 
multi-methods study, the following key cost elements 
were examined: (a) labour (by staff type, staff salaries); 
(b) medicines—ARVs, pain medicines, antibiotics, 
CTX, other—and their inventories—buffer stock; (c) 
laboratory items—supplies and equipment; (d) build-
ings—rent per month or estimated rental value—and 
utilities; and (e) capital inputs—high end equipment 
and vehicles.
Because only the major cost drivers were included, 
the costs in this report are likely to be an underestimate 
of the real costs of providing care. Cost elements that 
may be significant, but which were not accounted for 
include: costs of developing training and HMIS sys-
tems, training of health providers, supervision, monitor-
ing and evaluation including HMIS systems, clinic ad-
ministrative costs, drug and commodities management 
and maintenance and depreciation on capital assets.
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As HIV care and support is provided in a clinical 
setting in which other non-HIV services are provided, 
it was necessary to estimate the proportion of some cost 
elements which are measured for all clincial services 
and attribute a share for HIV care and support. This 
is a common issue with the costing of services that are 
provided in an environment where several medical spe-
cialities are simultaneously provided separately at one 
facility. For labour costs, only staff who were involved 
in providing care and support services were included so 
there was no allocation difficulty with staff costs.
To estimate non-ARV drug costs, facilities reported 
the use of their three most common analgesics, of 
strong and weak opioids, CTX, the three most com-
monly prescribed antibiotics for OIs, and TB treatment. 
The cost of these was divided by the proportion of facil-
ity patients who were HIV positive, as a proxy for drug 
use. Similarly, capital and building costs were allocated 
to HIV care and support using the proportion of all 
patients accounted for by HIV patients. Tools were 
piloted and revised to maximise validity of the data 
collected and ease of data provision for facilities. Tools 
were piloted and revised to maximise validity of the 
data collected, and ease of data provision for facilities.
3.4—Ethical Aapproval and Data Storage
Ethical approval to undertake the study in Uganda 
was received from the Ugandan National Council for 
Science and Technology (UNCST, Ref SS 1964) and 
the College Research Ethics Committee at KCL (Ref 
CREC/06/07-140). Subsequent tool changes following 
piloting were also approved.
During longitudinal data collection all question-
naires were stored separately from consent forms, in a 
locked filing cabinet at the facility. Upon completion of 
the study, anonymised questionnaires were taken from 
the facility to the APCA offices for storage in locked 
filing cabinets. These arrangements were in line with 
ethical guidance and the UK Data Protection Act 1998.
3.5—Selection and Recruitment
3.5.1—Health Facilities
In Phase 1, the approximately 600 facilities receiving 
PEPAR Care and Support funding in Uganda were di-
vided into three strata based on the number of patients 
treated in the past year, and 20 facilities were selected at 
random from each stratum. From these 60 facilities, the 
largest six were selected to participate in Phase 2. The 
inclusion criteria for Phase 2, which applied in addition 
to those for Phase 1, were that facilities recruited at 
least 30 new HIV patients a month, had sufficient staff 
with essential skills to conduct data collection, offered 
ongoing care and support to enable longitudinal data 
collection, and had sufficient capacity to engage. The 
six largest facilities were selected because they were the 
most likely to meet the inclusion criteria listed above. 
3.5.2—Participants
Longitudinal quantitative study: Consecutive patients 
who met all of the following criteria were approached 
for participation in the longitudinal study: (a) pa-
tients were 18 years of age or over; (b) patients were 
diagnosed HIV positive; (c) patients knew of their 
diagnosis; (d) patients had sufficient cognitive ability 
to answer the questions for the study; and (e) patients 
were new to service or presenting with a new problem 
(social, psychological, spiritual or physical). Participants 
gave informed consent to participate following provi-
sion of an information sheet and consent form. These 
documents were translated into local languages (Swahi-
li, Luo, Runyakitara and Luganda), and were read aloud 
by the health care worker if the participant was non-
literate. Participants were reimbursed travel expenses 
to the facility of US$5 per visit. Each facility recruited 
about 100 participants.
Qualitative interviews: Any staff member working 
at the facility who was involved in the care of patients 
was eligible to participate in the staff interviews. A 
purposive sampling strategy was undertaken in order to 
interview a variety of staff designations. The aim was to 
complete seven patient interviews, three carer inter-
views and five staff interviews per facility. 
Eligible participants for the patient qualitative 
interviews were patients of the facility who had already 
been diagnosed as HIV positive, over 18 years of age, 
had been under care for at least six weeks, and were not 
involved in the longitudinal study. These patient partici-
pants were asked for consent to approach an identified 
adult informal carer (i.e., family member or friend who 
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provides assistance/support) in order to undertake a 
separate qualitative interview. Patient, carer and staff 
participants gave informed consent to participate fol-
lowing provision of an information sheet and consent 
form, which was read aloud to the interviewee by the 
health care worker if the interviewee was nonliterate.
3.6—Data Collection
Facilities were informed of the planned survey through 
the Ministries of Health in each country.
3.6.1—Longitudinal Quantitative Study
Data collection took place between January and Sep-
tember 2008, with recruitment to the longitudinal 
quantitative study ending in June to allow all the 
intervews to be complete. With the exception of CD4 
counts, data for the longitudinal quantitative study were 
self-reported by the participants, and recorded in the 
questionnaire packs provided by health care workers 
(HCWs) already employed at each facility. 
HCWs recruited patients and completed question-
naires in the course of their regular duties. Funding 
was provided to the facility directors to support data 
collection, including purchase of a computer. HCWs 
were trained by APCA staff in the process of seeking 
informed consent and the completion of the question-
naires. A researcher maintained contact with each facil-
ity through regular visits which would include observ-
ing data collection, checking the use of appointment 
diaries and regular data entry, and delivering additional 
training as necessary. 
Data collection was conducted at recruitment (T0) 
and at three subsequent interviews a month apart, 
which coincided with clinical appointments where pos-
sible. Once participants had completed the longitudinal 
study, CD4 counts were extracted from patient records 
by the HCWs, or by the researchers themselves under 
the supervision of HCWs.
Early in data collection it became apparent that par-
ticipants could not always remember the date and result 
of their last CD4 count. Less than 50% of participants 
were able to provide a CD4 count and it appeared that 
these were biased towards people who were more ill or 
concerned about their health. Accordingly, permission 
was granted by the ethics board overseeing the study 
to search patients’ records for CD4 counts. Researchers 
visited each facility after the longitudinal quantitative 
study data collection had been completed, and copied 
CD4 counts for the study participants into a specially 
designed form which preserved anonymity while allow-
ing records to be linked to participants. CD4 count was 
the only piece of information obtained in this way. The 
decision to refer to patient records was taken because 
the researchers knew the information was collected by 
facilities, and participants had been informed of their 
result, but simply could not remember the information. 
One questionnaire pack contained all the data for 
one individual. The pages were colour-coded to indicate 
time points. The front cover of the pack was blank apart 
from the patient’s name. When the final time point 
was complete, this page was torn out, making the data 
unidentifiable. The second page included metadata log-
ging the progress of data collection and management at 
each timepoint.
3.6.2—Qualitative Interviews
The interviews took place between May and September 
2008. Single qualitative interviews with staff members, 
patients and informal carers were conducted by APCA 
staff and were digitally recorded. Interviews were car-
ried out in several languages including English, Swa-
hili, Luo and Luganda. Interviews were conducted in 
private, usually in consulting rooms at the care facility. 
Most patients were not accompanied by a carer 
and the few who were accompanied were often very 
ill, needing the carer’s constant presence. As a result, 
recruitment of sufficient carers for qualitative inter-
views was difficult. Researchers identified family carers 
through community outreach teams operating from 
the care facilities. In this way, a more representative 
sample of carers of patients at all disease stages could be 
interviewed. 
One facility was in a remote part of the country 
where the most widely spoken local language was very 
rare nationally, and spoken by none of the research-
ers. Rather than exclude an entire ethnic group from 
this section of the evaluation, the patient and carer 
interviews were conducted by a member of facility staff 
who was trained in qualitative interviewing, with the 
researcher present.
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3.6.3—Costing Study
A data collection instrument (Appendix H) was 
designed and tested to capture the identified cost ele-
ments in each of the Phase 2 facilities in which pa-
tients were being followed. Facility level data included 
number of patients seen by staff category in a typical 
day, hours spent with HIV patients per week and hours 
worked per week by staff category; number of staff by 
category involved in HIV care; quantities of medica-
tions dispensed in the last three months by kind of 
drug; numbers of laboratory tests conducted in the 
last three months; information on physical buildings 
such as space and an equivalent in rental value of the 
space; utility costs per month including water, electric-
ity, generator fuel, communications, waste disposal 
etc.; transport costs, fuel, costs of drivers, maintenance; 
clinical consumable costs per month, including gloves, 
syringes, cotton wool swabs, plasters, soap, sterilizing 
solution etc.; amount spent on volunteer staff includ-
ing training, travel reimbursements, payment in kind in 
past three months.
Researchers gathered the information required 
for the instrument with information provided by key 
informants at each facility. Key informants varied by 
facility but generally included the hospital administra-
tor or manager, the accountant, clinicians, nurses and 
pharmacists. In some cases, more than one site visit was 
required in order to interview all relevant respondents 
and to complete the questionnaire.
Unit costs were required for some cost elements. 
These included staff (i.e., full salaries including allow-
ances), prices of medicines and unit costs of laboratory 
tests. Salaries were obtained in Uganda from each site 
and were average levels paid for each staff category. 
Drug costs were largely obtained from international 
sources such as the WHO and the International Drug 
Price Indicator Guide while laboratory test costs were 
obtained from ATC.
3.7—Data Management and Entry 
3.7.1—Longitudinal Quantitative Study
Immediately after collection, data were entered into a 
pre-designed EpiData v3.1 database with conditional 
checks for internal consistency. Data entry was con-
ducted at the health care facility by an administrative 
staff member who had been trained in the use of the 
tools and the database. When participants had com-
pleted the study, the completed data collection tools 
were transferred to the APCA offices. There research 
staff conducted a second round of all data entry and 
validation of the two rounds. Discrepancies identified 
were corrected by manual checking of questionnaires 
and results were revalidated until the two datasets were 
identical. The CD4 information from patient records 
was entered into a separate EpiData database and 
merged into the main dataset.
3.7.2—Qualitative Interviews
Interview recordings were transcribed verbatim into 
MS Word 2003 in the language in which they were 
conducted. If the interview was not conducted in Eng-
lish, two independent translations into English were 
then performed, either by the researchers or by experts 
from the Department of Linguistics at the Institute of 
Psychology. A team of three then reconciled the two 
independent translations, referring back to the taped 
interview if necessary, and agreed upon a final version. 
For the three interviews conducted by a health worker, 
a team of three health workers at the facility translated 
the recordings into English, and a native-speaker lin-
guist later checked the transcript while listening to the 
tape and made corrections. After the final translation 
had been agreed, the tapes were destroyed.
A table containing background information on the 
participant was added to the beginning of each tran-
script. These data were extracted from interviews and 
entered into Excel tables.
3.7.3—Costing Study
The data were entered into predesigned Excel spread-
sheets. Analysis, including creation of graphs and linear 
regression, was conducted in Excel workbooks with 
data drawn together from the different sheets. Clini-
cal staff were defined as doctors, nurses and clinical 
officers.
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An analysis plan was developed and circulated to all 
contributors for comment after data collection was 
completed. The three main sources of data (longitudinal 
quantitative study, qualitative interviews and costing) 
were analysed separately. Analysis plans are outlined be-
low, with the research questions in boxed text. Follow-
ing the implementation of the analysis plans, the results 
were integrated. The six participating facilities are desig-
nated by numbers in this report to preserve anonymity. 
The same identifying numbers were used in the Phase 1 
report so that reference can be made between the two.
4.1—Longitudinal Quantitative Study
Analysis was conducted using Stata v10. 
4.1.1—Outcome Measures
The main outcome measures used were the MOS-HIV 
(health related quality of life) and APCA African POS 
(palliative care problems). In order to reduce multiple 
significance testing, for the purposes of this evalua-
tion the MOS-HIV was used as the primary outcome 
measure, owing to its previous use in longitudinal HIV 
research in Africa (11).
MOS-HIV: The 35 MOS-HIV items contribute to 
eight multi-item subscales (health perceptions, physi-
cal function, role function, cognitive function, pain, 
mental health, energy/fatigue, and health distress) and 
two single-item subscales (social function and quality of 
life). Subscales were computed by summation of indi-
vidual item scores and conversion to a score out of 100, 
with 0 indicating the poorest health and 100 indicating 
the best health. Two summary scores for physical health 
(PHSS) and mental health (MHSS) were calculated 
by weighting each subscale score with standard coef-
ficients, then aggregating the weighted scores across 
subscales, which were also scored out of 100 (12). These 
summary scores were the principal outcomes used from 
the MOS-HIV. 
The PHSS comprises the physical function, pain, 
role function and social function subscales, with a 
smaller component from the energy and general health 
perceptions subscales. The MHSS comprises mostly 
mental health, health distress, quality of life, cognitive 
function and energy subscales, with smaller contribu-
tions from social function and general health perception 
subscales. Both scores are standardised so that the mean 
is 50 and the standard deviation is ten (12). Point dif-
ferences of 3–5 are considered clinically significant (11). 
APCA African POS: For the APCA African POS, 
the scores for the first three items (pain, symptoms and 
worry) were reversed so that for all items, zero repre-
sented the worst situation and five the best. Three items 
are addressed to the main carer of the patient.
The POS is designed to be a multidimensional 
scale for progressive disease (13) and it is unlikely that 
all the items form a single factor. The APCA African 
POS items are commonly used separately for clinical 
audit (5). In this study, data from the instrument were 
used to give more detailed information on the problems 
of participants attending care facilities, and a total score 
was created using the seven patient items, but because 
of its limitations as a single scale it was not used as one 
of the main outcome variables.
4.1.2—Section A: Cross-Sectional Descriptive 
Analysis
Facility Characteristics
1. What are the six facilities like in terms of infrastructure and care offered?
Information from the cross-sectional survey in 
Phase 1 of the evaluation was used to provide a sum-
mary of facility characteristic for the six Phase 2 
facilities. The location, number of patients per year, type 
and referral system for inpatients, number and type of 
fulltime, part-time and volunteer staff at each facility, 
and the components of care offered were detailed. All 
this information was self-reported by a small group of 
senior staff at each facility.
Analysis Plan4
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Participants and Interview Numbers
2. How many people were there in the study? 
3. How far apart were the interviews?
4. How many people dropped out and why did they leave?
Time points were designated T0 (study entry, or 
baseline), T1, T2 and T3. Ideally these would each be 
one month apart but any data collection within two 
weeks either side of that point was acceptable, in order 
to minimise the burden of additional travel for par-
ticipants. Some recoding of timepoints took place. If 
a participant was recorded to have completed T0, T2 
and T3 but missed T1, then T1 was deleted from the 
record and T2 and T3 were renumbered T1 and T2, to 
obtain a continuous series of three points. Compressing 
timepoints in this way made the most efficient use of 
the data. 
An alternative would have been to consider that 
timepoint was defined by time elapsed since T0, rather 
than by number of interviews completed. However, 
as explained above, the time between interviews was 
not precisely one month and in some cases was con-
siderably more. Using exact time as the definition of a 
timepoint would have necessitated either renumbering 
some interviews to T4, T5 and so forth, or dropping 
them from analysis. 
The median, maximum, minimum and inter-quar-
tile range for time between interviews was calculated. A 
flowchart was produced indicating the loss to follow-up 
at each data collection point. The number of people 
recruited, completion rate and mean time between 
interviews was tabulated by facility.
Participant Characteristics
5. What kind of patients come to these six facilities for PEPFAR Care & 
Support services?
6. How long have they known they were HIV-positive?
7. Why do they come?
8. How advanced is their HIV disease?
The study group was described in terms of age, 
gender and number of dependants. The length of time 
between the date of HIV test result and the beginning 
of the study was calculated. 
The variables from the demography questionnaire 
which related to socioeconomic status were incorpo-
rated into a principal components analysis to generate a 
single factor. This factor was then split into five quin-
tiles of equal size, to create a categorical variable for 
relative wealth (14). The socioeconomic variables were 
presented by wealth quintile to portray the characteris-
tics of each level of relative wealth.
The variables included were those used in the 
DHS surveys: (a) material used to make the walls/roof/
floor of the house; (b) type of toilet; (c) main source of 
drinking water; (d) fuel used for cooking; (e) household 
ownership of car/bicycle/refrigerator/television/mobile 
phone/radio.
Reason for attending the facility was a closed 
question in the demography questionnaire. Individuals 
whose HIV test date was in the 14-day period prior to 
joining the study were recoded so that their reason for 
attending was “new HIV test result.” A free text option 
was provided for those who reported they came because 
of referral, a new illness or for another reason. The 
answers in the free text boxes were used to recode some 
responses. In particular, those who reported that they 
had been referred from VCT were recoded as having an 
HIV test result. Reason for joining were tabulated and 
presented by percentage.
CD4 count is the best measure of the progression 
of HIV disease commonly in use. CD4 count was used 
for two purposes: to establish a baseline measure of 
HIV disease severity at the time of the study, and to 
observe change in CD4 count over the course of three 
months of care. During data collection it was discov-
ered that very few participants had two CD4 counts so 
close together to enable the examination of change over 
the course of the study. The first purpose of CD4 count 
(i.e., measure of disease severity) accordingly came to 
be the main one.  
Available CD4 count data was categorised by time. 
CD4 T1 was fixed within the range from one year prior 
to the beginning of the study (T0) to the time of the 
second interview, designated T1. CD4 T3 was in the 
range from the third interview (T2) to three months 
after T3. These time ranges were set after consulta-
tion with clinicians as to the rate at which CD4 count 
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changed over time and assessment of the data available 
in patient records. It was important to get a valid count 
from as many people as possible. If the time period was 
too short not enough counts would be included, and if 
it was too long the result would no longer be valid. To 
balance these competing demands, one year before T1 
was agreed as the boundary.
For those individuals who had two CD4 counts to 
compare, change in CD4 counts from T1 to T3 was 
analysed using a paired t-test. The two other measures 
of illness severity, WHO stage and ECOG physical 
function score, were also analysed. ECOG at the begin-
ning of the study was tabulated and WHO stage at 
each timepoint was presented by facility.
Care Participants Received
9. What kinds of Care & Support do people receive?
10. What kind of care do they get from the PEPFAR-funded health facility 
and what do they get from other places?
11. What are the five categories of PEPFAR Care & Support?
12. Which of these five categories are people most likely to get?
13. What care do people get immediately after being diagnosed HIV 
positive?
14. What is the Preventive Care Package and how many people get it? 
The frequency of ever receiving each of the 52 care 
items listed in the CSRI was calculated. People who re-
sponded ‘don’t know’ when asked whether they received 
a component of care were grouped in the “no” category. 
Care receipt was reported separately for components 
received at the study facility and those received at 
elsewhere. The main figures presented were proportion 
receiving a care element at a particular time point (as 
a percentage of those completing the timepoint), and 
proportion ever receiving the care component (defined 
as receiving it at least once and up to four times, calcu-
lated as a percentage of all study participants).
PEPFAR Care & Support services consist of five 
categories: clinical, psychological, spiritual, social and 
preventive care. The 52 components were ordered into 
these categories based on existing guidelines (15) and 
the percentage of people receiving each category was 
calculated. 
The 196 participants (of 641) whose positive HIV 
test took place in the two weeks before entering the 
study were analysed separately in order to explore the 
care which newly diagnosed people received. 
PEPFAR encourages the development of a coun-
try-specific Preventive Care Package (PCP) of pro-
phylactic items such as insecticide-treated nets (ITNs), 
water filters and multivitamins. In Uganda a five-item 
PCP has been evaluated and is being rolled out across 
the country. The five elements of the Uganda Preventive 
Care Package were examined, for newly registered pa-
tients (who should be assessed for need of each compo-
nent) and existing patients.
Care Themes
15. What kind of problems do care components address?
16. What are the themes and patterns of care provision?
17. How many people get antiretroviral therapy and how regularly do they 
get it?
18. How many people get CTX and do they take it every day?
Care components were grouped into themes ac-
cording to the issues they addressed and the way in 
which they were provided. This approach allowed more 
detailed analysis of the relationships between care com-
ponents. The care themes were also used in later analy-
sis as an average of the number of people receiving care 
by facility. For this section, components of care which 
were very rare (received by fewer than 10% of par-
ticipants at any time) were removed from the themes, 
because as outliers they could have unwarranted effects 
on the results. Each care theme was tabulated. Further 
analysis is described below by care theme.
Spiritual: involves a visit by a religious leader, 
prayer with patients, and contact with traditional healer. 
Spiritual care is a distinct aspect of PEPFAR Care & 
Support. Staff praying with patients and a visit from a 
religious leader are the most common types of spiri-
tual care provided through health facilities in Uganda. 
Many people with HIV visit traditional healers (16) 
and the care delivered by them fits the PEPFAR defini-
tion of spiritual care being sensitive to individual and 
community culture (15).
Counselling and advice: involves pre-and post-
test counselling, adherence counselling, family plan-
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ning counselling, patient HIV support groups, family 
counselling and psychiatric therapy. This theme com-
prises all “talking therapies.” It is sometimes difficult to 
distinguish counselling as listening and responding to 
the patient’s worries and concerns from counselling as 
didactic imparting of information. VCT, for example, 
is a strategy of both prevention and care, assessed for 
its efficacy in reducing risk behaviour and HIV trans-
mission (17). While these are valuable goals, they are a 
departure from the usual purpose of counselling which 
is improved health for the individual.
Nursing: involves wound care and other nursing 
care. Nursing is a specific discipline and its status may 
vary between facilities. 
Pain management: involves assessment of pain and 
provision of strong and weak opioids or non-opioid 
analgesics and treatment for neuropathic pain. Pain is 
a common symptom in HIV  (18) and all five com-
ponents in this group are necessary for its relief. The 
WHO pain ladder (19) outlines the need for non-opi-
oid and opioid analgesics until pain has been controlled. 
Neuropathic pain, which is particularly common in 
HIV (20) is caused by damage to nerves and does not 
respond to traditional pain medication. 
Symptom management: involves treatment for 
anxiety/depression, nausea/vomiting, skin rash/itching, 
diarrhoea, laxatives, thrush, oral candidiasis, cryptococ-
cus, other fungal infections, herpes, malaria and other 
opportunistic infections. The components in this theme 
were usually defined by the symptom treated, rather 
than the underlying cause or pathogen, because the 
cause of a symptom is often not known in HIV disease 
(21). All these physical symptoms and conditions are 
common in HIV (21, 22).
Nutrition: involves food, multivitamins, nutri-
tional advice, safe drinking water, therapeutic feeding 
for malnutrition. As part of Phase 1 of the evaluation, 
patient focus group discussions revealed that food was 
one of the most commonly requested components of 
care. Poor nutrition comprises two problems: lack of 
macronutrients (wasting, malnutrition) and lack of 
micronutrients (vitamins and minerals). Both of these 
predispose individuals with HIV to infections and ill 
health. Lack of food is the most fundamental level of 
poverty.
Social: involves employment training/income gen-
erating activities (IGA), home help, household items, 
legal services, memory book work, loans/microfinance. 
The social group components were selected after advice 
from USG country mission teams. Phase 1 qualitative 
data indicated that the purpose of IGA and microfi-
nance programmes was not only to increase income for 
families, but to reverse the myth that people with HIV 
are incapable of acting for themselves. Memory book 
work was allocated to the social care group because it 
aims to reduce internalised stigma and improve rela-
tions between family members.
Prevention: involves prevention with positives, con-
doms, ITNs, infection control training, isoniazid for TB 
prophylaxis. This care group includes both components 
to protect the person with HIV from other infections, 
and components to prevent them from infecting oth-
ers with HIV. Prevention with positives is the general 
name for a package of care designed to encourage 
behaviour change (condom use, reduction of partners, 
and revealing HIV status). Condoms prevent further 
infection and also protect the individual from other 
strains of HIV and from other STIs such as herpes. 
Insecticide-treated nets protect against malaria, which 
is more common and more aggressive in people with 
HIV (23), and the TB drug isoniazid can be used as a 
prophylactic for those at high risk of TB. 
ART: involves ARVs and assessment of ARV 
treatment. Antiretroviral therapy consists of more 
than ARVs. It includes regular assessment to observe 
signs of developing resistance, toxicity and side effects. 
Receipt of antiretroviral therapy was tracked over time 
using a decision tree. Receipt of ARVs and of assess-
ment were compared by facility and timepoint. 
CTX: CTX is a broad-spectrum antibiotic proven 
to reduce morbidity and mortality in people with HIV 
(24, 25). At each interview participants were asked 
whether they had taken CTX on the previous day and 
whether they had been given daily prophylactic CTX 
in the last month. These answers were compared to test 
adherence.
TB: TB treatment was listed separately from 
treatment for other symptoms and infection, for two 
reasons. Firstly, it is the leading cause of death for 
people with HIV in Africa (26). Secondly, the course of 
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treatment lasts for four to six months, long after symp-
toms have resolved. The full course of treatment must 
be completed to prevent resistance and recurrence. 
Health at the Beginning of the Study
19. What level of physical and mental health do people have at the 
beginning of the study?
20. What kinds of multidimensional problems do people have?
21. What problems do informal caregivers and family members have?
Physical and mental health summary scores were 
calculated from the MOS-HIV as described above. 
The summary scores at the beginning of the study were 
grouped into blocks of 50 to present as histograms, and 
analysed for mean, median and standard deviation. 
Multidimensional problems were collected in 
the APCA African POS. Each of the seven patient-
completed items was graphed individually and all items 
were analysed for median and inter-quartile range. 
These were used rather than the mean and standard de-
viation because scores were not expected to be paramet-
ric. The scores of the seven patient items were added 
together to create an APCA African POS total score, 
which was presented as a histogram.
How Participants Differ by Facility
22. Do the six facilities care for different kinds of people?
23. Are the people at some facilities more ill than at others?
24. Do people at different facilities get different kinds of care?
25. Do people at different facilities get all the five categories of PEPFAR Care 
& Support?
26. Are people at some facilities more likely to get care from elsewhere? 
27. How do physical health and mental health vary by facility?
The demographic characteristics of participants 
were compared according to the facility with which 
they were registered. Gender split, mean age, median 
number of dependants and median time to travel to 
the facility were compared visually. Relative wealth and 
reason for attending were tabulated by facility. Illness 
severity was explored by tabulating ECOG scores and 
mean CD4 count by facility.
The mean, standard deviation, minimum and 
maximum number of care components received by in-
dividuals at each facility was calculated, along with the 
proportion of participants by facility receiving each of 
the 52 components of care. The proportion of partici-
pants ever to receive each of the five PEPFAR C&S 
categories was compared between the six facilities. The 
proportion of participants receiving care from the facil-
ity and from elsewhere was also calculated by facility, 
and a series of stacked bar charts was produced show-
ing the mean number of care components received from 
each location by facility and time. Finally, mean and 
standard deviation of physical and mental health scores 
and total APCA African POS scores were calculated at 
baseline for each facility, and the extent of the differ-
ence was analysed using Kruskal Wallis tests.
Participant Characteristics and Health
28. Do men and women have the same physical and mental health?
29. Do older people have the same physical and mental health as younger 
people?
30. Does education or wealth make a difference to physical and mental 
health?
31. Do people whose HIV is more advanced have worse physical or mental 
health?
32. Do people receiving ART or TB treatment have different physical or 
mental health?
33. Do patients accompanied by a carer have different physical or mental 
health?
The association of baseline physical and mental 
health with demographic characteristics was analysed 
using appropriate statistical tests, with a significance 
level of 5% throughout. Mean health scores for men 
and women were compared using t-tests. The ordinal 
variables, education, and wealth quintile, were analysed 
using ANOVA, and the continuous variable age was 
analysed using linear regression. 
CD4 count at T1 was used to represent illness 
severity. CD4 count was converted into an ordinal 
variable with four categories which are most commonly 
referred to for clinical decision-making(27) and epi-
demiological studies(28). The categories were (a) 0–50: 
increased mortality risk; (b) 51–200: severe immuno-
suppression; (c) 201–350: immunosuppression; and (d) 
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above 350. The association of health scores with CD4 
category was analysed using ANOVA. In addition, 
linear regression was used to identify whether mental 
health was associated with CD4 count after controlling 
for physical health.
Mean physical and mental health, with standard er-
ror, was calculated for people who received antiretrovi-
ral therapy at T1 compared to those who did not. CD4 
counts for T1 (and the year preceding it) were also 
compared according to receipt of ART. The hypothesis 
was that in this observational, non-randomised study 
of an outpatient population, participants not receiving 
ART would be those in earlier stages of illness who had 
not yet been prescribed it. Accordingly, people receiv-
ing ART at T1 would have a lower CD4 count (which 
is one of the criteria for beginning ART), and lower 
physical and mental health due to their more advanced 
disease. These hypotheses were tested using t-tests with 
a 5% significance level. The same analysis was repeated 
for TB treatment. It was hypothesised that participants 
with lower physical health would be more likely to be 
accompanied by a carer, but the same would not be true 
of mental health. To test this hypothesis, linear regres-
sion was used to separate the associations of carer pres-
ence with physical and mental summary scores at T0. 
4.1.3—Section B: Longitudinal Analysis
Longitudinal multilevel modelling is an approach 
which makes the most efficient use of data collected 
over time. Unlike most statistical tests, it includes all 
timepoints at once, which both reduces the number 
of tests to be carried out (making false positive results 
less likely) and allows change to be modelled as a 
continuous effect. This means that rather than simply 
finding variables which are associated with any change 
in outcome, the magnitude of the change can also be 
considered. 
A common problem in longitudinal studies of 
health outcomes is that patients with the worst health 
are the most likely to be lost to follow-up, so that a 
comparison between the beginning and end of the 
study could find improved outcomes only because a 
proportion of those with poor health would not con-
tribute to the later timepoint. Longitudinal analysis 
does not have this bias because all participants can be 
included whether they complete the study or not. Ad-
ditionally, longitudinal analysis can reveal patterns over 
time which would not be identified using traditional 
methods. 
For example, in this population a cross-sectional 
study at any time would have found that people with 
greater relative wealth had higher health scores. Lon-
gitudinal analysis showed that although this was true, 
wealth was not associated with change in outcomes 
over time. Rich and poor gained equally from the care 
they received, and the difference in health scores was 
due to poorer participants arriving at the facility with 
a lower level of health, not to any disparity in care. The 
technique adopted in this study was multilevel mixed-
effects linear regression, selected because it allowed 
data to be clustered at two levels, by individual and by 
facility. 
34. Were people with worse health at the beginning of the study more 
likely to drop out?
The question of whether people with lower health 
scores at the beginning of the study were more likely 
to be lost to follow-up was a very important one. Many 
longitudinal studies suffer from the bias caused by the 
most unwell individuals being most likely to leave the 
study. To determine whether this bias was present, 
t-tests were used to compare the mean physical and 
mental health scores of those who completed all four 
observations with those who missed at least one. Tradi-
tional analysis of longitudinal data involves comparing 
the earliest observation with the last, so any difference 
in the scores of completers versus non-completers 
would bias the findings.
In addition, the same tests were used to compare 
the mean scores of those who only completed a single 
observation with those who completed two or more. 
This was to test the suitability of multi-level modelling, 
which is explained below. Multi-level modelling uses 
all data points except the first one, so anyone who only 
completed one observation would be excluded and it 
was necessary to test whether this would also cause a 
bias. 
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Changes in Health Over Time
35. On average, does health improve, stay the same or get worse during 
three months of care?
36. On average, do multidimensional problems improve, stay the same or 
get worse?
37. Do the people with the worst physical and mental health at the 
beginning of the study get better, stay the same or get worse?
38. Do all six facilities find their patients’ physical and mental health 
changes by the same amount?
Mean, standard deviation and 95% confidence 
intervals of physical and mental health at each time-
point were calculated and graphed. The change in 
mean health score from T0 to T3 was calculated, with 
its standard deviation, and checked for clinical signifi-
cance. 
Comparing mental and physical health score 
change at different facilities was accomplished using 
graphs rather than multilevel modelling, because graphs 
were sufficient for the purpose and provided clarity on 
exactly how facilities varied. Change in outcomes over 
time was calculated separately for each participant at 
each timepoint. Mean change over time was reported 
as the mean of all individual score changes, rather 
than mean health score at one time point subtracted 
from mean health score at another. For example, mean 
change in mental health score from T0 to T2 was 
derived by finding the change in health score for each 
person who had completed both T0 and T2, and then 
taking the average of these, rather than by subtracting 
mean mental health at T0 from mean mental health at 
T2. This method removes the risk of bias due to non-
response. 
To test whether physical and mental health sum-
mary scores changed significantly over time throughout 
the course of the study, a multilevel modelling method 
was adopted (29). The methods are detailed in Ap-
pendix I. This analysis was repeated with the 20% of 
participants (n=128) who had the lowest physical health 
score at T0, and with the 20% who had the lowest men-
tal health score at T0, to determine whether the effect 
of improved outcomes over time extended to those in 
greatest need. For the APCA African POS, score dis-
tribution at each timepoint was tabulated for those who 
scored 0 (worst possible problem) on the items relating 
to pain and symptoms. This simple approach was ad-
opted because very few people scored 0 on these items 
and mean scores could have been biased by a single 
outlier. The items for pain and symptoms were selected 
because people with complex, intractable problems in 
advanced disease may not experience improvement 
although average scores for the population increase.
Changes in Health Over Time in Detail
39. Do men and women experience the same improvements in physical 
and mental health?
40. Do people of different ages or with different education or wealth levels 
show different changes in physical and mental health during the study?
41. Do people taking ART or having TB treatment experience the same 
change in physical and mental health as people not receiving such 
treatment?
42. Does being at a facility which offers certain kinds of care have an effect 
on whether physical and mental health improves?
Differences Between Individuals
To identify whether demographic variables were associ-
ated with different changes in physical or mental health 
over time, the multi-level models developed earlier were 
now rerun with the addition of each demographic vari-
able (age, gender, education level and wealth quintile), 
one by one. The models were run exactly as before, 
except that each contained one demographic covariate. 
This process of univariate analysis was adopted because 
it is more careful and the methods were new, to remove 
the risk of finding unwarranted associations. Education 
level and wealth quintile were treated as continuous 
variables for this analysis, because each of them had 
enough categories of sufficient size to approximate to a 
continuous distribution. 
ART and TB treatment were considered particu-
larly important variables to model over time, for several 
reasons. Both of them must be maintained over time 
(for TB treatment, usually for six months; for ART, 
usually indefinitely), both of them are lifesaving treat-
ments which are associated with side effects, possible 
drug resistance, and the need for monitoring. Multi-
level models were developed to show the association 
of physical and mental health with ART and with TB 
treatment over time. 
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These covariates, unlike any others studied so far, 
varied over time. Time-invariant characteristics such as 
age and relative wealth were only measured once and 
remain constant for each individual. Care availability, 
discussed below, is constant by facility. By contrast, 
receipt of ART or TB treatment was elicited at ev-
ery timepoint and so each of the (maximum of three) 
observations an individual contributes to the model has 
its own value. 
It was necessary to include CD4 count at T1 in the 
model as well, because previous analysis had shown that 
CD4 count was lower in people receiving ART or TB 
treatment at T1, and it was possible that any effect on 
health scores could be confounded by lower CD4 count 
and its consequences.
The intention had been to analyse CTX using the 
same techniques, but this was not carried out because 
CTX provision reached almost 100%, meaning that 
those few individuals who for some reason did not re-
ceive it could have been different from the rest in ways 
which would bias the findings. 
Differences Between Facilities
Examining the relationship between health outcomes 
and care received was complicated by the potential bias 
that those in the worst health would probably receive 
the most care, whereas a lack of care could mean either 
no need of it, or lack of appropriate provision. To avoid 
this problem, a variable representing available care 
needed to be developed, which might have a closer 
association with health outcomes than the level of care 
individually received. Availability of care was defined as 
the percentage of individuals at a facility who received 
care in a particular theme. Care themes were used rath-
er than individual components in order to reduce the 
number of variables needed in the model and ensure 
stability. For example, the variable “psychological care,” 
contains information on the percentage of people, per 
facility, who received at least one component of psycho-
logical care at T1, T2 or T3. T0 was excluded because 
the model analysed change from T0 onwards.
Each of the eight remaining care themes (coun-
selling/advice, nursing care, spiritual care, prevention, 
nutrition, social care, pain management and symptom 
management) was included one by one in a univariate 
multi-level model to identify which ones were as-
sociated with mental or physical health over time. As 
before, multilevel mixed-effects linear regression was 
used with repeated measures at the individual level and 
individuals clustered within facilities. The outcomes 
were mental health score and physical health score. 
Additional covariates included the baseline value of the 
other outcome variables (i.e., if mental health score was 
the outcome of the model, both T0 mental health score 
and T0 physical health score would be individual-level 
covariates) and any demographic covariates which had 
been identified as associated with the outcome. Both 
T0 outcome scores were included because a separate 
piece of analysis (Appendix I) showed that the two 
scores were closely associated and that in some cases an 
apparent association with mental health score was in 
fact entirely confounded by physical health score. 
All variables had fixed coefficients, with the excep-
tion of interview number which was allowed to vary at 
the individual level. All individual-level and facility-
level covariates which were associated with outcome at 
the 10% level in univariate analysis were taken forward 
into a multivariate model and eliminated in a down-
ward stepwise procedure if the association was lost. It is 
usual to use 10% as the acceptance level with stepwise 
downward regression to avoid dismissing variables too 
early. 
4.2—Qualitative Interviews
The interview transcripts were imported from Word 
into NVivo 7 for coding and analysis. Information on 
interviewees’ age, gender, household location, family 
size, profession (for staff ), whether they were receiv-
ing ART (for patients) and relationship to patient (for 
carers) was extracted into an Excel table, subsequently 
imported into NVivo. Identifying information such as 
names of individuals or care facilities was removed from 
transcripts. Thematic analysis of content was conducted 
concurrently on the patient, carer and staff interviews to 
enable multiple perspectives on each coded theme. 
43. How do facilities provide HIV care and what is the nature of the care 
they provide?
44. What is the experience of patients receiving care and their families?
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4.2.1—Development of Coding Frame
Two coding frames were developed and subsequently 
combined into a single version used for the remainder 
of the coding. One coding frame was developed in 
Uganda by the team of APCA researchers at APCA 
who had conducted the interviews. The other coding 
frame was developed at KCL in London. The intention 
was to explore cross-cultural differences and similarities 
in coding. 
In both three-person teams, each researcher coded 
eight randomly selected interviews (three with a 
patient, three with a member of staff and two with a 
carer), creating hierarchical codes. The team members 
agreed on a coding frame by discussion, comparison 
and consensus. At a meeting in Kampala, the two cod-
ing frames were compared and found to be similar in 
many respects. A unified coding frame was developed, 
combining the strengths of both country-level frames. 
Each code was reviewed for internal consistency and 
given an agreed definition to ensure it was applied us-
ing a standard meaning by each researcher. The Uganda 
researchers were trained in the use of NVivo 7 and in 
application of the new coding frame, which was applied 
to the entire dataset.
Each of the APCA researchers coded three inter-
views which were checked for consistency at KCL. The 
APCA researchers then proceeded to code all remain-
ing interviews. 
4.3—Costing Study
45. What is the cost of supplying the HIV care received by study 
participants?
46. What are the main cost drivers of HIV care and support?
47. Are there economies of scale in HIV care and support delivery?
The costing study also allows us to understand what 
factors influence costs per patient per year. For example 
we might expect the capital costs of rural facilities to be 
less than those in urban settings. Similarly if a facility 
tends to use relatively inexpensive providers it may be 
less expensive in providing the same service as a facility 
that has lots of trained physicians. Facilities that do 
not provide ARVs or do not provide testing may also 
have lower costs per patient. We might also expect to 
observe economies of scale with larger facilities (judged 
by numbers of patients) registering lower per patient 
costs than smaller ones.
Another possible use of costing data is to guide 
resource allocation. If two programs have similar out-
comes but different costs it may be possible to reallo-
cate program resources to the lower cost program with 
no loss in health benefits or the less efficient program 
might change the way it allocates resources so as to 
emulate the more efficient program. This cost-effective-
ness analysis, however, was not part of the present study.
Analysis was carried out using an Excel spread-
sheet. Most data were collected in local currency 
(Ugandan shillings), and converted to US dollars at 
the current exchange rates. Since only six facilities per 
country were included and these facilities were not 
meant to be statistically representative, all results are 
reported per facility without aggregation across the 
sample. The average costs per patient for one year of 
care and support were calculated using aggregated aver-
age costs per patient for each of the main components 
of care for a year. Scatter plots of per-staff member 
patient load against staff costs, and of per-patient costs 
against number of patients, were used to investigate 
economies of scale.
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5.1—Facility Characteristics
The facilities taking part in Phase 2 of this PHE also 
took part in Phase 1 (the facility survey). Phase 1 data 
collection took place between April and August 2007. 
Some of the key results from Phase 1 are presented 
here to provide context with respect to the nature and 
scope of HIV care and support provision at the Phase 
2 facilities. In Uganda, two of the six largest Phase 
1 facilities were located very close to each other and 
provided complementary services. To remove the risk of 
recruiting the same people twice, one of these facilities 
was replaced with the next largest which met the inclu-
sion criteria. 
Table 1 presents some information from Phase 1 of 
the evaluation to describe the six facilities. Three of the 
facilities were located in Kampala and three in other 
areas of Uganda. Two were branches of large national 
non-governmental organisations (NGOs) which had 
been developed in Uganda by and for people with 
HIV. The usual model of publicly-funded HIV care in 
Uganda is for patients to be referred to an ISS (Immu-
no-Suppression Syndrome) clinic in the grounds of a 
hospital or health centre. The ISS clinic is usually for 
outpatients. Those patients who need inpatient care are 
admitted to the main hospital. This model was followed 
by four of the facilities. The two NGOs lacked inpatient 
facilities, and referred to hospitals where necessary. 
Table 2 shows facilities’ self-reports of the care 
components they provided, either directly or by referral. 
“Yes” has been abbreviated to “Y,” and “referred” to “ref,” 
to make the table more readable with limited space. The 
majority of clinical and symptom management com-
ponents were reported by all facilities, whereas spiritual 
and social care components were often not reported 
present, particularly at Facilities 258, 259, and 260.
Table 3 shows the number of staff of several key 
professions working at each facility as reported in Phase 
1. Fulltime, part-time and volunteer staff were reported 
separately. Facility 259 had considerably more nurses 
and laboratory staff than any of the others.
5.2—Participant and Interview Nnumbers
Six hundred forty-one patients were recruited and 47 
people refused to take part in the study. One participant 
gave consent to take part in the study and then decided 
to drop out. All data relating to this participant were 
deleted. Six hundred fourteen participants completed 
more than one interview. The median number of days 
between each pair of interviews was 30 (Inter-quartile 
range 28–32). The shortest time between two interviews 
for a participant was 13 days and the longest was 203 
days. The shortest time to complete all four timepoints 
was 55 days. Table 4 shows that five of the facilities had 
a mean time between interviews which approximated 
5 Results of Longitudinal Quantitative 
Study Section A
Table 1: Characteristics of Facilities
Facility Type Location Patients in 2007 New Patients in 2007
252 HIV clinic in mission hospital Rural 2075 79
255 HIV NGO Urban 4772 401
256 HIV NGO Kampala missing missing
258 HIV clinic/research centre in public hospital Kampala 9698 828
259 HIV clinic/research centre in public hospital Kampala 7062 5774
260 HIV clinic in public hospital Urban 5602 683
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Table 2: Facility Self-Reported Care Provision from Phase 1 Survey
Type Component of Care Service Provided
Facility 252 255 256 258 259 260
General clinical Nursing care Y Y Y Y Y Y
ARVs Y Y ref Y Y Y
Weighing Y Y Y Y Y Y
Assess ARV treatment failure Y Y ref Y Y Y
Monitor ARV toxicity Y Y ref Y Y Y
Wound care Y Y Y Y Y ref
Physiotherapy Y ref No No Y ref
Pain management Assessment of pain Y Y Y Y No Y
Strong opioids ref Y No No Y Y
Weak opioids Y Y Y Y Y Y
Non-opioids Y Y Y Y Y Y
Treatment for neuropathic pain ref Y Y Y Y Y
Symptoms Anxiety/depression treatment Y Y Y Y Y ref
Treatment for nausea/vomiting Y Y Y Y Y Y
Treatment for skin rash/itching Y Y Y Y Y Y
Treatment for diarrhoea Y Y Y Y Y Y
Laxatives Y Y Y Y Y Y
Treatment for thrush Y Y Y Y Y Y
Treatment for oral candidiasis Y Y Y Y Y Y
Treatment for cryptococcus Y Y Y Y Y Y
Treatment for other fungal infections Y Y Y Y Y Y
Treatment for herpes Y Y Y Y Y Y
Treatment for malaria Y Y Y Y Y Y
TB detection Y Y Y Y Y Y
TB treatment Y Y Y Y Y Y
Therapeutic feeding for malnutrition Y ref Y No Y ref
Treatment for other opportunistic infections Y Y Y Y Y Y
Management of cancer ref ref ref ref Y ref
Psychological Pre- and post-test counselling Y Y Y Y Y Y
Adherence counselling Y Y Y Y Y Y
Family planning counselling Y Y Y Y Y ref
Patient HIV support groups Y Y Y Y Y Y
Family care-givers support group Y Y No No Y No
Family counselling Y Y Y Y Y Y
Psychiatric therapy No ref No Y ref ref
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Table 2: Facility Self-Reported Care Provision from Phase 1 Survey
Type Component of Care Service Provided
Facility 252 255 256 258 259 260
Spiritual Visit by religious leader Y ref Y ref No Y
Prayer with patients Y Y No No No no
Contact with traditional healer No No Y No No no
Social Home help Y No Y No No No
Transport to care centre Y Y Y No No No
Employment training Y Y Y Y No Y
Provide household items Y Y No No No No
Legal services No ref ref ref No No
Memory book work No Y Y No No No
Social con’t Family home help Y No No No No No
Loans/microfinance Y No No No No No
Infection control training Y Y Y No No Y
Prophylaxis/preventive care Support for family testing Y Y No Y Y Y
Prevention with positives Y Y Y Y Y Y
Multivitamins Y Y No Y Y Y
Nutritional advice Y Y Y Y Y Y
Access to safe drinking
 water at home
No Y Y Y No Y
CTX Y Y Y Y Y Y
Isoniazid Y No Yes No No Y
Condoms Y Y Y Y Y Y
ITNs No Y Y Y No Y
Laboratory Malaria film Y Y ref Y Y Y
AFB smear Y Y Y Y Y Y
CD4 count/test Y ref Y Y Y Y
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 Figure 1: Flowchart of Study Participation
Table 3: Staff Working at Each Facility (FT=full-time; PT=part-time; Vol=volunteer)
Facility 252 255 256 258 259 260
Staff type FT PT Vol FT PT Vol FT PT Vol FT PT Vol FT PT Vol FT PT Vol
Doctor 2 2 0 2 0 0 1 1 0 11 14 0 8 2 0 6 0 0
Clinical officer 2 0 0 4 2 0 1 0 0 1 0 0 0 0 0 1 0 0
Nurse 2 0 0 6 1 0 3 0 0 6 16 0 32 0 0 5 0 1
Lab staff 2 0 0 2 2 0 6 0 0 4 0 0 32 0 0 4 1 0
CHW 3 0 0 7 0 1 0 9 0 0 0 0 3 0 0 1 0 1
Social worker 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0
Spiritual leader 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 5
Nutritionist 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0
Counsellor 3 0 0 12 1 2 3 0 0 9 3 0 5 0 0 4 0 3
t0
N=696
Died 3
Left facility 1
Unable 3
Unknown 14
t2
N=613
88.1%
t3
N=592
85.1%
Died 5
Left facility 24
Unknown 33
t1
N=634
91.1%
Died 1
Left facility 5
Unknown 15
Table 4: Participant Numbers and Interview Details
Facility 252 255 256 258 259 260 Total
N recruited, baseline 
(T0)
107 105 112 107 102 107 641
N completing two 
timepoints
106 104 103 100 100 102 614
N completing three 
timepoints
103 103 85 95 100 97 583
N completing four 
timepoints
102 97 65 91 100 83 538
N dropouts 5 8 47 16 2 24 103
Mean time between 
interviews (days)
30.8 30.9 44.2 28.7 28.7 31.4 32.6
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one month, as expected, but Facility 256 had a consid-
erably longer time between interviews. 
Five hundred thirty-eight participants completed 
all four interviews, giving a loss to follow-up of 16.1%. 
The reasons for non-completion are displayed in Figure 
1. The proportion lost to follow-up varied greatly by 
facility (Table 4). The highest level of loss to follow-up 
was at Facility 256. 
5.3—Participant Characteristics
5.3.1—Demography
On average 31.9% of participants were men (n=204), 
ranging from 21.5% to 39.3% by facility. Participant 
mean age was 35 years (sd 9 years, range 18–70) and 
the median number of dependants for participants 
was 4 (range 0–20). Women were on average slightly 
younger than men with a mean of 34.2 years compared 
to 36.7 (t=3.22, p<0.01). Participant age is displayed in 
Figure 2.
Figure 3 shows the age of participants in five-year 
categories (scale on the left-hand side of the chart) and 
the average number of dependants for each age catego-
ry (scale on the right). Due to the age distribution of 
the group, represented in Figure 2, the older age groups 
contained very few participants. The trend was for 
increasing number of dependants with advancing age, 
for both men and women. Participants travelled for a 
median of one hour (IQR 40 minutes to 2 hours, range 
from 1 minute to 30 hours) to attend the facility. 
Nearly half of participants attended school until 
primary level. Participants most commonly lived in 
homes with cement or concrete floors and a corrugated 
roof (Table 5). Most people had a safe water supply, 
burned firewood or charcoal for fuel, and owned a radio 
and mobile phone. The majority had a private latrine, 
often of traditional type (covered or uncovered).
5.3.2—HIV Diagnosis and Reason for Attending 
the Clinic
At the first interview, participants gave their reason for 
coming to the facility that day (Table 6). Participants 
who reported the date of their HIV positive diagnosis 
within the 14 days prior to beginning the study were 
coded as coming because of a new HIV test result. Staff 
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Figure 2: Age of Participants
Figure 3: Age, Gender, and Number of Dependants
Table 6: Reason for Attending Dacility (One Missing)
Reason N %
HIV test result in last 14 days 196 30.6
HIV test result more than 14 days ago 55 8.6
Referred 42 6.6
Obtain medication, lab test or test result 119 18.6
New illness or new presenting problem 223 34.8
Other 5 0.8
Total 640 100.0
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reported that after a diagnosis was made, the first ap-
pointment slot available might be some weeks ahead. 
Fifty-five participants recorded that they attended 
because of a new test result which had taken place more 
than 14 days ago. Table 6 shows that participants were 
most commonly attending the clinic for an HIV test 
result. In a minority of cases the health care worker 
recorded the condition. Some examples were new infec-
tions (malaria, herpes zoster), pain (chest pain, body 
itching, back pain), symptoms (blisters, diarrhoea, skin 
rash, swollen legs) and other conditions (stroke paralysis, 
sight problems, dementia and psychological problems).
At the time the study started the median time since 
having been diagnosed as HIV positive for a participant 
was 196 days, or about six and a half months, for the 
Table 5: Population Demographic Characteristics
Population Characteristic N % Population Characteristic N %
Highest Level of Schooling Attended Source of Drinking Water
None 67 10.5 Pipe-borne inside/bottle 113 17.7
Began Primary 314 49.1 Pipe-borne outside 217 33.9
Began secondary 200 31.3 Other safe 234 36.6
Diploma + 59 9.2 Other unsafe 76 11.9
Wall Material Type of Toilet
Thatch/mud and poles 216 33.8 Private flush 37 5.8
Mud/unburnt bricks 75 11.7 Private VIP latrine 91 14.2
Burnt bricks with mud 142 22.2 Traditional covered pit latrine 167 26.1
Metal sheet/cement block 57 8.9 Traditional uncovered pit latrine 176 27.5
Stone/wood/burnt bricks 150 23.4 Public/shared/outside 169 26.4
Floor Material Roof Material
Earth 273 42.7 Natural 114 17.9
Cement/concrete 337 52.7 Corrugated iron 511 79.8
Other finished 30 4.7 Finished 15 3.3
Personal Property Fuel Source
Own Car 59 9.2 Electricity/gas 8 1.3
Own Bicycle 180 28.1 Paraffin/coal 20 3.1
Own Fridge 113 17.7 Charcoal 315 49.2
Own TV 177 27.7 Firewood/straw/grass 291 45.5
Own Mobile Phone 422 65.9
Own Radio 497 77.7
606 participants with a diagnosis date. The median time 
from registration at the facility to beginning the study 
was seven days.
5.3.3—Relative Wealth
The information presented above on home construc-
tion, fuel, water and sanitation use, ownership of goods 
and education was used in a principal components 
analysis to generate a factor which was then split into 
equal wealth quintiles. Table 7 presents the percentage 
of participants reporting assets by quintile. Details of 
how each component loaded onto the factor are pre-
sented in Appendix I.
As an example, 10.1% of people in the poorest 20% 
of the sample had a mobile phone in the household, 
Phase 2 uganda 26
results of longitudinal Quantitative study section a 26
59.8% of people in the next-lowest quintile owned a 
mobile phone in the household, and everyone in the 
wealthiest quintile lived in a household where someone 
owned a mobile phone.
5.3.4—Illness Severity
ECOG (physical function): The ECOG (Eastern Coop-
erative Oncology Group) is a measure of physical func-
tion, from fully active at 0 to dead at 5 (6). In this study, 
the relevant range was from 0 to 4 (completely disabled, 
cannot carry on any self-care). Patient physical function 
at baseline according to the ECOG is shown in Table 
8. Just over half of participants in the study were fully 
active, and most of the remainder were restricted from 
physically strenuous activity but able to carry out light 
work.
During the study, the number responding “fully ac-
tive” increased slightly over time, and all other responses 
became less common, but the change was minimal and 
without statistical significance.
WHO staging: Almost all participants at two facili-
ties reported knowing their WHO stage, at two facili-
ties almost no participants knew their stage, and at two 
facilities about half of participants knew their stage 
(Table 9). The stages were not reported for the two 
facilities with few participants recording their WHO 
stage, as the percentages would be more misleading 
than useful. The totals in the bottom row include data 
from all six facilities. WHO stage was not used in 
further analysis, due to the frequency of missing values 
and the potential bias caused by the association of 
WHO staging and facility. 
Table 9 shows that Facility 252 had the highest 
proportion of participants at stage 4, indicating a diag-
Table 8: Physical Function at T0
ECOG stage N %
0= fully active 321 50.2
1=restricted 232 36.3
2=ambulatory 67 10.5
3=limited self care 19 3.0
4=completely disabled 1 0.2
Total 640 100.0
Table 7: Percent of Participants in Each Quintile Reporting 
the Assets Surveyed
Asset
Wealth Quintile (1=poorest; 5=richest)
1 2 3 4 5
Floor Material
Earth 100.0 80.3 31.3 1.5 0
Cement 0 18.9 64.8 92.5 86.9
Finished 0 0.8 3.9 6.0 13.1
Wall Materials
Thatch/mud & poles 67.3 68.5 25.8 7.5 0
Bricks – mud or unburnt 33.3 13.6 34.4 41.8 36.1
Metal sheet/cement block 0 0.8 4.7 16.4 22.9
Stone/wood/burnt bricks 0 7.1 35.2 34.3 41.0
Roof Material
Natural 76.0 8.7 3.9 0 0
Corrugated iron 24.0 91.3 93.8 96.3 94.3
Finished 0 0 2.3 3.7 5.7
Type of Toilet
Public/shared/outside 19.4 16.5 28.1 41.8 25.4
Latrine 80.6 83.4 71.1 56.0 47.5
Private flush 0 0 0.8 2.2 27.0
Source of Drinking Water
Bottle/piped inside 0.8 3.1 14.8 24.6 45.9
Piped outside 5.4 7.1 39.1 65.7 51.6
Other, safe 81.4 57.5 32.8 9.0 1.6
Other, unsafe 12.4 32.3 13.3 0.7 0.8
Source of Cooking Fuel
Electricity/gas 0 0 0.8 3.0 7.4
Paraffin/coal 3.1 0.8 1.6 7.4 2.5
Charcoal 0 12.6 59.4 85.1 89.3
Firewood/straw/grass 96.9 86.6 38.3 4.5 0.8
Personal Property
Car 2,3 5.5 7.0 4.4 27.9
Bicycle 30.2 41.7 28.9 19.4 20.5
Refrigerator 0 3.1 6.3 14.9 66.4
Television 0 3.9 18.8 25.4 93.4
Mobile phone 10.1 59.8 70.3 90.3 100.0
Radio 46.5 88.2 75.8 81.3 97.5
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Table 9: WHO Stage by Facility
Facility
Participants at T1 with 
Recorded WHO Stage
WHO stage N (%) participants at T1
1 2 3 4
N % N % N % N % N %
252 84 79.3 0 0 3 3.6 51 60.7 30 35.7
255 1 1 – – – – – – – –
256 4 3.9 – – – – – – – –
258 55 55 0 0 38 69.1 13 23.6 4 7.3
259 99 99 25 25.3 46 46.5 18 18.2 10 10.1
260 93 91.2 11 11.8 54 58.1 54 58.1 3 3.2
Total 336 54.6 39 11.6 113 33.6 137 40.8 47 14
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CD4 counts: Of the 614 participants, 194 had no 
CD4 count on file within the accepted time period 
(i.e., between one year prior to T1 and three months 
after T3), 225 had a measure only at T1, 62 only from 
T3, and 160 had both. CD4 counts ranged from 1 to 
1569 with a mean of 331 and median of 297. The most 
representative sample is the set of CD4 counts from 
T1 presented in Table 10, drawn from 385 participants 
(63% of participants).
In a paired t-test for the 160 individuals who had 
CD4 counts at both the start and end of the study, 
there was a significant difference between the two sets 
of results, with CD4 count higher at T3 (t= -2.54, 
p=0.01). It is noticeable in Table 10 that the mean CD4 
count at T1 of those who had a second count taken at 
T3 was lower than the overall mean, although this dif-
ference was not statistically significant (p=0.2). 
Figure 4 shows the distribution of all CD4 counts 
at the two timepoints. It should be remembered that 
the T1 counts do not necessarily date from the time 
T1. Some were collected up to a year previously. Figure 
4, together with the low median, shows that the distri-
bution was positively skewed. More people had a low 
CD4 count than is reflected by the mean alone. 
Change in CD4 count is shown in Figure 5 for the 
160 individuals with two counts. Mean CD4 counts 
increased slightly between T0 and T3, but this change 
was not statistically significant (Table 10). 
Figure 4: CD4 Counts at T1 and T3
Table 10: CD4 Count Statistics
Group N Median Mean SD 95% CI
All CD4 T1 counts
384 297 331 235
308–
355
All CD4 T3 counts
222 301 357 225
328–
387
CD4 T1 for those 
with two counts
160 268 314 240
277–
352
CD4 T3 for those 
with two counts
160 299 348 218
314–
383
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Figure 5: Change Between T1 CD4 Count and T3 CD4 CountValidation of CD4 counts: A lowered CD4 count is 
associated with disease progression and loss of physi-
cal function. The T1 CD4 counts were compared by 
ECOG score to establish whether this expected asso-
ciation was confirmed in the study sample, and validate 
the use of CD4 in later analysis. As shown in Table 
11, there was a clear trend with higher ECOG being 
associated with lower CD4 count, but the confidence 
intervals overlapped for most ranges. A t-test was used 
to compare the distributions for those scoring 0 and 
1 on the ECOG scale, and found a highly significant 
association between ECOG and CD4 count (t=4.98, 
p<0.001). Other ECOG values were not used in a test 
due to low numbers. 
CD4 count was grouped into four categories used 
in clinical decision making and definitions of AIDS 
(Table 12), showing that in total 32% of participants 
recorded their most recent CD4 count was below the 
AIDS threshold of 200 at recruitment.
5.4—Care Participants Received
5.4.1—All Care Components
At each interview participants were asked which 
components of care from a list they had received in the 
previous month, from the facility or elsewhere. Out 
of the 52 components of care examined, a mean of 
12.8 (sd=6.6) was received by a participant during one 
month of the study (Table 13). The highest number of 
components reported at any one time point was 38 at 
T0, and the lowest was 0.
The maximum number of care components ever 
received by an individual was 34 and the minimum was 
zero, with a mean of 18.1 and median of 18. As shown 
in Figure 6, the distribution was approximately paramet-
ric. Table 14 shows that the most commonly received 
components of care (at any time) were CTX (97%), 
adherence counselling (93%), prevention with positives 
(PWP) (91%) and nutritional advice (89%). These are all 
part of the PEPFAR Care & Support programme. The 
most rarely provided items were strong opioids (5%), 
psychiatric therapy, (3%), cancer management (2%) and 
treatment for cryptococcal meningitis (1%).
For most symptoms, the percentage of participants 
receiving treatment was highest for T0 and dropped 
Table 12: CD4 Count Groupings at Baseline
CD4 Count 
Group
Description
N (%) with T1  
CD4 Count
<50 High risk of mortality 33 (8.6)
51–200 Severe immunosuppression 90 (23.4)
201–350 Immunosuppression 116 (30.2)
>350 145 (37.8)
Total 384 (100.0)
Table 13: Summary of Number of Care Components Received 
by Timepoint 
T0 T1 T2 T3 Total
Mean 12.5 13.0 12.6 13.0 12.8
SD 8.1 6.3 5.8 5.6 6.6
Maximum 38 35 35 30 38
N 640 615 583 538 2376
Table 11: T1 CD4 Count Statistics by ECOG Score
ECOG Score N Median Mean 95% CI
0—fully active 170 363 412 372.7–450.3
1—restricted 150 264 281 248.9–313.8
2—ambulatory 52 208 248 200.2–296.6
3—limited self care 12 174 177 102.2–251.0
4—completely disabled 0 – –
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Table 14: Percent of Participants Receiving a Component of Care During the Study
Component of Care T0 T1 T2 T3 Ever
n n=641 n=615 n=583 n=538 n=641
CTX 69.8 88.9 90.6 92.9 96.9
Adherence counselling 70.0 78.5 77.0 85.3 92.7
Prevention with positives 67.3 71.5 71.9 75.3 91.4
Nutritional advice 56.3 67.3 65.2 70.1 88.9
Non-opioid analgesics 56.7 54.5 49.4 43.7 82.8
Patient HIV support groups 38.8 45.7 55.6 63.4 73.3
ART/ARVs 41.4 49.6 55.1 57.3 61.3
Assess ART treatment 40.5 48.1 49.2 53.2 66.3
Family planning counselling 43.8 48.8 46.5 51.1 80.0
Multivitamins 39.2 48.9 46.3 50.6 75.8
Assessment of pain 38.0 50.9 44.8 40.5 76.0
Visit by religious leader 38.4 43.4 44.3 48.0 58.7
Other nursing care 42.5 39.4 43.7 46.1 61.3
Condoms 38.9 43.1 43.7 45.9 71.8
Treatment for other OIs 35.8 45.5 45.6 42.9 67.6
Treatment for malaria 39.1 30.9 29.0 31.0 57.9
Family counselling 30.0 31.4 32.4 36.1 63.0
Access to drinking water 32.5 33.7 34.7 27.7 62.2
Prayer with staff 22.7 27.8 30.9 36.3 57.6
ITNs 33.0 32.5 28.6 21.0 64.1
Wound care 24.5 26.5 29.3 30.3 46.6
Pre and post test counselling 59.2 33.5 11.8 4.5 68.2
Infection control training 25.0 29.3 24.4 29.4 49.3
Food 23.1 22.8 24.5 31.4 38.7
Treatment for skin rash/itching 20.5 24.9 22.3 21.8 46.3
Transport to care centre 4.8 10.4 31.4 34.9 39.6
TB testing 27.2 27.8 14.1 7.1 47.9
Treatment for genital thrush 20.6 18.1 10.8 8.2 32.4
Employment training/IGA 10.8 11.9 14.4 20.5 27.3
Treatment for fungal infections 16.4 10.9 8.2 5.6 25.7
Treatment for nausea/vomiting 13.9 9.6 8.6 8.0 26.1
Treatment for diarrhoea 15.2 9.3 5.3 6.9 26.7
Treatment for anxiety/depression 9.7 7.0 9.8 8.9 20.4
Treatment for oral thrush/candidiasis 14.8 9.9 5.5 4.8 23.2
Loans/microfinance 7.8 6.5 7.9 8.6 17.5
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Table 14: Percent of Participants Receiving a Component of Care During the Study
Component of Care T0 T1 T2 T3 Ever
n n=641 n=615 n=583 n=538 n=641
Treatment for neuropathic pain 6.1 8.6 6.4 6.3 17.8
Contact with traditional healer 12.3 5.7 4.1 5.0 17.8
TB treatment 8.3 6.5 5.8 6.5 13.6
Legal services 6.1 5.4 7.4 6.3 13.7
Isoniazid for TB prevention 8.0 6.2 3.4 2.0 12,6
Memory book work 5.3 4.1 4.3 5.4 12.5
Therapeutic feeding for malnutrition 8.6 5.5 2.1 1.9 13.4
Home help 3.6 3.6 2.9 4.7 9.2
Treatment for herpes 5.8 3.3 2.7 1.5 10.5
Household items 3.3 2.4 2.2 3.2 8.4
Treatment for constipation/laxatives 4.8 2.9 1.5 0.7 7.8
Weak opioids 4.4 2.8 1.5 1.3 8.4
Physiotherapy 3.4 1.6 1.5 1.3 6.6
Strong opioids 2.8 1.3 1.5 0.6 5.3
Cancer management 0.8 1.1 0.5 0.7 2.0
Psychiatric therapy 1.3 0.3 0.9 0.6 2.8
Treatment for cryptococcal meningitis 1.1 0.2 0.0 0.2 1.2
over time. For instance, 16% of participants received 
treatment for fungal infections at T0, 11% the fol-
lowing month and only 6% by T3. Receipt of CTX 
also increased steadily over time, reaching over 90% of 
participants after three months. 
5.4.2—Care Received from a Different Facility
Of the mean 12.8 components received in a month, a 
mean of 9.3 components was received by participants 
at the facility involved in the study (sd=6.3, maxi-
mum=31). The remainder were received elsewhere.
Table 15 shows that the proportion of participants 
who received care from somewhere other than the facil-
ity decreased over time for most components of care. 
People obtained similar care from other sources as they 
did from the facility, with some exceptions. Contact 
with a traditional healer was usually outside the facil-
ity, and tailed off rapidly after T0. Loans and microfi-
nance were usually received separately from the facil-
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Figure 6: Number of Care Components Ever Received by an 
Individual During the Study
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Table 15: Percent of People Receiving a Component of Care at the Facility and Elsewhere
Component of Care
T0
n=640
T1
n=615
T2
n=583
T3
n=538
fac else fac else fac else fac else
CTX 50.8 19.1 81.5 7.5 83.7 6.9 85.5 7.4
Adherence counselling 48.9 21.1 70.2 8.3 67.4 9.6 72.9 12.5
Prevention with positives 53.6 13.8 62.3 9.3 61.4 10.5 65.2 10.0
Nutritional advice 41.1 15.2 58.4 8.9 54.0 11.1 57.2 12.8
Non-opioid analgesics 27.0 29.7 38.4 16.1 35.7 13.7 31.6 12.1
Patient HIV support groups 21.9 16.9 31.7 14.0 38.3 17.3 44.1 19.3
ART/ARVs 35.2 6.3 46.2 3.4 51.3 3.8 53.2 4.1
Assess ART treatment 35.0 5.5 45.5 2.6 47.7 1.5 50.6 2.6
Family planning counselling 28.4 15.3 40.3 8.5 41.0 5.5 46.3 4.8
Multivitamins 30.5 8.8 43.1 5.9 38.8 7.5 42.0 8.6
Assessment of pain 26.3 11.7 42.1 8.8 35.3 9.4 31.0 9.5
Visit by religious leader 4.2 34.2 4.1 39.3 2.2 42.0 3.0 45.0
Other nursing care 25.2 17.3 28.9 10.4 30.9 12.9 33.5 12.6
Condoms 22.5 16.4 33.5 9.6 34.0 9.8 35.7 10.2
Treatment for other OIs 26.1 9.7 36.3 9.3 34.8 10.8 32.2 10.8
Treatment for malaria 19.2 19.8 18.2 12.7 15.1 13.9 15.1 16.0
Family counselling 17.3 12.7 22.1 9.3 22.0 10.5 22.3 13.8
Access to drinking water 17.2 15.3 22.1 11.5 22.6 12.0 16.9 10.8
Prayer with staff 9.7 13.0 13.7 14.1 14.6 16.3 19.3 16.9
ITNs 16.1 16.9 24.9 7.6 24.0 4.6 17.1 3.9
Wound care 16.4 8.1 21.6 4.9 26.1 3.3 26.2 4.1
Pre and post test counselling 38.1 21.1 29.6 3.9 9.6 2.2 3.0 1.5
Infection control training 15.0 10.0 26.0 3.3 23.2 1.2 28.8 0.6
Food 16.3 6.9 17.4 5.4 20.6 3.9 27.3 4.1
Treatment for skin rash/itching 11.3 9.2 19.2 5.7 19.2 3.1 18.0 3.7
Transport to care centre 0.3 4.5 8.8 1.6 30.4 1.0 34.9 0.0
TB testing 21.1 6.1 24.9 2.9 11.5 2.6 5.8 1.3
Treatment for genital thrush 10.3 10.3 13.8 4.2 8.9 1.9 6.3 1.9
Employment training/IGA 4.8 5.9 8.1 3.7 8.4 6.0 11.5 8.7
Treatment for fungal infections 9.4 7.0 7.6 3.3 5.7 2.6 3.7 1.9
Treatment for nausea/vomiting 7.0 6.9 5.5 4.1 4.6 3.9 5.2 2.8
Treatment for diarrhoea 8.6 6.6 6.2 3.1 3.9 1.4 4.1 2.8
Treatment for anxiety/depression 6.1 3.6 5.0 2.0 8.2 1.5 8.4 0.6
Treatment for oral thrush/candidiasis 8.0 6.9 8.5 1.5 4.1 1.4 3.7 1.1
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Table 15: Percent of People Receiving a Component of Care at the Facility and Elsewhere
Component of Care
T0
n=640
T1
n=615
T2
n=583
T3
n=538
fac else fac else fac else fac else
Loans/microfinance 1.7 6.1 1.1 5.4 1.2 6.7 0.7 7.8
Treatment for neuropathic pain 4.1 2.0 7.5 1.1 5.0 1.4 5.8 0.6
Contact with traditional healer 0.0 12.3 0.8 4.9 0.2 3.9 1.1 3.9
TB treatment 5.6 2.7 5.0 1.5 5.5 0.3 5.8 0.7
Legal services 2.0 4.1 3.1 2.3 5.7 1.7 4.8 1.5
Isoniazid for TB prevention 6.4 1.6 5.4 0.8 3.1 0.3 1.7 0.4
Memory book work 2.3 3.0 1.3 2.8 3.1 1.2 3.9 1.5
Therapeutic feeding for malnutrition 5.6 3.0 2.8 2.8 1.2 0.9 0.9 0.9
Home help 1.9 1.7 3.1 0.5 2.1 0.9 3.3 1.3
Treatment for herpes 3.3 2.5 3.3 0.0 2.2 0.5 1.5 0.0
Household items 1.4 1.9 2.3 0.2 2.1 0.2 3.2 0.0
Treatment for constipation/laxatives 1.4 3.4 2.0 1.0 1.2 0.3 0.4 0.4
Weak opioids 2.2 2.2 1.6 1.1 0.9 0.7 0.9 0.4
Physiotherapy 2.0 1.4 1.0 0.7 1.0 0.5 0.6 0.7
Strong opioids 0.8 2.0 0.5 0.8 0.3 1.2 0.4 0.2
Cancer management 0.5 0.3 0.8 0.3 0.2 0.3 0.2 0.6
Psychiatric therapy 0.5 0.8 0.0 0.3 0.5 0.3 0.6 0.0
Treatment for cryptococcal meningitis 0.5 0.6 0.2 0.0 0.0 0.0 0.0 0.2
ity, although legal services, after T0, were more often 
provided by the facility directly. Interventions such as 
improved access to safe drinking water were provided 
by another organisation as often as by the facility.
5.4.3—PEPFAR Care and Support Categories
The CSRI components were grouped according to the 
PEPFAR categories of clinical, spiritual, social, psy-
chological, and prevention (of new HIV infections) as 
listed in Appendix J. ART, with assessment of ART 
treatment, was kept as a separate care component. 
Table 16 shows that while almost all participants 
received clinical and preventive care during the four 
months of data collection, many did not receive psycho-
logical, spiritual or social care. Almost 70% of partici-
pants received ART at some point and over a third of 
participants received social care. 
Table 16: Percent of Participants Receiving Care
Area of Care
T0
n=641
T1
n=614
T2
n=583
T3
n=538
Ever 
n=641
Clinical 97.8 98.4 99.0 98.7 99.7
Psychological 34.1 36.1 38.9 42.9 67.7
Spiritual 52.5 56.9 60.4 65.4 77.9
Social 16.3 16.6 19.4 26.0 34.6
Prevention 82.7 88.1 90.7 91.3 97.5
ART 41.4 49.6 55.1 57.3 69.8
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Table 17: Percent of Newly-Diagnosed Participants Receiving a Component of Care
Component of Care T0 T1 T2 T3 Average Ever
CTX 37.8 80.1 88.0 87.3 71.4 93.4
Adherence counselling 52.0 67.4 66.9 77.5 65.0 87.2
Prevention with positives 51.5 59.4 64.5 66.9 59.9 82.7
Nutritional advice 37.8 49.7 54.2 62.7 50.1 83.2
Family planning counselling 35.2 48.6 55.4 59.9 48.8 78.6
Condoms 31.6 45.9 50.0 57.0 45.1 73.0
Pre and post test counselling 85.7 47.5 18.7 8.5 43.4 94.9
Non-opioids 46.4 41.1 36.1 35.9 40.4 76.0
Multivitamins 16.3 42.8 36.1 42.3 33.5 65.8
Other nursing care 29.1 23.2 36.1 43.7 32.3 51.5
Patient HIV support groups 13.3 26.5 37.2 54.7 31.0 53.6
ITNs 24.0 31.5 31.3 29.6 28.9 66.8
Assessment of pain 17.4 31.7 33.7 34.5 28.7 59.7
Visit by religious leader 21.9 24.9 27.7 38.0 27.5 38.8
TB testing 29.1 41.4 23.5 7.8 26.6 57.1
Wound care 15.8 21.6 30.7 36.6 25.3 42.3
Other OIs 15.8 26.0 31.9 26.1 24.5 53.6
Infection control training 19.4 23.2 23.5 32.4 24.1 43.4
Family counselling 11.7 16.6 30.1 39.4 23.2 48.5
ART/ARVs 11.7 21.7 30.1 30.3 22.7 40.3
Assess ART treatment 12.2 27.8 24.1 26.1 22.1 43.9
Treatment for malaria 26.5 18.2 21.1 19.7 21.6 46.9
Access to drinking water 13.8 23.2 27.1 21.8 21.2 52.6
Prayer with staff 5.6 13.7 25.3 31.7 17.8 39.8
Treatment for skin rash/itching 12.2 21.0 16.3 13.4 15.8 36.2
Transport to care centre 3.1 7.2 24.1 32.4 15.3 29.1
Treatment for genital thrush 16.3 19.3 10.2 9.2 14.2 26.0
IGA 7.1 6.6 9.6 21.8 10.7 20.9
Food 4.6 6.6 6.0 18.3 8.3 18.9
Contact with traditional healer 14.8 5.0 2.4 4.9 7.2 18.4
Treatment for oral thrush 9.2 8.8 2.4 6.3 6.9 16.8
Treatment for nausea/vomiting 7.7 6.1 4.2 8.5 6.6 15.8
Treatment for fungal infections 6.6 6.6 7.2 5.6 6.6 13.3
TB treatment 5.1 6.1 7.8 7.0 6.4 13.8
Isoniazid 5.6 8.8 6.0 4.9 6.4 17.3
Treatment for diarrhoea 7.7 5.5 1.2 5.6 5.1 13.3
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Table 17: Percent of Newly-Diagnosed Participants Receiving a Component of Care
Component of Care T0 T1 T2 T3 Average Ever
Treatment for neuropathic pain 1.5 6.1 4.2 6.3 4.4 11.7
Loans 3.1 2.8 6.0 5.6 4.2 11.2
Treatment for anxiety and depression 4.6 3.9 3.0 2.1 3.5 9.7
Legal services 3.1 1.1 2.4 7.8 3.4 10.2
Therapeutic feeding 5.1 5.0 0.6 0.7 3.1 7.7
Memory book work 4.1 5.0 1.8 0.7 3.1 7.1
Treatment for herpes 3.6 2.8 1.8 1.4 2.5 5.6
Treatment for constipation/laxatives 3.1 3.3 1.2 0.7 2.2 7.1
Weak opioids 1.0 2.8 3.0 1.4 2.1 6.6
Strong opioids 1.5 1.7 4.2 0.7 2.1 4.6
Physiotherapy 1.0 1.7 1.2 1.4 1.3 3.1
Household items 1.0 0.6 0.6 2.1 1.0 3.6
Psychiatric therapy 0.5 0.6 1.2 2.1 1.0 2.6
Cancer management 1.5 0.6 0.0 0.7 0.7 2.6
Home help 0.5 1.1 0.6 0.7 0.7 0.0
Treatment for cryptococcal meningitis 0.0 0.0 0.0 0.0 0.0 93.4
5.4.4—Care for People Newly Diagnosed with 
HIV
The people whose positive HIV test was dated less than 
two weeks before beginning the study were designated 
“newly diagnosed.” The list of most common compo-
nents received was similar for the newly diagnosed and 
the whole group (Table 17), with CTX, adherence coun-
selling, prevention with positives and nutritional advice 
ranking highest. All these components were provided 
less frequently on average to the newly diagnosed group.
Three months after diagnosis, 87% of newly diag-
nosed participants were receiving CTX and 55% were 
in a patient HIV support group. Food receipt trebled 
between T2 and T3. Over three quarters of newly 
diagnosed participants received non-opioid analgesics, 
considerably more than were assessed for pain. Figure 7 
shows that participants newly diagnosed with HIV re-
ceived on average fewer components of care than those 
who had been diagnosed previously, and that over time 
the mean number of care components converged. Previ-
ously existing patients received fewer care components 
over time while those newly diagnosed received more.
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Figure 7: Mean Number of Care Components Received Over 
Time for New and Existing Patients
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5.4.5—Basic Care Package
PEPFAR developed the concept of the Preventive Care 
Package (PCP), a number of specified care components 
which should be considered essential to prevent op-
portunistic infections, delay disease progression and 
prevent HIV transmission (30). In Uganda this concept 
was developed into the Basic Care Package (BCP), 
which consists of CTX prophylaxis, an ITN, water 
disinfection, family VCT information and condoms 
(31, 32).
Table 18 shows the elements of the Uganda BCP 
as they were delivered to participants diagnosed within 
two weeks of the beginning of the study and diagnosed 
earlier. The 34 participants had no diagnosis date were 
not included here. In this sample, of 196 people di-
agnosed with HIV at T0, just over half (103, 52.6%) 
received a safe water source such as a filter or treat-
ment tablets, 131 (66.8%) received an ITN and 143 
(73.0%) received condoms. CTX was the most widely 
received component of the five for both groups. A 
higher proportion of previously diagnosed than newly 
diagnosed participants received VCT information and 
water treatment during the course of the study. As with 
other results, it is important to remember that a par-
ticular component of care would not always have been 
required. 
5.5—Care Themes
The components of care were grouped into eight 
themes as described in the Methods section.
5.5.1—Spiritual Care
Seventy-seven percent of participants received at least 
one component of spiritual care during the study (Table 
19). Contact with a traditional healer most commonly 
occurred in the month leading up to T0. The two 
paradigms of health care were more likely to be applied 
sequentially than concurrently.
5.5.2—Counselling and Advice
The proportion of men and women who received family 
planning counselling was almost identical; seventy-nine 
percent compared to eighty percent. The use of HIV 
support groups increased over time while pre- and 
post-test counselling reduced (Table 20).
Table 18: Components of the PCP Ever Received by New and 
Existing Patients, at the Facility or from Anywhere
Newly  
Diagnosed n (%)
n=196
Previously  
Diagnosed n(%)
n=410
fac else fac else
Family VCT information 69 (35.2) 95 (48.5)
 218 
(53.2)
281 (68.5)
Safe water supply 84 (42.9) 103 (52.6) 176 (42.9) 268 (65.4)
ITN 103 (52.9) 131 (66.8) 170 (41.5) 252 (61.5)
Condoms 133 (67.9) 143 (73.0) 243 (59.3) 290 (70.7)
CTX 165 (84.2) 183 (93.4) 395 (96.3) 404 (98.5)
Two components 35 (17.9) 20 (10.4) 98 (23.9) 60 (14.6)
Three components 40 (20.4) 37 (18.9) 107 (26.1) 87 (21.2)
Four components 54 (27.6) 71 (36.2) 69 (16.8) 118 (28.8)
Five components 24 (12.2) 37 (18.9) 71 (17.3) 113 (27.6)
Table 19: Percent of Participants Receiving Spiritual Care 
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 614 583 538 641
Visit by religious leader 38.4 43.4 44.3 48.0 58.7
Prayer with staff 22.7 27.8 30.9 36.3 57.6
Contact with traditional healer 12.3 5.7 4.1 5.0 17.8
Table 20: Percent of Participants Receiving Counselling Care  
Components Over Time
Component of care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Adherence counselling 70.0 78.5 77.0 85.3 92.7
Patient HIV support groups 38.8 45.7 55.6 63.4 73.3
Family planning counselling 43.8 48.8 46.5 51.1 80.0
Family counselling 30.0 31.4 32.4 36.1 63.0
Pre and post test counselling 59.2 33.5 11.8 4.5 68.2
Psychiatric therapy 1.3 0.3 0.9 0.6 2.8
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5.5.3—Nursing
Almost half of the study participants required wound 
care during the course of the study (Table 21). Sixty-
nine percent of people who received wound care had 
infection control training during the study, compared to 
31% of people who did not have wound care. 
5.5.4—Pain Management
Non-opioid analgesics were a very common component 
of care, although receipt declined over time (Table 22). 
Of the 641 study participants, 34 ever received a strong 
opioid and 54 ever received a weak opioid. Twenty-
two people received both. Usually, those who received 
an opioid had it only in one month. Those who ever 
received non-opioi d analgesics received a mean of 23 
components of care during the study, as compared to 14 
for those who did not receive a non-opioid. The differ-
ence was highly significant (t= -12.2, p<0.001).
5.5.5—Symptom Management
All symptom treatment components were included in 
the care theme, whether they were rare or common, 
because of evidence from Phase 1 that all of them were 
available at most facilities. The most common symptom 
management at T0 was treatment for malaria which 
39% of participants had received (Table 23). At the 
other three timepoints the most common symptom 
management component was treatment for other op-
portunistic infections, remaining relatively constant 
between 46% and 43%. 
5.5.6—Nutrition
Table 24 shows that nutritional advice was a com-
mon component and receipt of this increased over 
time, while receipt of therapeutic feeding decreased. 
Seventy-three people (14% of those who completed 
all timepoints) received food every month, all of them 
from Facilities 252 and 255. Therapeutic feeding was 
normally received only once.
5.5.7—Social Care
Only one social component of care was received by 
more than 10% of participants at any time, which was 
employment training/income generation assistance 
(Table 25). Participants at Facilities 255 and 259 most 
Table 21: Percent of Participants Receiving Nursing Care 
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Other nursing care 42.5 39.4 43.7 46.1 61.3
Wound care 24.5 26.5 29.3 30.3 46.6
Table 22: Percent of Participants Receiving Pain  
Management Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Non-opioid analgesics 56.7 54.5 49.4 43.7 82.8
Assessment of pain 38.0 50.9 44.8 40.5 76.0
Treatment for neuropathic pain 6.1 8.6 6.4 6.3 17.8
Weak opioids 4.4 2.8 1.5 1.3 8.4
Strong opioids 2.8 1.3 1.5 0.6 5.3
Table 23: Percent of Participants Receiving Symptom  
Management Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Treatment for other OIs 35.8 45.5 45.6 42.9 67.6
Treatment for malaria 39.1 30.9 29.0 31.0 57.9
Treatment for skin rash/itching 20.5 24.9 22.3 21.8 46.3
Treatment for genital thrush 20.6 18.1 10.8 8.2 32.4
Treatment for fungal infections 16.4 10.9 8.2 5.6 25.7
Treatment for nausea/vomiting 13.9 9.6 8.6 8.0 26.1
Treatment for diarrhoea 15.2 9.3 5.3 6.9 26.7
Treatment for anxiety/depression 9.7 7.0 9.8 8.9 20.4
Treatment for oral thrush/candidiasis 14.8 9.9 5.5 4.8 23.2
Treatment for herpes 5.8 3.3 2.7 1.5 10.5
Treatment for constipation/laxatives 4.8 2.9 1.5 0.7 7.8
Treatment for cryptococcal meningitis 1.1 0.2 0.0 0.2 1.2
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commonly received IGA, which was received by 28% of 
women and 25% of men (p=0.36 on a chi squared test).
5.5.8—Prevention
Table 26 shows that 80% of men and 68% of women 
received condoms during the study (chi=10.7, p=0.001). 
Prevention with positives was one of the three most 
common components of care, received by 91% at some 
point, although its definition was not standardised. 
Some participants received an ITN more than once 
during the study. 
5.5.9—ART
The percentage of participants receiving ART increased 
from 41.4% at T0 to 57.3% at T3 (Table 27), which was 
matched by similar increases in receipt of ART treat-
ment assessment. 
Assessment of ARVs, including monitoring toxic-
ity, side effects and suspected resistance, was not always 
provided with the ARVs. Table 28 shows the percent-
age of months that support services were provided with 
ARVs, by facility and time. Facility 255 did not provide 
sufficient support services to over half its ARV-receiv-
ing participants. Only Facility 252 had almost 100% 
coverage.
5.5.10—CTX
The percentage of participants receiving CTX in-
creased from 69.8% at T0 to 96.8% at T3 (Table 29). 
The results in Table 30 show that a high proportion of 
Table 24: Percent of Participants Receiving Nutrition  
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Nutritional advice 56.3 67.3 65.2 70.1 88.9
Multivitamins 39.2 48.9 46.3 50.6 75.8
Access to drinking water 32.5 33.7 34.7 27.7 62.2
Food 23.1 22.8 24.5 31.4 38.7
Therapeutic feeding for malnutrition 8.6 5.5 2.1 1.9 13.4
Table 25: Percent of Participants Receiving Social Care  
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Employment training/IGA 10.8 11.9 14.4 20.5 27.3
Loans/microfinance 7.8 6.5 7.9 8.6 17.5
Legal services 6.1 5.4 7.4 6.3 13.7
Memory book work 5.3 4.1 4.3 5.4 12.5
Home help 3.6 3.6 2.9 4.7 9.2
Household items 3.3 2.4 2.2 3.2 8.4
Table 27: Percent of Participants Receiving ART Components 
Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
ARVs 41.4 49.6 55.1 57.3 61.3
Assess ART treatment 40.5 48.1 49.2 53.2 66.3
Table 26: Percent of Participants Receiving Prevention 
Components Over Time
Component of Care T0 T1 T2 T3 Ever
n 641 615 583 538 641
Prevention with positives 67.3 71.5 71.9 75.3 91.4
Condoms 38.9 43.1 43.7 45.9 71.8
ITNs 33.0 32.5 28.6 21.0 64.1
Infection control training 25.0 29.3 24.4 29.4 49.3
Isoniazid for TB prevention 8.0 6.2 3.4 2.0 12.6
Table 28: People Who Received ARVs to Receive Support and 
Monitoring, by Facility and Timepoint
Facility
T0 T1 T2 T3
n % n % n % n %
252 98 100.0 97 97.0 100 100.0 97 99.0
255 28 73.7 14 41.2 12 37.5 11 37.9
256 5 50.0 12 85.7 7 46.7 7 50.0
258 14 93.3 14 93.3 25 78.1 34 94.4
259 33 84.6 52 98.1 56 98.3 61 100.0
260 48 73.9 80 89.9 72 84.7 59 84.3
Total 226 85.3 269 88.2 272 84.7 269 87.3
Phase 2 uganda 38
results of longitudinal Quantitative study section a 38
Table 29: Percent of Participants Receiving CTX Over Time
T0
n=641
T1
n=615
T2
n=583
T3
n=538
Ever
n=641
69.8 88.9 90.6 92.9 96.9
Table 30: Adherence to CTX
T0 T1 T2 T3
Took CTX yesterday yes no yes No yes no yes no
Received daily CTX 399 48 521 26 513 15 494 6
Did not receive daily 
CTX
35 158 38 30 39 16 28 10
Table 31: Percent of Participants Receiving TB Treatment 
Over Time
T0
n=641
T1
n=615
T2
n=583
T3
n=538
Ever
n=641
8.3 6.5 5.8 6.5 13.6
Table 32: Percent of Participants Receiving Each Care Theme 
Over Time
Theme T0 T1 T2 T3 Ever
Counselling/advice 91.6 88.6 90.1 93.7 99.2
Prevention 80.4 84.4 82.8 84.6 97.4
CTX 69.8 88.9 90.6 92.9 96.9
Nutrition 64.8 78.0 77.2 78.3 93.9
Symptom management 66.7 72.5 70.5 64.9 91.0
Pain management 62.7 65.5 59.2 51.9 87.1
Spiritual 51.4 56.1 59.0 64.5 77.0
ART 46.6 54.0 57.6 60.4 69.8
Nursing 45.9 42.8 47.2 49.3 65.4
Social 10.8 11.9 14.4 20.4 27.3
TB  8.3  6.5  5.8  6.5 13.6
Figure 8: Proportion Receiving Each Care Theme Over Time
those who were provided with daily CTX prophylaxis 
had taken it on the previous day, and that adherence 
increased over the course of the study (89% at T0, 95% 
at T1, 97% at T2 and 99% at T3). 
5.5.11—TB Treatment
TB testing was dropped from analysis on the grounds 
that it was not a component of care in itself. The idea 
had been that all participants should receive TB screen-
ing. This does happen, but it emerged that screening 
consists of checking for signs of TB (including per-
sistent cough, night sweats and weight loss) and only 
people showing these symptoms are sent for a sputum 
test which was recorded as a TB test. TB treatment 
was received by less than 9% of participants at any time 
point (Table 31).
5.5.12—All Care Themes
Table 32 and Figure 8 show the proportion of individu-
als receiving any component of care within each theme, 
by timepoint and overall. Receipt of spiritual care, social 
care and ART increased steadily over time. Receipt 
of care in several other themes increased from T0 to 
T1 and then stabilised, including CTX, nutrition and 
prevention. Receipt of care in two themes, TB treat-
ment and symptom management, decreased over time. 
Receipt of nursing and counselling care decreased from 
T0 to T1 and then increased. 
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5.6—Health at the Beginning of the Study
5.6.1—Physical and Mental Health Scores
Figures 9 and 10 present baseline distributions of 
physical health and mental health summary scores, 
from 0=worst possible health to 100=best possible 
health. At baseline the mean physical health score was 
43.5 (sd 12.0) and the mean mental health score was 
44.2 (sd 9.5). Helath scores could not be calculated for 
one participants due to an unanswered question.
The physical and mental health summary scores 
are scaled from worst possible health at 0 to best pos-
sible health at 100. Both distributions (Figures 9 and 
10) were centred below 50 and there were no outliers 
towards the extreme values. Mental health scores ap-
peared to be more normally distributed whereas physi-
cal health possibly had a bimodal shape.
5.6.2—Multidimensional Care Scores
Each item in the APCA African POS is scored from 0 
to 5. The scores were reversed for some items, such that 
in all cases 0 represented the worst situation and 5 the 
best. This direction was used because it corresponds to 
the MOS-HIV, where a higher score corresponds to a 
better quality of life.
The item scores at baseline are displayed in Figures 
11–17 for the first seven items, addressed to the patient. 
In the figures, the phrases rather than numbers are dis-
played; in each case, the worst outcome, in the furthest 
left column, was coded 0, and codes increased by one 
until the best outcome on the far right, coded 5.
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Figure 9: Physical Health Score at Baseline
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Figure 10: Mental Health Score at Baseline
Figure 11: APCA African POS at T0: Please Rate Your Pain  
During the Last Three Days
Figure 12: APCA African POS at T0: Have Any Other Symptoms 
been Affecting How You Feel in the Last Three Days?
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Figure 13: APCA African POS at T0: Over the Past Three Days 
Have You Been Worried about Your Illness?
Figure 14: APCA African POS at T0: Over the Past Three Days 
Have You Been Able to Share How You Feel?
Figure 15: APCA African POS at T0: Over the Past Three Days 
Have You Felt that Life Was Worthwhile?
Figure 16: APCA African POS at T0: Over the Past Three Days 
Have You Felt at Peace?
Figure 17: APCA African POS at T0: In the Past Three Days Have 
You Had Enough Help and Advice for Your Family to Plan for 
the Future?
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Table 34: Demography of Participants by Facility
Facility Males Mean Median Time to Facility
N % Age SD Dependants IQR Median IQR
252 23 21.5 37.9 9.8 7 6–8 1hr30 40mins–2hr30
255 37 35.2 38.8 8.3 4 3–6 2hrs 1hr–3hrs
256 44 39.3 32.1 8.6 3 1–5 1hr 40mins–1hr30
258 41 38.3 33.7 8.2 4 2–6 1hr 30mins–2hrs
259 29 28.4 34.9 7.3 3 2–5 1hr 30mins–1hr30
260 30 28 33 9.5 3 2–6 1hr 30mins–2hrs
Total 204 31.9 35 9 4 2–7 1hr 40mins–2hrs
Figures 11–17 show that the biggest problems par-
ticipants reported at baseline were not having enough 
help and advice, not being able to share feelings, and 
not being at peace.
The scores of the seven patient APCA African POS 
items were added together to create an APCA African 
POS total score. The score has an approximately Normal 
distribution (Figure 18), with a mean of 19.8 (sd 4.9), 
and the range is 5–34 out of a possible total of 0–35.
5.6.3—Problems Facing Family Caregivers
The APCA African POS contains three items for 
informal carers accompanying the patient to answer. 
APCA African POS domains for carers were frequent-
ly not completed, as carers were usually not present at 
the patient’s clinical appointment. Of the number of 
participants completing each timepoint, a mean of 158 
Table 33: Median (IQR) APCA African POS Carer Item  
Responses
Item T0 T1 T2 T3
n 158 108 104 91
How much information have you and 
your family been given?
3 
(2–4)
3 
(2–4)
4 
(3–4)
3 
(3–5)
How confident does the family feel 
caring for the patient?
4 
(3–5)
4 
(3–5)
4 
(3–5)
5 
(4–5)
Has the family been feeling worried 
about the patient over the last 3 days? 
3 
(2–5)
3 
(1–4)
4 
(2–5)
4 
(3–5)
(25%) carers completed all three APCA African POS 
carer questions at baseline, 107 (17%) at T1, 104 (18%) 
at T2 and 89 (17%) at T3. Owing to the small propor-
tion of completed carer questions, responses to these 
items are described here but were not included in the 
APCA African POS factor calculations.
In Table 33 , the item scales were adjusted as neces-
sary so that in all cases, 0 represents the worst pos-
sible problem and 5 no problem. The number of carers 
completing each question is slightly different from the 
numbers reported above who completed all three carer 
questions, as some carers completed fewer than three 
questions. Carers most commonly reported the central 
responses to each question, and there was little change 
in responses over time.
5.7—How Participants Differ by Facility
5.7.1—Participant Characteristics at Different 
Facilities
The facilities included in the study were from different 
parts of the country. The characteristics of the facilities 
themselves have been studied in detail in Phase 1 and 
summarised in section E1. In addition, the variety of 
locations of the facilities is likely to mean the character-
istics of the participants attending varied also. These are 
presented in Table 34.
Facilities 255, 256, and 258 had a higher propor-
tion of men than the other three facilities, and people at 
Facility 252 had more dependants than participants at 
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other facilities. Table 35 shows that on average partici-
pants at Facility 252 had a lower level of education. The 
facility with the highest proportion of participants at 
secondary school or above was Facility 256.
The greatest different between facilities was in the 
relative wealth of participants (Table 36). Over three 
quarters of participants at Facility 252 were in the poor-
est overall quintile, making up 64% (82 of 129) of the 
people in that quintile. The majority of Facility 255 par-
ticipants were in the second quintile. Facilities 256, 258, 
and 259, each had less than 3% of their participants in 
the poorest quintiles and over 30% in the richest.
Figure 19 shows that the poorest quintile was 
almost all cared for at Facility 252, and Facility 255 
cared for most of the participants in the second poorest 
quintile. The wealthiest quintile was only represented at 
four of the facilities. 
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Table 35: Education Level by Facility
Facility
None Began Primary Began Secondary Diploma Degree
N % N % N % N % N %
252 27 25.2 57 53.3 22 20.6 1 0.9 0
255 15 14.3 60 57.1 27 25.7 1 1.0 2 1.9
256 5 4.5 40 35.7 54 48.2 7 6.3 6 5.4
258 4 3.7 62 57.9 28 26.2 11 10.3 2 1.9
259 7 6.9 38 37.3 40 39.2 14 13.7 3 2.9
260 9 8.4 57 53.3 29 27.1 9 8.4 3 2.8
Total 67 10.5 314 49.1 200 31.3 43 6.7 16 2.5
Table 36: People at Facilities within Wealth Quintile (1=poorest; 5=richest)
Facility
1 2 3 4 5
Total
N % N % N % N % N %
252 82 76.6 11 10.3 12 11.2 1 0.9 1 0.9 107
255 31 29.5 60 57.1 10 9.5 4 3.8 0 0 105
256 2 1.8 3 2.7 25 22.3 45 40.2 37 33 112
258 2 1.9 12 11.2 26 24.3 32 29.9 35 32.7 107
259 3 2.9 9 8.8 18 17.7 32 31.4 40 39.2 102
260 9 8.4 32 29.9 37 34.6 20 18.7 9 8.4 107
Total 129 20.2 127 19.8 128 20 134 20.9 122 19.1 640
Figure 19: Wealth Quintiles by Facility
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Table 37 shows participants’ reasons for attending 
the facility at T0, analysed by facility. There was con-
siderable variation; for example, 73% of Facility 256 
participants were newly diagnosed whereas the next 
highest proportion (Facility 259) was only 35% and 
Facility 252 recruited none at all. According to Table 
37, two facilities did not accept any patients by referral 
during the study period. At Facility 258, the most com-
mon reason for attending was an HIV test result more 
than 14 days ago, which was rare at all other facilities.
5.7.2—Illness Severity at Different Facilities
The WHO staging system was rarely used at two facili-
ties, and used about half the time at two others, with the 
result that WHO scores cannot be compared between 
the facilities. ECOG scores at baseline are displayed 
in the table below. All scores of 2 or above were com-
bined, as only 3.1% of participants scored 3 or 4. Table 
38 shows that more participants had impaired physical 
functioning at Facility 252 than at other facilities. 
There was great variation in the physical function 
of participants in the study by facility. The percentage 
of participants who were fully active at baseline ranged 
from 20.6% at Facility 252 to 82.1% at Facility 256 
(Table 38). The percentage of participants who had 
limited physical ability (ECOG of 2–4) ranged from 
1.9% at Facility 255 to 39.1% at Facility 252. At three 
facilities, mean CD4 count dropped during the study for 
those with a measurement at the beginning and the end 
(Table 39).
5.7.3—Care Received at Different Facilities
All care components: The number of care components 
received by participants in the course of the study 
(displayed in Figure 6) varied considerably by facility, as 
shown in Table 40, from a mean of 13.0 at Facility 256 
to 23.9 at Facility 252. The lowest number of compo-
nents received by a participant was zero (Facility 256), 
compared to a minimum of 14 components of care 
being received by participants at Facility 252 and 11 at 
Facility 259. Some participants at Facilities 252 and 255 
received 34 care components out of the 52 examined 
over the course of the study. Participants at Facilities 
255 and 256 reported the greatest variation in number 
of components (shown by the standard deviation).
The percentage of participants who received each 
component of care at any time through the study was 
calculated for each facility (Table 41). Components 
Table 37: Reason for Attending at T0 by Facility
Facility
252 255 256 258 259 260 Total
N % N % N % N % N % N % N %
HIV test result in last 14 days 0 0 20 19.1 82 73.2 27 25.2 36 35.3 31 29 196 30.6
HIV test result more than 14 days ago 0 0 2 1.9 8 7.1 42 39.3 2 2 1 0.9 55 8.6
Referred 0 0 12 11.4 0 0 6 5.6 13 12.8 11 10.3 42 6.6
Obtain medication or lab test 47 43.9 34 32.4 11 9.8 4 3.7 23 22.6 0 0 119 18.6
New illness or new presenting problem 58 54.2 37 35.2 11 9.8 27 25.2 27 26.5 63 58.9 223 34.8
Other 2 1.9 0 0 0 0 1 0.9 1 1 1 0.9 5 0.8
Table 38: ECOG Score at Baseline by Facility
Facility
0
fully active
1
restricted
2–4
ambulatory/limited self 
care/completely disabled
n % n % n %
252 22 20.6 40 37.4 45 39.1
255 83 79.1 20 19.1 2 1.9
256 92 82.1 11 9.8 9 8.0
258 55 51.4 47 43.9 5 4.7
259 44 43.1 46 45.1 12 11.8
260 25 23.4 68 63.6 14 9.1
Total 321 50.2 232 36.3 87 13.6
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Table 39: CD4 Counts at T1 and T3 by Facility
Facility CD4 Count at T1 CD4 count at T1 CD4 count at T3 CD4 count at T3
CD4 count at T3 
and T0
Change in CD4 
count
N % Mean Sem N % Mean Sem N % Mean Sem
252 106 100 267 15 80 74.8 317 16 80 74.8 65 14
255 42 40.4 493 52 14 13.3 674 106 12 11.4 -11 59
256 54 52.4 412 34 5 4.4 349 81 5 4.4 4 28
258 45 45 291 30 61 57 367 30 27 25.2 55 35
259 91 91 299 23 29 28.4 281 32 22 21.6 -28 57
260 36 35.3 341 33 33 30.8 370 38 14 13.1 -32 39
Total 374 60.8 331 12 222 41.3 357 15 160 25 34 13
Table 40: Care Components Ever Received, by Facility
Facility Mean SD Minimum Maximum N
252 23.9 4.2 14 34 107
255 22.0 6.3 6 34 105
256 13.0 6.4 0 28 113
258 13.8 3.9 1 22 107
259 20.1 4.1 11 31 102
260 16.0 4.3 3 27 107
are listed in order of the total percentage across all six 
facilities who received the care, from CTX with the 
highest coverage to cryptococcal meningitis treatment 
with the least. It can be seen that three facilities provid-
ed CTX to all their participants while the other three 
provided it to over 90%. The largest differences between 
facilities were in their provision of social and spiritual 
care components. 
At Facility 252 (a mission hospital), 95% of partici-
pants had prayed with a member of staff at least once 
during the three months of the study, while at Facility 
256 only a fifth had done so. Only Facilities 255 and 
259 provided a substantial programme of loans and 
IGA. Facility 260 provided no treatment for anxiety or 
depression. Two facilities (260 and 258) did not provide 
strong opioids and Facility 258 did not provide weak 
opioids either.
Other notable differences between facilities in 
Table 41 include:
 » Facilities 252, 255 and 259 provided pastoral visits 
more frequently than the others.
 » Almost half of Facility 255 participants had contact 
with a traditional healer.
 » Facilities 256 and 260 had fewer than 40% of 
participants who attended patient HIV support 
groups.
 » Provision of infection control training and nursing 
care was extremely varied; infection control train-
ing varied from 18% to 97% and nursing care from 
12% to 98%
 » Facility 255 had almost 5% receiving cryptococcal 
meningitis treatment, as compared to virtually none 
at all other facilities.
 » Almost no-one at Facilities 258 and 260 received 
food while over 90% at Facility 2525 were given 
food.
 » Facility 255 gave home help and household items 
to 40% of participants, most other facilities gave 
none.
Care received away from the facility: Substantial lev-
els of care were received at other locations besides the 
facilities where the study was based (Table 42). Clini-
cal items such as malaria treatment and treatment for 
nausea were often sought elsewhere, as well as spiritual 
care (a visit from a religious leader was very often inde-
pendent of the facility) and preventive care, for example 
improved access to water.
Figure 20 shows the mean number of care com-
ponents per person reported at T0, at each facility. At 
three of the facilities (255, 258, and 259) the majority 
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Table 41: Percentage of Participants Ever Receiving Care Components, by Facility
Facility 252 255 256 258 259 260
CTX 100.0 100.0 90.3 96.3 95.1 100.0
Adherence counselling 99.1 81.0 81.4 98.1 98.0 99.1
Prevention with positives 98.1 90.5 71.7 91.6 99.0 99.1
Nutritional advice 99.1 96.2 80.5 77.6 82.4 98.1
Non-opioid analgesic 100.0 94.3 63.7 77.6 80.4 82.2
Family planning counselling 72.0 75.2 73.5 78.5 97.1 85.0
Pain assessment 96.3 85.7 45.1 84.1 56.9 88.8
Multivitamins 83.2 95.2 59.3 47.7 73.5 97.2
Patient HIV support groups 98.1 87.6 37.2 88.8 97.1 34.6
Condoms 61.7 82.9 72.6 61.7 94.1 58.9
Pre- and post-test counselling 64.5 49.5 92.9 83.2 68.6 48.6
Treatment for other OIs 97.2 96.2 54.9 43.9 27.5 85.0
Assess ART treatment 99.1 56.2 39.8 38.3 75.5 90.7
ITNs 66.4 88.6 66.4 59.8 73.5 30.8
Family counselling 85.0 82.9 26.5 39.3 89.2 58.9
Access to drinking water 89.7 87.6 61.1 59.8 35.3 39.3
Other nursing care 97.2 93.3 41.6 29 98 12.1
ART/ARV 99.1 40.0 30.1 38.3 66.7 95.3
Visit by religious leader 99.1 85.7 18.6 40.2 95.1 17.8
Prayer with staff 95.3 38.1 20.4 62.6 72.5 58.9
Treatment for malaria 99.1 78.1 49.6 32.7 46.1 42.1
Infection control training 17.8 69.5 20.4 23.4 97.1 72.0
TB testing 42.1 19.0 82.3 17.8 73.5 51.4
Wound care 63.6 70.5 23.9 10.3 98 17.8
Treatment for skin rash/itching 53.3 66.7 17.7 54.2 43.1 44.9
Transport to care centre 8.4 62.9 4.4 88.8 69.6 7.5
Food 95.3 70.5 11.5 0.9 55.9 0.9
Treatment for genital thrush 34.6 41.0 14.2 23.4 49.0 34.6
IGA 4.7 76.2 6.2 19.6 58.8 1.9
Treatment for diarrhoea 61.7 45.7 14.2 10.3 6.9 21.5
Treatment for nausea/vomiting 45.8 56.2 11.5 6.5 12.7 24.3
Treatment for fungal infections 56.1 38.1 9.7 14 19.6 17.8
Treatment for oral thrush 36.4 34.3 12.4 7.5 26.5 23.4
Treatment for anxiety and depression 63.6 29.5 15.9 4.7 8.8 0
Contact with traditional healer 1.9 48.6 10.6 21.5 20.6 4.7
Loans/microfinance 3.7 58.1 3.5 0 42.2 0
Phase 2 uganda 46
results of longitudinal Quantitative study section a 46
Table 41: Percentage of Participants Ever Receiving Care Components, by Facility
Facility 252 255 256 258 259 260
Treatment for neuropathic pain 18.7 16.2 15 29.9 11.8 15.0
Legal services 0.9 68.6 6.2 0 7.8 0
TB treatment 19.6 9.5 20.4 13.1 12.7 5.6
Therapeutic feeding 20.6 41 11.5 2.8 2.9 1.9
Memory book 26.2 14.3 4.4 0 20.6 10.3
Prophylactic isoniazid 13.1 20 36.3 0 2 2.8
Treatment for herpes 10.3 6.7 6.2 20.6 10.8 8.4
Home help 5.6 45.7 0 0.9 3.9 0
Household items 5.6 40 0.9 0 3.9 0.9
Weak opioids 12.1 9.5 13.3 0 13.7 1.9
Constipation treatment/laxatives 10.3 12.4 2.7 1.9 11.8 8.4
Physiotherapy 15.9 9.5 8.0 0.9 2.9 1.9
Strong opioids 4.7 11.4 13.3 0 2 0
Psychiatric therapy 3.7 2.9 5.3 0.9 3.9 0
Cancer management 0.9 2.9 2.7 0 5.9 0
Treatment for cryptococcal meningitis 0.9 4.8 0.9 0 0 0.9
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Table 42: Percentage of People Ever Receiving Care at the Facility and Elsewhere (fac = facility, else = elsewhere)
Facility
252 255 256 258 259 260
fac else fac else fac else fac else fac else fac else
CTX 100 7.5 98.1 50.5 74.3 45.1 91.6 55.1 92.2 30.4 100 7.5
Adherence counselling 97.2 29.9 76.2 44.8 57.5 51.3 91.6 57 96.1 24.5 98.1 8.4
Prevention with positives 93.5 39.3 72.4 59 57.5 28.3 86 20.6 98 29.4 98.1 8.4
Nutritional advice 94.4 35.5 78.1 65.7 63.7 38.9 75.7 21.5 77.5 24.5 98.1 5.6
Non-opioid analgesics 98.1 15 39 89.5 21.2 54 69.2 32.7 47.1 58.8 80.4 15
Patient HIV support groups 79.4 70.1 66.7 56.2 20.4 18.6 83.2 32.7 88.2 49 30.8 7.5
Family planning counselling 53.3 29 62.9 41 52.2 38.1 72 26.2 97.1 22.5 84.1 5.6
Multivitamins 81.3 7.5 80 53.3 49.6 24.8 40.2 14 66.7 25.5 97.2 11.2
Condoms 35.5 32.7 81 27.6 67.3 20.4 59.8 10.3 73.5 82.4 57.9 2.8
Assessment of pain 95.3 14 47.6 63.8 14.2 37.2 73.8 36.4 52 12.7 88.8 3.7
Pre and post test counselling 58.9 11.2 7.6 47.6 88.5 22.1 73.8 51.4 52 22.5 44.9 3.7
Treatment for other OIs 96.3 13.1 68.6 75.2 20.4 44.2 39.3 9.3 21.6 9.8 85 0.9
Family counselling 60.7 49.5 61.9 46.7 9.7 18.6 28 21.5 73.5 33.3 57 10.3
Other nursing care 94.4 27.1 45.7 85.7 15.9 32.7 11.2 18.7 98 19.6 10.3 1.9
Access to drinking water 39.3 84.1 68.6 46.7 51.3 15.9 59.8 0.9 3.9 34.3 36.4 5.6
ITNs 25.2 49.5 86.7 22.9 61.9 9.7 59.8 0.9 10.8 69.6 30.8 0
Assess ART treatment 99.1 1.9 47.6 13.3 23 21.2 35.5 9.3 72.5 6.9 90.7 4.7
Treatment for malaria 99.1 37.4 22.9 73.3 13.3 41.6 13.1 25.2 4.9 42.2 27.1 21.5
ART/ARVs 99.1 0 35.2 16.2 8.8 23.9 36.4 6.5 63.7 10.8 95.3 6.5
Visit by religious leader 38.3 91.6 2.9 84.8 0.9 17.7 0 40.2 2 95.1 10.3 10.3
Prayer with staff 34.6 86.9 28.6 15.2 2.7 18.6 59.8 8.4 2 72.5 57.9 2.8
Infection control training 13.1 7.5 57.1 32.4 15 6.2 15 8.4 97.1 20.6 72 6.5
Wound care 59.8 17.8 58.1 28.6 8 18.6 2.8 8.4 98 15.7 16.8 3.7
Treatment for skin rash/itching 49.5 8.4 48.6 43.8 3.5 15.9 50.5 9.3 30.4 24.5 43 3.7
TB testing 40.2 2.8 4.8 15.2 74.3 21.2 13.1 6.5 67.6 8.8 49.5 2.8
Food 75.7 43.0 66.7 22.9 6.2 6.2 0 0.9 53.9 2.9 0.9 0
Transport to care centre 0 8.4 62.9 2.9 2.7 1.8 88.8 1.9 61.8 20.6 6.5 1.9
Treatment for genital thrush 33.6 3.7 28.6 24.8 6.2 8.8 18.7 8.4 32.4 35.3 32.7 4.7
Employment training/IGA 1.9 2.8 70.5 36.2 1.8 4.4 19.6 0 7.8 55.9 0 1.9
Treatment for nausea/vomiting 41.1 5.6 26.7 43.8 3.5 10.6 2.8 3.7 5.9 12.7 19.6 7.5
Treatment for fungal infections 50.5 10.3 20 29.5 4.4 5.3 10.3 3.7 9.8 16.7 15 4.7
Treatment for diarrhoea 54.2 11.2 19 28.6 2.7 11.5 5.6 5.6 1 5.9 17.8 4.7
Treatment for oral thrush/candidiasis 32.7 4.7 24.8 19 4.4 8 4.7 2.8 16.7 18.6 21.5 3.7
Treatment for anxiety/depression 53.3 12.1 19 13.3 4.4 11.5 2.8 1.9 8.8 1 0 0
Loans/microfinance 0 3.7 24.8 44.8 0 3.5 0 0 0 42.2 0 0
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Table 42: Percentage of People Ever Receiving Care at the Facility and Elsewhere (fac = facility, else = elsewhere)
Facility
252 255 256 258 259 260
fac else fac else fac else fac else fac else fac else
Treatment for neuropathic pain 18.7 1.9 10.5 6.7 0.9 14.2 29.9 2.8 9.8 2.9 15 0
Contact with traditional healer 0 1.9 4.8 46.7 0.9 10.6 2.8 18.7 0 20.6 2.8 1.9
Legal services 0 0.9 51.4 31.4 0.9 5.3 0 0 0.0 7.8 0 0
TB treatment 17.8 2.8 3.8 6.7 15.9 5.3 12.1 4.7 11.8 2 5.6 0.9
Therapeutic feeding for malnutrition 16.8 3.7 25.7 22.9 3.5 8 1.9 0.9 2 1 1.9 0
Memory book work 23.4 3.7 11.4 3.8 0.9 3.5 0 0 1 20.6 8.4 1.9
Isoniazid for TB prevention 11.2 1.9 16.2 5.7 32.7 5.3 0 0 1 1 1.9 0.9
Treatment for herpes 7.5 2.8 4.8 2.9 2.7 3.5 17.8 3.7 6.9 4.9 8.4 0
Home help 0 5.6 40 12.4 0 0 0.9 0 0 3.9 0 0
Household items 0 5.6 38.1 3.8 0 0.9 0 0 2 2 0 0.9
Treatment for constipation/laxatives 7.5 2.8 1.9 10.5 0 2.7 1.9 0 6.9 8.8 3.7 4.7
Weak opioids 11.2 0.9 1 8.6 0.9 12.4 0 0 11.8 2 1.9 0
Physiotherapy 12.1 5.6 6.7 2.9 1.8 6.2 0 0.9 1 2 1.9 0
Strong opioids 4.7 0 2.9 8.6 0.9 12.4 0 0 2 0 0 0
Psychiatric therapy 1.9 1.9 0 2.9 1.8 3.5 0.9 0 3.9 0 0 0
Cancer management 0.9 0 1.9 1 1.8 0.9 0 0 2 4.9 0 0
Treatment for cryptococcal meningitis 0.9 0 0 4.8 0.9 0 0 0 0 0 0.9 0
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of care in the month preceding T0 came from outside 
the facility.
Figures 21–23 show the mean number of com-
ponents of care received at each facility by timepoint. 
All three graphs are drawn to the same scale and the 
facilities are ordered from 252 at the bottom to 260 at 
the top as in Figure 20. The proportion of components 
received elsewhere to those received at the facility re-
mained relatively stable over time for each facility. The 
mean number of care components was also quite stable 
although participants at Facility 252 received fewer 
over time and those at Facility 255 received more.
Care Themes: Table 43 shows that Facility 256 
had the lowest proportions of participants receiving 
spiritual care, support/counselling, pain management, 
symptom control, nutrition, social care and preventive 
care. The only care group in which Facility 256 did not 
offer the lowest proportion of care was nursing care. 
In general, support/counselling and preventive care 
were widely received, often by over 90% of participants. 
Other themes were more mixed. Social care was widely 
provided at Facilities 255 and 259, provided to a fifth 
of participants at Facility 258 and to almost no-one at 
the remaining three. Nursing care was also polarised, 
received by the great majority at Facilities 255, 259 and 
260, but by less than a third at Facilities 256 and 258. 
PEPFAR Care and Support: Table 44 shows that al-
most everyone in the study received at least one compo-
nent of PEPFAR C&S clinical care during the period of 
observation. The care category least commonly provided 
Figure 20: Mean Number of Care Components Received at Each 
Facility and Elsewhere at T0
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Figure 21: Mean Number of Care Components Received at Each 
Facility and Elsewhere at T1
Figure 22: Mean Number of Care Components Received at Each 
Facility and Elsewhere at T2
Figure 23: Mean Number of Care cComponents Received at 
Each Facility and Elsewhere at T3
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was social care, which varied greatly by facility, with 
Facilities 255 and 259 providing the most social care.
5.7.4—Health at Baseline at Different Facilities
Mean physical health summary score ranged from 37.9 
(sd 9.7) at Facility 252 to 49.0 (sd 11.4) at Facility 256 
(Table 45). Mean mental health summary score ranged 
from 40.3 (sd 8.9) at Facility 255 to 47.7 (sd 9.4) at Fa-
cility 259. There was significant variation in participant 
baseline physical and mental health between facilities 
(physical health: F=17.36, p<0.001; mental health: 
F=9.36, p<0.001).
The variation in mean baseline APCA African 
POS total score appeared small, from 19.1 at Facility 
260 to a maximum of 21.3 at Facility 252. This range 
was about half of the smallest standard deviation found 
within a facility. Nonetheless, APCA African POS total 
score at T0 was significantly associated with facility 
on an ANOVA test (F=2.87, p=0.014) demonstrating 
significant variation in the score between facilities.
5.8—Participant Characteristics and Health
5.8.1—Gender
There was no significant difference between men 
and women in their MOS-HIV physical or mental 
health scores at baseline. Mean physical health score at 
baseline was 42.53 for males and 43.93 for females (t= 
-1.39, p=0.17). For mental health the mean score was 
44.52 for males and 44.08 for females (t=0.55, p=0.58).
5.8.2—Age
At baseline, there was no difference in mental health 
according to age of the patient. Treating age as a con-
tinuous variable, mental health score at the intercept 
(where age=0) was 44.60. For each increasing year of 
age mental health score decreased by 0.01, but this 
change was not significant (t=-0.26. p=0.80). However, 
there was a significant decrease in physical wellbeing 
with increasing age. Physical health score was 48.86 at 
the intercept and decreased by 0.15 for each increasing 
year of age (95% CI -0.05 to -0.26, t= -2.92, p=0.004).
Table 43: Percent of Participants at T1 to Receive Care Theme 
in T1-T3, by Facility
Care Theme
Facility
252 255 256 258 259 260
Spiritual 99.1 84.8 23.9 69.2 96.1 55.1
Counselling/advice 99.1 94.3 76.1 92.5 98 94.4
Preventive 97.2 97.1 69.9 89.7 98 94.4
Nursing 88.8 92.4 30.1 12.1 98 94.4
Pain 99.1 89.5 46 78.5 69.6 91.6
Symptoms 96.3 97.1 53.1 86 73.5 90.7
Nutrition 98.1 97.1 69 86.9 81.4 95.3
Social 1.9 73.3 1.8 20.6 59.8 1.9
Table 44: Percent of Participants Ever to Receive PEPFAR 
Care Categories, by Facility
Care category
Facility
252 255 256 258 259 260 Total
n 107 105 112 107 102 107 640
Clinical 100 100 99.1 99.1 100 100 99.7
Psychological 95.3 84.8 38.1 42.1 90.2 58.9 67.7
Spiritual 100 95.2 34.5 78.5 97.1 65.4 77.8
Social 12.1 87.6 14.2 20.6 75.5 1.9 34.6
Prevention 100 100 90.3 97.2 99.0 99.1 97.5
Table 45: Mean Outcome Scores at T0, by Facility
Facility
Physical Health 
Score
Mental Health 
Score
APCA African POS 
Total Score
mean sd mean sd mean sd
252 37.9 9.7 42.6 7.3 21.3 4.9
255 38.5 12.3 40.3 8.9 19.2 4.4
256 49 11.4 43.9 10.6 19.7 4.3
258 45.8 10.9 47 9.4 20 5.5
259 46.7 12.5 47.7 9.2 19.6 4.5
260 42.8 10.7 43.9 9.6 19.1 5.3
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5.8.3—Education
There was no difference in physical or mental health 
score between participants who had completed different 
levels of education, at the 5% confidence level using an 
ANOVA test (Table 46, p=0.09, p=0.05 respectively). 
APCA African POS total score was statistically signifi-
cantly higher for people with more education (p=0.04), 
although in clinical terms the difference was marginal.
5.8.4—Relative Wealth
At baseline, both mental health score and physical 
health score were significantly associated with wealth 
quintile. Participants who had higher relative wealth 
reported higher outcome scores (Table 47). APCA 
African POS total score was not associated with wealth 
quintile.
5.8.5—Illness Severity
Baseline CD4 count was divided into four categories: 
up to 50, 51–200, 201–350, and above 350 cells/ml. A 
higher CD4 count was significantly associated with 
higher physical health score, mental health score and 
APCA African POS total score (Table 48).
5.8.6—Individual Care Components
Table 49 below shows that the 40 people who received 
TB treatment in the month preceding T1 had a mean 
physical health score over eight points lower than those 
who did not, and a mean mental health score over three 
points lower. These were both statistically significant 
on t-tests (physical score t=4.72, p<0.001, mental score 
t=2.34, p=0.02) and are considered clinically significant. 
People receiving TB treatment at T1 had a lower mean 
CD4 count, for the people with a recorded CD4 test in 
the 13 months before T1 (t=2.95, p=0.02).
Almost half of T1 participants received ART in the 
month preceding T1. Their mean physical health was 
almost six points lower than those who did not receive 
ART (t=6.58, p<0.001) and their mean mental health 
was 2.5 points lower (t=3.46, p<0.001). People receiv-
ing ART had a lower CD4 count than non-recipients 
(t=6.97, p<0.001). 
Table 46: Mean Health Scores at Baseline for Different 
Education Levels
Education Level
Mean Physical 
Health Score
Mean Mental 
Health Score
APCA African 
POS Mean 
Total Score
None 41.2 42.7 19.0
Begun primary 42.7 44.1 19.8
Begun secondary 44.8 43.9 19.7
Diploma or higher 45.0 44.7 20.0
F 2.03 2.37 2.49
p 0.088 0.052 0.042
Table 48: Mean Health Scores at Baseline for Different Levels 
of CD4 Count
CD4  
cells/ml
N
Mean Physical 
Health Score
Mean Mental 
Health Score
Mean APCA 
African POS 
Total Score
<50 33 35.6 41.2 18.0
51-200 90 39.7 42.5 19.5
201-350 116 43.8 45.1 20.8
>350 145 46.5 46.6 20.2
F 11.89 5.60 3.36
p <0.001 0.001 0.019
Table 47: Mean Health Scores at Baseline for Different Level 
of Wealth (1=poorest; 5=wealthiest)
Wealth  
Quintile
Mean Physical 
Health Score
Mean Mental 
Health Score
Mean APCA African 
POS Total Score
1 38.1 41.3 20.4
2 38.6 41.9 19.1
3 44.1 44.1 19.3
4 47.6 46.3 19.7
5 49.2 47.8 20.6
F 26.56 12.02 2.35
p <0.001 <0.001 0.053
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Table 49: Comparison of Outcomes Between Participants Receiving and Not Receiving Specific Care Components at T1
Received
Physical Health CD4 Count Mental Heath
n mean se n mean se n mean se
TB treatment Yes 40 37.5 1.99 40 44.1 1.33 26 233 43
No 575 46.2 0.46 575 47.6 0.38 348 341 12
ART Yes 305 42.7 0.63 305 46.1 0.50 213 265 12
No 310 48.5 0.62 310 48.6 0.53 161 424 21
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6.1—Association of Outcomes with Loss to  
Follow-Up
To determine whether missing data were missing at 
random with relation to the outcomes, or whether the 
outcomes were associated with the probability of loss 
to follow-up, mean physical and mental health scores at 
T0 for completers and non-completers were compared 
using t-tests. Table 50 shows that the 26 people who 
only completed the first observation had a mean physi-
cal health score almost four points lower than the mean 
for the remaining participants, but the difference was 
not statistically significant (t=1.60, p=0.109). The people 
who left the study before completion had a lower mean 
physical health score than those who completed all four 
observations but again the difference was not statisti-
cally significant at the 5% level (t=-1.80, p=0.072).
In Table 51, the 26 people who only completed 
one observation did not have significantly lower mental 
health scores than people who completed more than 
one (t=0.80, p=0.42).However, the 102 people who 
dropped out at some point during the study had signifi-
cantly lower mean mental health scores than the 537 
who completed all observations (t= -2.95, p=0.003). 
The implication of these tests is that any analysis 
which only included people who had completed all four 
observations would be biased towards a higher level of 
mental health than was visible in the whole study popu-
lation. Conversely, analysis which included all partici-
pants except the 26 who only completed an interview 
at T0 would not necessarily bias the results. Therefore, 
multilevel modelling, which operates using all observa-
tions except the first, is a more appropriate way of ex-
ploring change over time in this study than traditional 
techniques which often exclude non-completers.
6.2—Changes in Health Over Time
6.2.1—Physical and Mental Health Scores
Mean summary scores at each timepoint are presented 
in Table 52 and illustrated in Figures 24 and 25. The in-
6
Table 50: Mean Physical Health Scores at T0 by Number of  
Observations Completed
Observations Completed N Mean sd 95% CI
One 26 39.8 14 34.1–45.5
More than one 613 43.6 11.9 42.7–44.6
Less than four 102 41.5 13.4 38.9–44.2
Four 537 43.9 11.7 42.9–44.8
Table 51: Mean Mental Health Scores at T0 by Number of  
Observations Completed
Observations Completed N Mean SD 95% CI
One 26 42.7 10.5 38.5–47
More than one 613 44.3 9.5 43.5–45
Less than four 102 41.7 10 39.7–43.6
Four 537 44.7 9.4 43.9–45.5
Table 52: MOS Summary Score Changes Over Time
T0 T1 T2 T3
mean sd mean sd mean sd mean sd
Mental 
health
44.2 9.5 47.3 9.1 49.3 8.8 51.5 9.1
Physical 
health
43.5 12 45.6 11.4 47.7 10.6 49.9 10
crease in mean from baseline to T3 was 6.03 (sd 11.51) 
for physical health score and 6.74 (sd 9.84) for mental 
health score, which were both clinically significant (11). 
The figures show that mean physical and mental health 
scores increased steadily over time.
Multilevel linear regression, with three levels 
(facility, individual and interview levels), accounting 
for baseline and including a time variable, showed that 
mental health and physical health summary scores 
increased significantly over the three month follow up 
compared to baseline (Tables 53 and 54).
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Table 54: Mixed-Effects Model of Mental Health Score Adjusting for Mental Health at T0 and Time
Coefficient Standard Error Z P 95% CI
Baseline mental health score 0.421 0.026 15.92 <0.001 0.370–0.473
Interview number 1.948 0.177 10.98 <0.001 1.600–2.296
Constant 26.710 1.543 17.31 <0.001 23.686–29.734
Table 53: Mixed-Effects Model of Physical Health Score Adjusting for Physical Health at T0 and Time
Coefficient Standard Error Z P 95% CI
Baseline physical health score 0.452 0.025 18.11 <0.001 0.403–0.501
Interview number 2.167 0.200 10.81 <0.001 1.773–2.559
Constant 23.713 1.589 14.92 <0.001 20.598–26.828
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Figure 24: Change in Average Physical Health Score Over Time Figure 25: Change in Average Mental Health Score Over Time
Tables 53 and 54 contain the fixed effects output 
only, which can be read as ordinary linear regression. 
The interpretation of Table 53 is that with each increase 
in time, from T1 to T2 and from T2 to T3, average 
physical health score goes up by 2.17. Each additional 
point in physical health score at T0 means subsequent 
physical health measures for that person are on average 
0.45 points higher. 
The 95% confidence intervals represent the range 
within which the true regression coefficient has a 95% 
probability of falling, and is calculated by the coefficient 
plus or minus 1.96 times the standard error. 
6.2.2—Multidimensional Care Scores
During the study period all APCA African POS items 
except feeling that life was worthwhile and feeling at 
peace showed increases in the median scores, although 
feeling that life was worthwhile was the most highly 
scored domain (median = 4) at the beginning of the 
study (Table 55) and so there was very little potential 
for improvement.
Table 56 presents a different summary of the same 
information. The proportion reporting “severe” (the 
worst two scores) and “moderate” (the middle two 
scores) problems on each item are reported by time. The 
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results show that the reduction in median scores shown 
in Table 52 had clinical meaning. In most cases the 
proportion experiencing severe and moderate problems 
decreased, particularly between T0 and T1 when the 
largest reduction in severe problem scores occurred. 
Lack of help and advice was the only item in which 
the majority of people had severe problems at T0. The 
proportion to have moderate problems with feeling at 
peace did not change much over time, probably caused 
by moderate problems becoming mild at the same rate 
that severe problems became moderate. On the help 
and advice item, moderate problems actually increased 
substantially between T0 and T1. By T3, just under a 
quarter of participants still had severe problems with 
sharing their feelings, while severe pain and symptoms 
were very rare.
Using multilevel modelling with levels for indi-
vidual and facility and interview, and controlling for 
baseline APCA African POS total score and time, the 
APCA African POS total score significantly increased 
over the three-month time period compared to baseline 
(p<0.001, Table 56). Figure 26 shows the mean and 
95% confidence intervals for APCA African POS total 
score at each timepoint. 
6.3—Participants with the Most Need at Baseline
It is of particular concern that individuals with the 
most severe problems relating to their HIV status 
should receive appropriate care. It is possible that the 
most intractable problems are not dealt with sufficient-
ly, and that an average improvement in scores hides 
Table 55: APCA African POS Scores for Items (All 0–5)
APCA African POS Item T0 T1 T2 T3
Median IQR Median IQR Median IQR Median IQR
Pain 3 2–4 4 3–5 4 3–5 4 3–5
Symptoms 3 3–5 4 3–5 4 3–5 4 3–5
Worry 3 2–4 4 3–5 4 3–5 4 3–5
Sharing 2 1–4 3 1–4 3 1–4 3 2–5
Life worthwhile 4 3–5 4 3–5 4 3–5 4 3–5
Peace 3 1–4 3 2–4 3 2–4 3 3–4
Help and advice 1 0–3 2 1–3 3 1–4 3 2–4
Table 56: Percent of Participants Reporting Severe and Mod-
erate Problems by Multidimensional Item Over Time
T0 T1 T2 T3
n 641 614 583 538
Pain Severe 11.4 2.1 3.6 2.0
Moderate 53.6 46.7 39.1 31.2
Symptoms Severe 5.8 2.1 2.1 1.7
Moderate 44.4 38.4 33.3 26.2
Worry Severe 15.0 8.1 4.6 4.8
Moderate 42.5 37.1 33.6 25.1
Share feelings Severe 31.7 27.3 28.4 24.9
Moderate 36.9 38.7 32.3 25.7
Life worthwhile Severe 11.1 9.1 5.3 5.2
Moderate 35.5 30.6 30.5 24.5
Peace Severe 26.9 15.9 14.2 9.9
Moderate 44.8 44.9 44.3 41.5
Help and advice Severe 52.0 35.9 27.3 21.9
Moderate 30.3 44.7 47.5 39.6
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this. For this reason the participants with the worst 
outcomes at baseline were examined to see how their 
outcomes changed over time.
6.3.1—Physical and Mental Health Scores
The 128 people with the lowest physical health sum-
mary score at baseline (20% of the sample of 640) had 
a mean physical health score at T0 of 25.60 (sd=3.75), 
increasing at T3 to a mean of 42.45 (sd=10.64). Table 
57 shows that physical health increased significantly 
over time (p<0.001) for this group of people with low 
physical health at the beginning of the study. This 
increase is observed in Figure 27 showing the means 
score at each time. The 95% confidence intervals widen 
over time, indicating that the sample size was shrinking 
because of loss to follow-up. 
In the 128 people with the lowest mental health 
score at baseline, mean mental health increased from 
31.12 (sd=4.39) at T0 to 45.76 (sd=10.67) at T3. In a 
multi-level model, the passage of time was associated 
with an improved mental health outcome, showing 
that mental health improved for those with the lowest 
starting value (Table 58). Figure 28 displays the mean 
mental health score and 95% CIs for the group.
6.3.2—Multidimensional Care Scores
Severe pain and symptoms are sometimes complex and 
intractable. The scores over time for those who reported 
overwhelming pain and symptoms at T0 were analysed 
to determine whether these problems were resolved. 
Only 19 people reported experiencing the worst catego-
ry of pain, overwhelming pain, at T0, and 14 reported 
overwhelming symptoms. Table 60 displays the scores 
of these groups over time. By T2, the worst score for 
the group previously in overwhelming pain was severe 
(2), and this was maintained to T3. The group with 
overwhelming symptoms also generally improved in 
scores although there were still two people experiencing 
overwhelming symptoms at T3. Further analysis was 
not performed on these data because the small numbers 
involved would make interpretation unreliable. 
6.4—Variation by Facility
Table 61 and Figure 29 show that mean physical health 
score increased at all six facilities over time. Mean 
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Table 57: Mixed-Effects Model of APCA African POS Total 
Score Adjusting for Baseline APCA African POS Total Score 
and Time
Coefficient
Standard 
Error
Z P 95% CI
Baseline APCA 
African POS 
total score
0.333 0.027 12.38 <0.001
0.280–
0.385
Interview 
number
1.367 0.113 12.12 <0.001
1.146–
1.588
Constant 14.083 0.926 15.21 <0.001
12.268–
15.898
Figure 27: Mean Physical Health Score Over Time for the 20% 
with the Lowest Physical Health Score at T0
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Figure 26: Change in APCA African POS Total Score Over Time
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Table 58: Mixed-Effects Model of Physical Health Score  
Adjusting for Baseline Physical Health Score and Time for 
the 20% with the Lowest Physical Health Score at Baseline
Coefficient
Standard 
Error
Z P 95% CI
Baseline physical 
health score
0.364 0.189 1.92 0.054
-0.007–
0.735
Interview 
number
4.350 0.547 7.95 <0.001
3.277–
5.422
Constant 20.700 5.140 4.03 <0.001
10.626–
30.775
Table 59: Mixed-Effects Model of Mental Health Score 
Adjusting for Baseline Mental Health Score and Time for the 
20% with the Lowest Mental Health Score at Baseline
Coefficient
Standard 
Error
Z P 95% CI
Baseline 
mental health 
score
0.317 0.133 2.38 0.017
0.056–
0.579
Interview 
number
3.276 0.472 6.94 <0.001
2.351– 
4.202
Constant 27.642 4.474 6.18 <0.001
18.873–
36.412
Figure 28: Mean Mental Health Score Over Time for the 20% 
with the Lowest Mental Health Score at T0
Figure 29: Change in Mean Physical Health Score Over Time for 
Each Facility
Table 60: APCA African POS Pain and Symptom Item Scores 
Over time for Participants Who Experienced the Worst Score 
at T0
Item
Number of Participants
Pain Symptoms
T0 T1 T2 T3 T0 T1 T2 T3
Overwhelming (0) 19 0 0 0 14 0 1 0
Very severe (1) 0 3 0 0 0 0 0 2
Severe (2) 0 2 3 4 0 4 2 2
Moderate (3) 0 7 6 2 0 4 2 1
Slight (4) 0 2 4 5 0 2 2 4
None (5) 0 2 3 4 0 2 3 1
Total 19 16 16 15 14 12 10 10
Table 61: Mean (SD) Physical Health Score by Timepoint and 
Facility
Facility T0 T1 T2 T3
252 37.9 (9.7) 39.8 (10.3) 41.6 (8.5) 46.4 (8.9)
255 38.5 (12.3) 40.6 (11.4) 43.5 (11.0) 43.7 (10.6)
256 49.0 (11.4) 51.0 (10.7) 52.3 (8.8) 54.6 (8.0)
258 45.8 (10.9) 50.1 (8.7) 51.7 (8.7) 52.0 (8.3)
259 46.7 (12.5) 48.0 (10.9) 52.3 (10.2) 56.3 (8.2)
260 42.8 (10.7) 44.4 (10.9) 46.2 (10.5) 47.7 (9.2)
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Table 62: Mental Health Score by Timepoint and Facility
Facility T0 T1 T2 T3
mean sd mean sd mean sd mean sd
252 42.6 7.3 46.5 7.1 47.7 6.8 50.2 7.1
255 40.3 8.9 43.2 8.8 44.4 8.4 44.5 7.7
256 43.9 10.6 47.1 10.9 48.6 9.2 52.1 7.9
258 47 9.4 51.4 8.1 52.9 8.1 53.7 9.3
259 47.7 9.2 49.9 8 54.3 7.4 58.1 7.4
260 43.9 9.6 46.2 9.1 48.3 8.9 50.1 9
improvement was considerably higher at Facilities 
252 and 259. There was no clear tendency for change 
in physical health score to be associated with physical 
health at T0. For example, the two facilities with the 
highest and lowest mean physical health score at base-
line, Facility 256 and Facility 252 respectively, had very 
similar trajectories on Figure 22.
6.5—Participant Characteristics
In Tables 63 and 64, each line corresponds to a different 
univariate model, used to identify variables which might 
be associated with the outcomes. In each case, baseline 
summary score and timepoint were also included.
Change in physical health score over time was 
significantly greater for participants who had attended 
higher levels of education (p=0.036) and who had 
greater relative wealth (p=0.077). There was no statisti-
cal difference at the 10% level in the change in physical 
health score between male and female participants, or 
those of different ages, different levels of wealth or dif-
ferent CD4 levels. Change in mental health score was 
not associated with any participant characteristics. 
6.6—Antiretroviral Therapy and TB Treatment
Having established using t-tests that participants who 
received ART or TB treatment at T1 had lower physi-
cal and mental health than participants not receiving 
this treatment, multi-level modelling was used to inves-
tigate whether the difference was maintained over time.
Table 65 shows the results of three models of 
physical health over time, all of them including CD4 
count and physical health score at the beginning of the 
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Figure 30: Change in Mean Mental Health Over Time for Each 
Facility
study. In addition, one model includes the receipt of TB 
treatment and another includes ART. 
TB treatment was significantly associated with 
physical health (coefficient= -3.117, p=0.013). This 
means that if a participant had received TB treatment 
in the previous month, their physical health was on 
average over 3.1 points lower than it would have been 
for someone who had not received TB treatment. In 
longitudinal analysis, the coefficient must be inter-
preted as a combination of effects within individuals 
and effects between them. Of course, this association 
does not mean that the TB drugs were actually lower-
ing physical health. 
ART was also negatively associated with physical 
health (coefficient= -1.783, p=0.025). On average, a 
person on ART had a physical health score 1.8 points 
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Table 65: Multi-level Mixed-Effects Models of Physical Health Over Time Adjusting for Individual Care Received
No Treatment TB Treatment ART
coeff se p coeff se p coeff se p
Time-invariant
Intercept 22.285 2.089 <0.001 23.433 2.175 <0.001 23.789 2.138 <0.001
Physical health score at T0 0.458 0.035 <0.001 0.438 0.035 <0.001 0.452 0.035 <0.001
CD4 at T1 0.001 0.002 0.459 0.001 0.002 0.546 0.000 0.002 0.875
Time-varying
ART – – – – – – -1.783 0.795 0.025
TB treatment – – – -3.117 1.251 0.013 – – –
Time 2.566 0.248 <0.001 2.563 0.249 <0.001 2.606 0.248 <0.001
var se var se var se
Random 
Between facilities 10.755 7.538 12.279 8.501 8.954 6.463
Between individuals 1.973 0.902 1.885 0.890 2.014 0.903
Time slope 28.744 4.432 27.304 4.359 28.959 4.447
Residual 39.110 2.301 39.552 2.330 38.795 2.285
Table 63: Association of Physical Health Score with  
Demographic Variables (One at a Time), Using Fixed Effects
Variable Coefficient
Standard 
Error
Z P 95% CI
Gender 0.406 0.605 0.67 0.502 -0.780–1.592
Age -0.007 0.032 -0.21 0.831 -0.070–0.056
Education 0.701 0.334 2.10 0.036 0.047–1.356
Wealth 0.501 0.283 1.77 0.077 -0.054 to 1.056
CD4 count 0.001 0.002 0.74 0.459 -0.002 to 0.005
Table 64: Association of Mental Health Score with  
Demographic Variables (One at a Time), Using Fixed Effects
Variable Coefficient
Standard 
Error
Z P 95% CI
Gender 0.303 0.528 0.57 0.566 -0.732–1.338
Age 0.036 0.028 1.30 0.195 -0.019–0.091
Education 0.378 0.293 1.29 0.197 -0.196–0.952
Wealth 0.178 0.249 0.71 0.475 -0.311–0.667
CD4 count -0.000 0.001 -0.07 0.948 -0.003–0.003
lower than a person with the same CD4 count who 
was not on ART would expect. As ART increases CD4 
count, a person with the equivalent CD4 count who 
was pre-ART would be in an earlier stage of disease. 
CD4 count predicted baseline physical health but was 
not associated with change over time in any of the 
models(p=0.459, p=0.546, p=0.875).
Mental health (Table 66) was associated with 
receipt of ART. A person who had received ART 
in the previous month scored on average two points 
lower than someone who had not (coefficient = -2.044, 
p=0.003). However, there was no association between 
mental health and TB treatment (p=0.416). As with 
physical health, CD4 count showed no association with 
change in mental health over time. 
6.7—Care Availability
Each of the eight care themes was included in a multi-
level model to identify which ones were associated with 
mental or physical health over time. These models also 
included T0 physical health score, T0 medical health 
score and time. The models for physical health included 
wealth quintile and education level because these had 
been found significant in univariate analysis. No demo-
graphic covariates were included in the mental health 
models because none of them had achieved significance 
at the 10% level in univariate analysis. Mental health 
was not associated with any care themes at the 10% 
significance level (Table 68). Physical health was associ-
ated with three care themes: pain management, symp-
tom management, and nutrition (Table 67).
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Table 67: Mixed-Effects Model of Physical Health Score Over 
Time with Personal and Care Variables
Care group Coefficient
Standard 
Error
Z P
Spiritual -0.032 0.037 -0.86 0.388
Counselling and advice -0.137 0.119 -1.16 0.248
Nursing -0.038 0.023 -1.62 0.105
Pain management -0.099 0.034 -2.90 0.004
Symptom management -0.110 0.041 -2.65 0.008
Nutrition -0.177 0.051 -3.44 0.001
Social -0.004 0.035 -0.11 0.915
Prevention -0.119 0.088 -1.36 0.174
Table 68: Mixed-Effects Model of Mental Health Score Over 
Time with Personal and Care Variables
Care Group Coefficient
Standard 
Error
Z P
Spiritual 0.021 0.037 0.58 0.560
Counselling and advice 0.067 0.127 0.53 0.597
Nursing -0.013 0.028 -0.46 0.648
Pain management -0.023 0.056 -0.41 0.684
Symptom management -0.032 0.063 -0.52 0.606
Nutrition -0.061 0.092 -0.67 0.504
Social -0.004 0.034 -0.15 0.883
Prevention 0.023 0.101 0.23 0.817
Table 66: Multi-level Mixed-Effects Models of Mental Health Over Time Adjusting for Individual Care Received
No treatment TB treatment ART
coeff se p coeff se p coeff se p
Time-invariant
Intercept 28.208 2.032 <0.001 28.549 2.078 <0.001 30.514 2.114 <0.001
Mental health score at T0 0.376 0.037 <0.001 0.370 0.037 <0.001 0.374 0.037 <0.001
CD4 at T1 -0.000 0.001 0.948 -0.001 0.001 0.903 -0.001 0.001 0.391
Time-varying
ART – – – – – – -2.044 0.682 0.003
TB treatment – – – -0.880 1.083 0.416 – – –
Time 2.245 0.217 <0.001 2.244 0.037 <0.001 2.290 0.218 <0.001
var se var se var se
Random 
Between facilities 7.243 5.142 7.544 5.342 6.246 4.525
Between individuals 1.518 0.680 1.506 0.679 1.643 0.684
Time slope 20.226 3.327 19.954 3.332 19.688 3.305
Residual 30.087 1.765 30.224 1.779 29.766 1.746
6.8—Multivariate Modelling
Mental health was not taken further as an outcome 
variable because it was not found to be associated with 
any care theme in univariate analysis. The three care 
themes with which physical health score was associ-
ated at the 10% level (pain management, symptom 
management and nutrition), with the two demographic 
variables (relative wealth and education) were included 
in a multivariate model. This is designated Model A in 
Table 69. The increased number of variables made these 
models less stable and the Davidon-Fletcher-Powell 
algorithm was iterated as the default algorithm failed 
to converge. The change of algorithm would have had 
no effect on the results and is mentioned only to allow 
replication of the results. 
Pain management, education and relative wealth 
dropped out of Model A as they were nonsignificant 
at the 5% level. Nutrition and symptom management 
remained significant; however, symptom management, 
which had been negatively associated with physical 
health when analysed alone, was now positively associ-
ated. This change of direction indicates instability of 
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Table 69: Multi-level Mixed-Effects Models for Physical Health Over Time
Model A Model B Model C
Fixed effects coeff se p coeff se p coeff se p
Time 2.165 0.201 <0.001 2.167 0.201 <0.001 2.168 0.201 <0.001
Physical health at T0 0.390 0.031 <0.001 0.390 0.031 <0.001 0.390 0.031 <0.001
Mental health at T0 0.118 0.037 0.001 0.125 0.037 0.001 0.125 0.037 0.001
Nutrition -0.899 0.266 0.001 -0.673 0.267 0.012 -0.212 0.054 <0.001
Symptom control 0.286 0.116 0.014 0.314 0.179 0.080 - - -
Pain control 0.182 0.110 0.098 - - - - - -
Relative wealth 0.312 0.274 0.256 - - - - - -
Education 0.612 0.342 0.073 - - - - - -
Random effects var se var se var se
Facility 0.013 0.466 0.727 0.985 1.343 1.294
Individual—time slope 1.239 0.671 1.265 0.676 1.219 0.673
Individual 25.767 3.311 25.846 3.319 25.956 3.323
Residual 42.467 1.944 42.423 1.943 42.479 1.943
the coefficient, suggesting that the presence of nutrition 
in the model drives the symptom management covari-
ate to behave in the opposite direction to that which it 
normally would.
The next stepwise downward model (Model B) 
included only symptom management and nutrition. 
Symptom management was nonsignificant (p=0.08) 
leaving a final Model C in which increased physical 
health was apparently associated with passing time, a 
higher value of physical health at T0, and reduced avail-
ability of nutrition care. The three models are shown 
and interpreted below. 
Table 69 shows the final three models of physi-
cal health and care. The fixed effects portion of the 
results can be read as ordinary linear regression results. 
All fixed effects were time-invariant. The random ef-
fects consist of ways to divide the remaining variance 
in the model into variance between facilities (0.013 
for Model A), variance between individuals (25.767), 
variance in the slope of the time coefficient (1.239), 
and the remainder which cannot be explained at any 
level (42.467). The residual was large, meaning that 
the model did not successfully explain a great deal of 
variation. Most of the variance was between individuals 
rather than between facilities. The best way to explain 
the way physical health changes over time was to allow 
the effect of time to vary for each individual, with a 
variance in the slopes of 1.239. When time was mod-
elled as a fixed effect, the mean slope was used to give a 
coefficient of 2.165.
As the downwards stepwise regression reduced the 
number of covariates, variance between facilities in-
creased. This variance had previously contributed to the 
pain and symptom coefficients which required facility-
level variation to fit the model. The removal of pain and 
symptom control reduced the effect of nutrition, as seen 
by the change in coefficient from -0.899 in Model A 
to -0.212 in Model C. In the final Model C, all covari-
ates were significantly associated with the outcome. As 
Table 69 shows, in the final model, physical healthw as 
predicted to increase by 2.7 at each timepoint, was 
slightly increased if baseline scores for mental and 
physical; health were good, but was slightly reduced if 
the facility-level probability of nutrition care was high. 
6.9—Further Exploration of Multivariate 
Modelling
Two unexpected findings in the multivariate model 
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were addressed through further analysis. The first of 
these was the fact that higher levels of nutrition care 
seemed to be associated with a lessened improvement 
in physical health over time. The second was the way 
that the coefficients for pain control and symptom 
management changed sign, from negative to positive.
6.9.1—Negative Association Between Care and 
Outcome
The apparent association between nutrition and physi-
cal health was explored using graphs. The multilevel 
model appeared to show that participants at facilities 
which offered nutritional care to the majority of par-
ticipants experienced less physical health improvement 
over time. 
Figure 31 shows the mean physical health score for 
each facility at each timepoint, with 95% confidence 
intervals, plotted against the proportion of facility 
participants to receive nutrition care between T0 and 
T3. There is a negative trend associating physical health 
score and nutrition care. Facilities which offered nutri-
tion care to a higher proportion of their participants 
tended to have a low mean physical health score at 
baseline and over time. As a result, the analysis appeared 
to show that nutrition reduced physical health scores. 
In reality, low health scores at baseline limited improve-
ment and also made high nutrition care more likely.
Figure 32 shows the increase in mean physical 
health score (from mean score at T0) for each facility at 
each timepoint, with 95% confidence intervals. Facili-
ties are positioned along the x axis according to the 
proportion of their participants receiving nutrition care 
at any time between T0 and T3. The difference between 
Figure 31 and Figure 30 is that baseline physical health 
score has been removed, allowing a direct comparison 
between gain in health score and nutrition care. There 
does not appear to be a relationship between receipt of 
nutrition and improvement in physical health score.
6.9.2—Instability
When analysed alone, symptom management and pain 
control were negatively associated with physical health 
score; at facilities where few participants received pain 
control or symptom management, the improvement in 
physical health over time was higher (Table 67). When 
Table 70: Percent of Facility Participants Receiving Nutrition 
and Symptom Management Care Between T0 and T3 (order)
Facility Nutrition Symptom Management
252 98.1 (first) 96.3 (second)
255 97.1 (second) 97.1 (first)
256 69.0 (sixth) 53.1 (sixth)
258 86.9 (fourth) 86.0 (fourth)
259 81.4 (fifth) 73.5 (fifth)
260 95.3 (third) 90.7 (third)
Figure 31: Mean Facility Physical Health Score Over Time, by 
Proportion of Participants Receiving Nutrition Care
Figure 32: Increase in Mean Facility Physical Health Score Over 
Time, by Proportion of Participants Receiving Nutrition Care
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included in a multivariate model with nutrition, these 
two care themes switched signs and became positively 
associated with the outcome (Table 69). Both relation-
ships were statistically significant but little importance 
could be attached to this since they were clearly unstable
The values of nutrition and symptom management 
were tabulated by facility (Table 70), showing that the 
two variables were closely associated. The rank order 
of each was almost identical, except that two of the 
facilities exchanged first and second place. The effect 
of nutrition in the model was to drive the symptom 
management variable to explain this reversal of direc-
tion, because any possible negative association between 
symptom management and health, as suggested by the 
univariate analysis, would already have been absorbed 
by the nutrition variable which so closely matched it. 
The same applied to the pain control care theme.
This high level of collinearity between three care 
themes also meant that all three were negatively associ-
ated with physical health score at baseline, as shown 
for nutrition in Figure 30. It appears that the facilities 
where participants had the worst physical health at 
baseline were the ones most likely to provide nutri-
tion, pain control and symptom management to their 
patients. As a result, each of these care themes appeared 
to predict worse outcomes. When they were put to-
gether in a model, the three worked against each other 
and gave rise to unstable results.
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Results of Qualitative Interviews
The coding frame used to code the qualitative inter-
views is presented below. Italicised phrases are examples 
and explanations of the codes. This frame was derived 
from two independently developed frames, one in 
Uganda and one in the UK, which are presented in 
Appendix K. Patient, carer and staff interviews were all 
coded using the same frame. 
7.1—Agreed Coding Frame
 » Unmet needs—not what is provided, but what is self-
identified as needed
•	 staff
•	 carer
•	 patient
 - social/financial
* food
 - clinical (e.g., CD4, pain, skin rash, diarrhoea)
 - emotional/psychological (e.g., stigma, worry, 
bereavement, anxiety, desire for child)
 - preventive (e.g., ITNs, safe water, condoms)
 » Components of care provided—what facilities say 
they actually do and what patients say they got
•	 bereavement/care of dying
•	 carers
•	 spiritual
•	 socio-economic
•	 psychological and emotional (e.g., information, 
advice)
•	 clinical (e.g., VCT, RCT,ART, curative, lab ser-
vices)
 - adherence counselling
•	 preventive (e.g., ITNs, CTX [Septrin], condoms, 
water) 
 » Experiences of delivering and receiving—care staff, 
patient, and carer views
•	 experiences of receiving care—patient and carer 
only
 - positive
 - negative
•	 facility strengths and challenges
 - strengths 
* best practice and lessons learned
 - challenges
•	 suggestions for improvement
 » Multiple identities: patient, staff and carer roles—
description of how patients perform multiple patient, 
staff and carer roles
 » Access to care—factors associated with starting care 
and choice of facility
•	 health seeking behaviour—reason for initiating 
care
•	 process of choosing facility—including being 
given referral letter
•	 eligibility criteria
•	 retention/shopping around
•	 costs to patient
 » Clinical standards—care processes and protocols
•	 process of enrollment
•	 frequency of contact
•	 monitoring and documentation
•	 referral mechanisms and reasons
•	 education and training of staff
•	 supervision of staff
The data are presented by each category in turn 
as presented in the coding frame, and then the broad 
themes are reviewed and integrated. Each data theme is 
illustrated using a direct quote from the transcripts and 
the anonymous identification for each respondent is 
given. The inclusion of identification numbers demon-
strates the selection of data from across the sample. The 
number represents the facility ID, and P=patient inter-
view, S=Staff interview and C=family carer interview. 
7
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7.2—Description of Sample
The sample consisted of 41 patients, 29 staff members 
and 21 carers. Each facility hosted seven patient inter-
views (except for Facility 255 where there were six) and 
five staff interviews (except for Facility 259 where there 
were four). Carer interviews ranged from one at Facil-
ity 256 to five at Facilities 255 and 258. The sample of 
patients was 51% male (n=21), aged from 18 to 61 with 
a median of 37. 
The majority (68%, n=28) were receiving ART and 
the mean household size was 4.7. Two thirds of carers 
(n=14) were female. Carer self-reported relationship to 
patients consisted of one mother, one sister, four broth-
ers, four daughters, six wives, one husband, one aunt 
and three friends. The brothers and sister all specified 
that they were younger than their patient. Carers were 
aged 18–52 (median 27) and were more likely than 
patients to live in rural areas. 
Staff represented many disciplines and consisted of 
seven counsellors, five clinical officers, five nurses, three 
nurse counsellors, two doctors, two medical officers and 
five other grades. The median time they had worked at 
the facility was four years, ranging from two months to 
24 years. 
7.3—Unmet Needs 
The data category of unmet needs demonstrate that 
patients and families reported having multidimensional 
needs across domains. Further, the clinical staff identi-
fied their own professional needs to enhance care. 
7.3.1—Staff Needs
A wide range of professional needs to be able to 
perform their roles were described. Firstly, staff had 
a number of training and education needs that were 
broadly non-clinical and managerial by nature, encom-
passing administration, management and IT:
“I have some basic but I think I need more training and skills in computer I 
would like to go for further training.” —S001 259
“Of course I would like to have, as a project coordinator I would like to 
know some issues in administration. In fact in management basically like 
Health Management related course.” —S003 252
Second, the clinical management of paediatric HIV 
patients was identified as a staff need:
“I would like to get training in Pediatric HIV counseling.” —S001 252
“As we were going through the interview I was just thinking about the 
children, yes we offer some care for children but I would really want to be 
something better and I want it to be in the minds of every one that we 
have children and many are getting affected and infected so a lot should 
be put towards their care and support. There are many child headed home 
and we are doing much about all this. They are a quiet but crying group.” 
—S001 260
Third, general clinical updates were identified, 
including ART and palliative care, to keep clinical skills 
up to date:
“I think still trainings towards drug resistance and also on the third and 
fourth line dugs which are coming. I would like to have that because that 
is were we are moving because we have had second line and there are 
patients who are failing on second line and the third line drug is not out 
open in the market, but soon it might be out there and to us but I would 
like to have training in that” —S001 259
“I think it would be good to get oral morphine for pain management 
because we get certain patients in severe pain and all we have is codeine 
phosphate.” —S001 260
“I also want to have a course in Palliative care because patients who come 
here are very sick (terminally ill) and they need to be supported in that 
area.” —S002 259
Fourth, training needs were described in general 
psychosocial care and in relationship counselling:
“Then may be an in-depth training in counseling as a health worker you 
can’t keep on referring patients to a counselor. There at times when you 
need also to counsel them and I have the basic skills like peer counseling 
of course like before you graduate at University they teach you about peer 
counseling but that is not enough because I would like to get in-depth 
training in counseling in HIV.” —S003 252
“Ya mainly in spiritual and social care, I feel we handicapped because they 
are not institutionalised and you cannot do it as a person. You need the 
institution to strengthen those components.” —S004 260
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Fifth, staff were keen to be able to engage mean-
ingfully in research within their facility, to be able to 
collaborate with overseas research partners and to lead 
research locally:
“I would also like to get more training in research methodologies.” —S001 
259
“Now that I have spent all these years in a research facility, I think I want 
very much to continue with research, I have been attached to different 
studies as a research nurse so I don’t want to deviate a way from research 
but however as a nurse I would like also to do clinical management on the 
ward, handle patients and I can do counseling.” —S002 259
7.3.2—Family/Carer Needs
Family carer needs focused mainly on the socioeco-
nomic problems of feeding and caring for the patient 
and enabling them to attend clinical care, and on the 
psychological challenges of being a carer:
“Since the patient who is my husband has been the bread winner and now 
he is bed ridden, that is my biggest problem. I don’t have money to take 
care of the patient, I was told to give him a good diet but I cannot afford. At 
times the food I have potatoes and beans he does not want to take it so I 
find it a very big problem.” —C004 255
Family poverty was compounded by caring for the 
HIV positive family member, and basic resources to 
provide home care are limited:
“The problem I am seeing is that we as care givers some times we don’t 
have any thing when we visit these people and we just move bear handed 
and when you get there you find the condition of the patient is not good 
and you can not leave him without giving him anything like money.” —
C001 252
“Since he became ill he no longer works although he gets the salary it is 
not enough. We have many children, mine are two and his are about seven 
so the challenge I have is school fees and the feeding. Even transport to the 
facility, because of his condition we need fuel to go the facility because we 
must use a vehicle. I do not have enough money to feed him so I usually 
struggle so much, inside my heart I feel he is not feeding properly because 
I cannot afford the food , I do not have enough money.” —C001 255
There could also be health costs to caring, such as 
the strain of queuing for hours at the health facility:
“Whenever I go there I over stand waiting for the drugs and end up feeling 
a headache and some backache pain.” —C002 255
The needs of family caregivers were rarely discussed 
with clinic staff:
Respondent: “No, we don’t normally share with this [emotional and 
psychological problems]… For me as care giver I have never shared such 
with the health workers here.” 
Interviewer: “Yes, tell more, what do you talk about with a health care 
worker about your finances well being?”
Respondent: “No we don’t discuss this with the health care … surely for 
me, I have never.” —C001 259
It is important to note that for ambulatory patients, 
clinic staff may rarely come into contact with patients’ 
families:
“We don’t see the families. May be if they have come with their families 
at the very first day of coming for treatment or testing for HIV, that’s the 
only day we can see their families—if that patient has come with a family 
member but we never see them again. On return they always come back 
alone.” —S004 256
7.3.3—Patient Needs
The multidimensional needs of patients spanned the 
social/financial (especially food), the clinical/medical, 
the emotional/psychological and preventive areas. 
The ability to attend and benefit from a clinic is 
challenged by poverty even if the patient is able to pay 
for transport to attend:
“I am not okay with the services, we have three clients in the family and 
we have so many problems including food, money for transport, that is a 
problem… You find a family where all members are infected and they are 
too poor and they need help. They also need more of home visits because 
you cannot take all family members to the centre to receive care it is very 
expensive and such families have unique problems and challenges so it is 
good for health care workers to come right to the home, assess the situa-
tion and help accordingly.” —C005 255
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“At times you cannot afford transport costs to come for treatment. And again 
with these drugs we take, one must feed well and because you cannot really 
work hard enough because of compromised health at times even getting 
this food is a big problem. So you may have to stop the drugs because they 
really raise your appetite. Those are the major challenges.” —P001 259
Money spent getting to a care facility means that 
there was less money available for food once admitted 
and waiting, and access to ART means that food may 
be more acutely needed:
“When we come to hospital, they should help us with food, sometimes pa-
tients are badly off in terms of food, you can really feel it if you have starved 
for two days. If they can give us some posho at least because after spending 
on transport you cannot again spend on food… No I just want to re-affirm 
that we need food support if possible these drugs are strong and if you take 
with out food you feel sick and uncomfortable.” —P001 260 
“Much as we give our patients the medicine, but having to take the 
medicine goes beyond having the medicine at home. If I don’t have food, I 
will not take the medicine.” —S004 258
The most commonly reported patient physical 
problems were pain and other symptoms, which can 
prevent access to healthcare: 
“Sometimes she has this severe pain in her right leg and some times she 
applies medicines and it stops but it is recurrent. May be after a month or 
two weeks or even after a week. Like now she is experiencing the pain and 
that’s why she is not able to walk up here with me and that is why I am 
here to collect her drugs from this clinic.” —C001 259
“Yes, like the ARVs at times cause me stomach pains and pains in the legs 
and at times severe headache and rotational dizziness and I feel as if I lose 
balance and focus. Even now I have a problem with my sight and there is 
away the skin itches particularly in my face and in the chest and not all 
body parts and I usually report these symptoms and I am prescribed a few 
tubes and ointments.” —P003 259
“She has been falling sick often, time and again she is down with malaria, 
fever, diarrhoea and general body pain and these days she gets severe 
pain in the bones and this pain has limited her from doing any other work. 
There is a lot of pain in the joints, she feels these are the problems she 
has being HIV positive client and these never used to have them before.” 
—C004 252
Cognitive problems were also reported and could 
hamper treatment:
“What is almost disturbing me is my chest pain. This one is always disturb-
ing me and now let us say this month, the last two weeks I have also been 
forgetful. In fact I am beginning to forget some things a lot like I forgot 
where I had put my keys and some times I have forgotten the time to take 
my drugs but the children I have at home they tell me Baba, have you 
taken your drugs and even that’s why I look like this.” —P004 252
Patients recognised that while their medical care 
was highly valued, there are other equally necessary 
areas of care:
“Fine they give us the drugs but again there is that other side for instance 
when your husband gets to know that you are positive he runs away leav-
ing you at home with the children who in turn will need food.” —C003 
258
Emotional and psychological problems were caused 
both by the experience of living with the diagnosis of 
HIV and by the financial worries experienced as a result 
of it:
“Any way, my biggest worry is about my future. I have no child and my 
dreams are shuttered down and it hurts lots. It is an inner most pain which 
I can’t explain to anybody.” —P003 259
“Some of us we are over burden with children at school, nothing to eat and 
the Umeme people (Electricity bill) are there, so when you go to bed you 
don’t sleep and sometimes I don’t sleep at night and that is the problem I 
have and I know that it is because of what I think about.” —P006 259
However, emotional issues were often not ad-
dressed, even in counselling:
“The first day I came here, counsellor told me that I have to always use 
condoms. That’s the only thing I was told… I have never gone back to the 
counsellor. Besides the counsellor knows nothing about my feeling lonely 
actually no one knows anything of that sort. On my side, I receive every 
thing that I need but I am not happy.” —P001 258
HIV-related stigma from family members, friends 
and the wider community was often a cause of emo-
tional distress:
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“There is stress and stigma, you find this in the community like our neigh-
bours peep at us to see they say there is no family there they are all going 
to die so we have that stigma.” —C005 255
“One neighbour commented recently, ‘I am surprised this lame woman 
contracted HIV, do they also engage in sex? It is funny.’ Others keep reckon-
ing that one has a danger notice she is a moving grave.” —P001 259
“Some of the people laugh at people who are HIV positive, you can see that 
they have not tested but they talk about you that you are sick that thing 
can is something which bring a lot of fear in us, seeing people pointing at 
you that you are HIV Positive. Some people are not taking us well, not all of 
them but some do it.” —P005 260
“During those days when they confirmed that I was HIV positive, I lost all 
my friends and even some of my relatives started ignoring me, even some 
other friends of mine started abandoned me.” —P006 252
This community stigma leads to isolation:
“So I tend to solve them on my own because one thing I know is that if I 
over expose my self to people that I have AIDS it will bring me more prob-
lems than trying to solve this problem before it gets bad.” —P002 259
The burden of knowledge on friends also discour-
aged patients from disclosing:
“Yes sir, because the problems I have stem from psychological wellbeing and 
thoughts because you don’t relate well with others because its like If you tell 
some one that you are positive that persons starts to react in a funny way. 
Like it has now become difficult now to disclose to some one because even 
that person you disclose tends to become closed to himself.” —P003 259
Psychological problems prevented patients from 
accessing clinical care:
“Usually you find that these patients have withdrawn away from the 
community and their close people. They just stay alone and give up and 
lose hope in life and also feel that they have already gone to the end of 
life. They have a thinking that AIDS has marked the end of their life and 
because of this negative thinking towards life usually they don’t come for 
medication. Some feel that they are useless.” —C002 252
In terms of preventive care, patients and families 
in Uganda described a need for the skills of managing 
safer sex within relationships (rather than the provision 
of condoms alone):
“The health worker had a discussion with me and told me that since 
my husband and I are positive we should never have sex without using 
a condom because we may be infected with other sexually transmitted 
diseases and that won’t be good as well. But when I reached home I told 
my husband what the health worker had told me but my husband refused 
that I am his wife therefore he cannot use a condom. And because of the 
husbands set laws, I am in his house and cannot run away so we don’t use 
condoms though we don’t regularly meet.” —C001 260
7.4—Components of Care Provided
When staff, patients and families were asked about 
the care they have specifically delivered and received, 
prompts were given for the multidimensional possible 
areas of care.
7.4.1—Bereavement Care and Care of the Dying
“Under bereavement counseling, we tell them that you know every thing 
has a beginning and every thing has an end. So, one time one day one has 
to die when things become worse but before things become worse off we 
have to prepare our selves ready to receive what ever may come our away. 
So here also spiritual counseling comes in one has to get ready and family 
members have to know that things will come to an end one day because 
with HIV it has no cure, so one time one can die, so if one has to die are we 
ready to accept what will happen? If we have lost one today what have we 
prepared ready? Are we ready to support the family members, may be the 
children or if it’s the father are we able to support the family or children 
who will be left or wife? So we have to prepare and be ready to accept what 
ever case may come We also make if possible if he is still able to make a will 
such that it will help the family members who are around.” —S001 252
The availability of centres locally to refer for provi-
sion of specialist palliative care is essential:
“For the terminally ill patients, say patients who have a difficult condition 
in stage IV probably Lymphoma we take them to the cancer institute and 
from the cancer institute some are sent to HOSPICE Africa Uganda for joint 
management, both cancer therapy, ARVs from [facility] as well Hospice 
treatment and care.” —S001 259
The need for specialist training to provide holistic 
palliative care within the facility was recognised:
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“We need to be close to them and that’s why the hospital discovered that 
there is need to train some other counselors to have the component of 
spiritual counseling.” —S002 252
For those adequately skilled staff, an appropriate 
psychological and spiritual care response was described:
“When we know that the patient has no chances of improving we contact 
the relatives and prepare them psychologically because some of us have 
had special training in hospice, they taught us how to handle them and 
prepare them for eventualities, and by the time the patient reaches the 
time of dying they are already prepared psychologically they know this 
patent may have to die and some of them we assist them to write wills or 
show us their next of kin can be approached and assisted in a special way. 
In that way I think by the time a patient dies they are prepared enough to 
handle the situation.” —S002 259 
It was also suggested that the need for spiritual care 
at the end of life was culturally evident:
“We are Africans and we know even from our homes we know someone 
who is very sick you can do what we call spiritual care assessment, if the 
person is very sick and people at home are saying ha that one we don’t 
have any hope they have lost hope so we bring in the spiritual care and the 
usual counselling. The drugs are no longer working and they are saying this 
one will not even reach tomorrow then that is the time you say at least me 
go with a reverend because for me I don’t know how to pray.” —S005 255
However, good terminal care is more than emo-
tional support, and the need for additional components 
of palliative care was expressed:
“There is nothing much but when I get to know in time and I have time 
and I am able at time when we are doing the home visiting I go there and 
feel sorry for the family but there is nothing much that we offer. Except 
that psycho social support some bit of counselling being there with the 
family members.” —S003 255
For care of the dying, a significant barrier was the 
lack of availability of home-based care:
“We advise the care takers to take them back home and in the past we 
would provide those home visits- caring for them at home, home based 
care and palliative care but the funding for home based care was cut so, we 
no longer have active home based care and when we use the community 
groups to visit those ill patients we also go.” —S003 252
“Here at [place] if we have a patient dying around here we transport the 
body, we have ambulances, we help transport the body probably to their 
homes and of course we console the next of kin and then we end it there. 
If the patient is at home we cannot do much because we don’t have much 
contact.” —S003 259
Bereavement care was rarely mentioned:
“Bereavement care, it is very important very few provide it, I think I have 
given it two times since I have been here.” —S003 260
In summary, end of life care focused on prepared-
ness and emotional support rather than comprehensive 
palliative and terminal care. 
7.4.2—Family Carers
The focus on carers within clinical time was challenged 
by lack of contact, although there were good examples 
of family-based care. The family carer was sometimes 
treated as part of the unit of care. This was confirmed 
by family carers:
“They normally ask me about the problems I am experiencing during 
provision of care to my patient. And for our problems; also we should come 
to them and tell them what we are facing/where we are challenged so that 
they get to know how to assist us.” —C001 252
Respondent: “Basically, what we discuss about with this health worker is 
about this brother of mine; how he is feeling and how we are caring about 
him.”
Interviewer: “Do they ever ask you any problems that you have as a carer?”
Respondent: “They do… The problems at home such as; if you have any 
financial problem, any extended family problem, financial problem etc.” 
—C003 259
Carers wanted help to be able to give psychologi-
cal support to their patients and to manage emotional 
stress:
“They should get more counsellors and those counsellors should be 
capable of talking to the care takers and tell them how to their patients. For 
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instance you might be having a patient and you are always barking at her, 
yet she is sick. You know how people stigmatize others like asking ques-
tions like who sent her there. I wasn’t with you when you were getting the 
virus? etc that’s bad because a patient will get a bad heart and can do any 
thing so they should talk to the care takers and tell them what they have to 
do to support their patients and that’s what I really want.” —C002 259
The lack of off-site provision was a challenge:
“Occasionally we get into contact with the patient’s family but that is 
mostly when the family member comes with the patient. We do not have 
a very well established outreach department where it would involve us 
going to the patient’s home. But mostly when the patient comes with 
a family member we are able to get in touch. okay, we give the family 
information about the patient’s illness and we also encourage them to test 
as well and we also counsel them together.” —S001 260
As were the financial and opportunity costs to car-
ers of getting to the facility:
Interviewer: “Do you involve families in your services?”
Respondent: “We are trying our best it’s been such a challenge given the 
socio economic factors of the patients that come in, like I don’t know 
whether it happens in other HIV clinics.” —S004 258
“Wherever I go there I dont get time to talk to the health worker only who 
writes for me septrines I get them and then rush back home because I am 
usually on a hurry and I have left children alone at home, the business so I 
don’t usually talk to the counsellor.” —C002 255 
Sometimes the facility required a family carer/
guardian to be identified by the patient:
“For the TB people we encourage them to have someone they trust or 
someone that can help them take their treatment. If like someone is on 
treatment, the TB treatment, we ask for another contact person in case they 
are not able to come, in case they have a problem and they are not able 
to pick the drugs, or someone to remind them take their drugs. So if they 
are able to come with that person in the clinic we encourage them to do 
it, if they are not able, we tell them to at least give us the number of that 
person who is in charge of them.” —S005 256
“At the initial stage we emphasize at least one member of the family or 
closest member of kin has to be there. Actually that is one of the criteria 
and if you don’t have a close member of the family as a supporter you 
are not started on treatment so that the person when the patient fails on 
adherence issues and can give an independent report on the client if the 
person is responding well or taking the drug properly.” —S005 252 
7.4.3—Spiritual Care
Spiritual wellbeing and support are important compo-
nents of the patient disease experience. The awareness 
of spiritual care needs sometimes formed part of the 
ongoing contact assessment:
“Any way they normally ask whether these people (spiritual leaders- 
priests and pastors) from church ever come to visit me at home to share 
spiritual needs.” —P001 252
As well as providing support and meeting patients 
needs for spiritual wellbeing, religious observance is 
also instructed as part of clinical advice, and this was 
confirmed by staff and patients: 
“Yeah, they talk about it and like me mostly we talk about issues related to 
God and first we pray and we tell them that they should also pray because 
any thing in this world can happen but not for his or her need but it’s a God 
given gift and when you are like that first you should know that God exists 
and secondly the other things also follow.” —C001 252
Interestingly, training also incorporated instruction 
for family carers on how to meet spiritual care needs so 
that it is not a professional responsibility when patients 
are not at clinic, and that spiritual care providers would 
attend patients when they are attending facilities for 
care:
“I am busy most of the time and those sessions are usually held during 
working days. For example she told me that we have to keep him in a clean 
environment to reduce on infections. The patient needs love, he should 
sleep under a mosquito bed net, he should take clean and boiled water, he 
should be given comfort and spiritual guidance. The spiritual leaders come 
with a message of love, faithfulness in relationship and they encourage 
us to ask God to give us courage and strength so Tuesdays afternoon they 
come here and pray with us.” —C001 255
A key message is that while religious attendance is 
essential to wellbeing and should be observed, it should 
exist alongside adherence to medical intervention:
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“They health workers told us that we should pray to God as well as taking 
drugs because God cannot work alone but work hand in hand.” —C001 260
Sexual fidelity, preventing HIV reinfection or 
transmission, was a spiritual issue:
Interviewer: “What do you discuss with the health workers about spiritual 
care?”
Respondent: “To be faithful with their partners that’s the most important 
thing and to be faithful means that you know God. A person being faithful 
that means he loves his God and has the spiritual care.” —P004 260
Encouraging fellowship was also seen as a means 
to facilitate community and social participation and 
interaction: 
“Yes, it is one the things they talk about. Like how to maintain a personal 
relationship with God. They tell us that when we are at home we have to 
love one another and also interact well with neighbours and attend mass 
at church and be part of fellowship.” —P003 252
However, not all patients across facilities had ex-
perience of spirituality being a component of their care 
received:
Interviewer: “Do the health care workers talk to you about things to do 
with your spirituality?”
Respondent: “No I have never heard of it here.” —P006 259 
Interviewer: “Tell me frankly do they ask you anything about your 
spirituality?”
Respondent: “About spiritual care I have to boldly say no because I have not 
heard of any spiritual care here. Personally I don’t know.” —P007 259
7.4.4—Socio-economic Care
There were excellent examples given of social care being 
an integral component of the multidimensional care 
given:
“First of all, he comes for treatment and secondly he comes for counselling 
in case of something and thirdly when there is food distribution because he 
is one of the beneficiaries.” —C001 252 
“They offer her transport in form of cash to facilitate her when coming back 
for the next appointment date. They ask her the progress, whether she has 
improved with her condition or not. You know talking to a sick person is 
good as they need to find out how the patient is feeling and what is really 
bothering her. So that is one of the good things they do for her. They talk to 
her in privacy for confidentiality.” —C002 259
“They normally say that clients should be able to know clearly their 
financial status because when they don’t know their financial status they 
may be able to demand what they can’t afford or what they care taker can’t 
afford.” —C003 252
This comprehensive care approach was well de-
scribed as a complement to ART access:
“Apart from ARVs, they normally give me transport refund and some 
assistance like some money, sugar and floor… The hospital helps a lot like 
in a month for instance gives us food stuffs like beans and posho and they 
also help to monitor the drug toxicity and any other drug side effects that 
may occur.” —P003 252
There were also examples of the absence of inte-
grated care:
“The challenge I have seen is I think is about nutrition they don’t have food 
someone is the bread winner but he is the one who is sick, the children 
when they see you riding a motor bicycle they expect may be you have 
something to give them but we don’t give. They see someone coming we 
just take drugs but on their faces you see something like they are expecting 
something from you.“ —S005 255
In addition to social assistance, counselling and 
guidance on how to generate income, budget, and meet 
needs was given: 
“They usually come and tell us to budget well for our income so that we 
can sustain ourselves. We are told not to waste our money in expensive 
things which do not help us. We are also encouraged to socialise with other 
people so even if we are positive, this should not stop us from socialising 
with other people, we should isolate our selves and there are many other 
people living with this virus of HIV.” —C001 255
“About the social aspect they say that… and the financial issues they ask 
about how I use my salary over the month like how I utilise the 93,000 I 
earn on a monthly basis.” —P001 252 
Phase 2 uganda 72
results of Qualitative interviews 72
“There was a seminar where they brought somebody who taught us how 
to make soap. I think they also bring people who can teach us to some 
income generating activities.” —P005 259
“They encourage us to raise small amounts of money to rear chicks or pigs 
or even goats , you may then get some help sometimes.” —P007 255
7.4.5—Psychological and Emotional Care
Along with medical treatment and social support, 
emotional support was seen as an integral component 
of holistic care: 
“First of all, he comes for treatment and secondly he comes for counselling 
in case of something and thirdly when there is food distribution because he 
is one of the beneficiaries.” —C001 252 
Some very tangible outcomes attributed to emo-
tional support and counselling were described:
“The problem that I had before sharing with the health worker was that 
the children used to disturb me a lot and as a result I would beat them 
saying that after all I am going to die [laughter] but after the health worker 
educating me on what to do, It’s no longer a problem but that was my 
problem. Whenever I could see them, I would get angry that I would even 
start thinking that maybe they are also infected and beat them the more 
but now I am okay. But the only thing that I am told whenever I come is 
to be strong and have confidence. I was told to leave to relax and leave the 
children alone basically I am always told constructive things which help 
me to remain strong.” —C003 258
Interviewer: “You said you had a problem with stigma, how did the facility 
help you to solve the stigma issue?”
Respondent: “Through the counsellors I was counselled and I have tried 
to adhere to what they tell me to do I am now coping. They also say that 
if I have a problem I should express it to them. And I am fine its ok not to 
discuss.” —P001 252
“They help us to remain strong in the mind so you think, despite all this 
I still have a life to protect to live longer. For instance I had despaired lost 
hope and I even wanted to take poison and commit suicide because I felt 
were not fitting in society but when I shared it with the counsellor she told 
me that I am not alone neither the first nor the last to have HIV and that I 
had no authority to take it away.” —P003 258
Significant emotional support was gained through 
being part of a larger community of HIV-positive 
people attending the facility:
“Maybe I will say that they give us a good environment. When you come 
here you find so many other HIV positive people and this consoles you. You 
will appreciate that you are not alone, and you gain the courage. We also 
share experiences, challenges and how to deal with them so I find this very 
very helpful.” —P001 259
This encouragement to access support beyond facil-
ity staff included spiritual community, the HIV com-
munity, and cognitive strategies:
“So they health care worker will ask you about your worries, if you appear 
depressed they will ask you what is depressing you and may be give you 
counselling. They also ask about your relationship with your family, such 
things. They encourage us to love each other and they encourage us to dis-
close to each other. We are also told to join support groups so that we can 
share our problems with colleagues. We are told that you can live happily 
if you do that. Well I was worried over loan and after reaching the doctor’s 
room I told him that I am having a problem and you know such problems 
can even cause your CD4 count to drop and you weaken because of over 
thinking and worry. So they console you and encourage you to contact a 
spiritual leader to pray for you. You are also encouraged to talk to friends 
they can help.” —P001 260
Carers were also encouraged to provide emotional 
support and psychological help to patients:
Interviewer: “What about on issues concerning how you feel and think, do 
they ever tell you anything?”
Respondent: “Yes they do talk to us.”
Interviewer: “How should you handle the patients?”
Respondent: “We have to take good care of our patients so that they avoid 
worrying. You comfort her; counsel her so that she doesn’t worry about 
anything.” —C004 258
7.4.6—Clinical and Medical Care
CD4 monitoring, receipt of ART and CTX are un-
surprisingly the core medical care described. In order 
to enhance access to medicines, community health 
workers support patients who are too physically frail to 
access medicines: 
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“If my patient is weak, I just bring form V to collect the drugs and I take the 
drugs to that patient. I always do it to help the patient.” —C002 252 
Patients frequently described being able to present 
problems and complications:
“Of recent she has been coming here frequently because she has been hav-
ing complications like dizziness, etc. The drugs she was taking at first were 
resisting her body and she had to come back and switch to another line. 
She has been coming here because of these complications like dizziness, 
diarrhoea.” —C002 259
However, in one instance a facility encouraged 
patients to present minor ailments elsewhere:
“For minor illnesses we are encouraged to go to near by health centres.” 
—P002 260
Advice on how to take (and adhere to) medications 
was also a commonly described aspect of medical care:
“Like today, she was not feeling very well and she has malaria, so she 
came today to get medicines. The health care worker tells her how she is 
supposed to take the medicine, gives her advice on how to do it and all the 
necessary information she needs to know about the medicines. She should 
take the medicines the time they tell her, she should take it in the morning 
after lunch and then at night.” —C004 259
The fact that ART was free was of great importance:
“That time we used to pay some little money for the drugs but some how 
I failed to raise the money and gave up. So, I started on herbal medicine- 
the liquid solution and my health deteriorated and I started shivering and 
when I came back and the doctor realised that had seen me before and 
said; you woman I think I know you, aren’t you one of my clients on ARVs? I 
said yes and told him the truth that I had absconded because I failed to pay 
for the drugs. He told me that there is free treatment and I should begin on 
medication. And that’s my story.” —P004 259
7.4.7—Preventive Care
The final component of care described was compro-
mised of preventive care activities. All three elements 
of the ABC strategy were promoted to patients. Zero 
grazing originally meant being faithful but for the 
many widowed patients it was effectively abstinence:
“Zero grazing is number one-that means you don’t go in for sexual inter-
course, we are told if you are unable then you have to use condoms, I think 
I have missed one.” —P005 258
“Ever since I came to know that I have HIV, my sex life changed that I no 
longer play sex. I believe that when I play sex I use a lot energy and I will 
become weak. But now I am used to that. They even gave us condoms but 
ever since we tested with my wife, the appetite is no more.” —P003 256
Within discussion about prevention of transmission, 
the concepts of reinfection and resistance were offered:
“For example she told me that we have to keep him in a clean environment 
to reduce on infections. The patient needs love, he should sleep under a 
mosquito bed net, he should take clean and boiled water, he should be 
given comfort and spiritual guidance…They told both of us that since 
my husband is on ARVS, we should not have un protected sex we should 
use a condom or else they talk of re-infections, and since he is on drugs if I 
have unprotected sex I may acquire a virus strain that is resistant to ARVs so 
when my time comes to us these drugs, the virus can be stubborn and so 
the drugs may not help me.” —C001 255
Basic universal safety precautions and health pro-
moting daily living were taught to patients:
“Okay, may be like we are not supposed to share any sharp things with 
her such as needles, razor blades and if she has used them we dispose 
them off immediately to a secure place which is out of reach for any other 
person.” —C001 259
“Well, they normally tell us to maintain hygiene at home and they also 
tell us that when we are home, our environment must be clean, our house 
must be clean and we have to eat a balanced diet and hot food. They have 
been teaching us these things I have mentioned above.” —P003 253
“Ya they told me to use condoms and they taught me how to use them. 
They asked me if I take alcohol, of which I used to take and they advised 
me if possible I reduce or I abandon it completely. They also asked me if 
I smoke, good enough since I was born I have never smoked. Again they 
advised me about eating well. Eating well needs money so with eating 
well I have not changed because I don’t have money. I only eat as I used to 
eat.” —P006 256
And prophylactic medication was provided along-
side the Basic Care Package:
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“I get medicines in particular septrin and I was told that they will help me 
to fight against opportunistic infections.” —P001 258
“We have to sleep under the nets, to take boiled water-not to take this 
un boiled water. Ya it is just to take boiled water to sleep under the nets.” 
—P004 256
“Its courage. They give me courage, they tell me how to live positively, and 
they gave me a kit containing a jerican, mosquito net, water guard, and 
condoms.” —P006 256
Nutritional counselling was not thought to be 
sufficient:
“As people living with HIV, they tell us to have good nutrition or feeding 
but most of us do not money or even land to cultivate and those who have 
the land do not have power.” —P005 255
7.5—Experience of Delivering and Receiving Care
7.5.1—Patient and Carer Experiences of 
Receiving Care
Positive experiences: The vast majority of respondents 
reported positive experiences of being under care. The 
three factors that appeared to constitute a positive 
experience were good staff attitude, availability of drugs, 
and emotional support. Patients’ most frequent view 
on their experience of care received was the tangible 
change on their health since being provided with ART, 
and their gratefulness for this (particularly free-of-
charge medication access):
“Because of the patient’s improvement which I am now seeing, like in the 
past he could not even do anything like carrying even water to bath, but 
now days he even carries a five litre jerrican of water to a bath room. And 
he can also now move around; from home to the trading centre and to 
the hospital and back. Because at first I used to carry him, I used to bring 
him for refill and CD4 count tests and then take him back and then I would 
bring him back for results.” —C001 252 
“The good thing I am receiving here is the drugs. They have given me 
energy and al least I can do some work because by the time before I was 
taking this ART drug I was weak, so after taking this ART drugs even now 
I am just from the garden and at least I am trying to do some thing for 
myself.” —P004 252
However, the emotional support and advice re-
ceived from staff and other patients that complement 
ART was also valued:
“Like the treatment I am getting has now improved the quality of my life 
and because I get treatment only from here and may be the advise from 
the counsellors.” —P001 252
“We are like a family because of our status. You get to a time when you 
meet people in similar situations.” —P001 256
“Maybe I will say that they give us a good environment. When you come 
here you find so many other HIV positive people and this consoles you. You 
will appreciate that you are not alone, and you gain the courage. We also 
share experiences, challenges and how to deal with them so I find this very 
very helpful.” —P001 259
A good staff attitude was associated with being 
welcoming, and an ability for patients to communicate 
effectively their needs and experiences to clinicians:
“They do not shout at patients, they are so gentle and calm. The situation 
here is different you come just once and receive everything and you away 
very satisfied. They give me ARVs they gave me the right regimen that does 
not give me problems. I was battling with lack of appetite but that went 
away I eat very well these days, I worry less because I am healthy most 
of the time. I lost my child and my husband but I have peace of mind and 
when I come here at [facility] and my doctor, my nurse treat so well like 
I explained I really feel peaceful and happy, and I want to thank them so 
much and it is only God who can reward them, and grant their greatest 
desires. that is my prayer.” P001 259
“When I come here the health care workers are friendly.” —P001 260
“Well, doctors and nurses are doing very well here because once you go 
to them with a problem they counsel you and they don’t want you to be 
worried so much all the time.” —P001 252
“Ah, that one I have to be frank. I have never got a problem with the staffs 
here because I am even happy that even some when they meet you on 
the road they are so happy to talk to you and they are so open minded and 
good.” —P002 259
Lastly, the provision of socioeconomic support was 
mentioned as a positive experience of care:
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“The first one is the drugs I am taking and secondly there is some money 
they give me like transport and I am a beneficiary of the World Food 
Programme support like beans and maize floor for posho.” —P003 252
Negative experiences: Many more positive than 
negative experiences were reported. The major problem 
reported was that of delays due to staff shortages in see-
ing clinic staff, with implications for hunger, ability to 
earn money/work crops, and frustration: 
“Basically, what I don’t see good here is time, either it is some times we 
spend here too long here like this morning I arrived here close to 9:30 AM 
and we are approaching mid day I have not got the service yet and basi-
cally that one.” —P002 259
“Oh the major problem is delays. We come here in the morning sit and 
wait, the process takes too long and there are so many people. The other 
problem is transportation, we come from very far so it is expensive and 
also since the journeys are long you may get here late. For example they 
close at midday sometimes so you cannot take there your documents 
[prescriptions] to get drugs, this is big challenge.” —P002 260 
“They are very many people and the line is very long you come here early 
in the morning but you leave the clinic in the afternoon or evening because 
of too many people.” —P005 260
This following quote also exemplifies patients not 
being able to have emotional needs met due to lack of 
counselling staff: 
“They (hospital) have only few doctors and the patients are very many and 
that they can not handle them. So, that is why they are delaying here and 
they take long without taking (feeding) any thing. Besides they come here 
very early like at 6:00AM in the morning hours and so they delay here up 
to lunch time without taking anything and that’s the problem they are fac-
ing. And secondly, they are having few counsellors. And that’s the problem 
and you know a doctor can not give maximum advice to a patient because 
he needs to see other patients also.” —C001 252 
A further problem frequently cited was the avail-
ability of medicines, and the associated costs to patients 
and reduction in the likelihood that they will access the 
drugs that have been prescribed for them:
“Of course once in a while they say that the drugs or a particular type of 
drug is not available, go and buy it but this normally happens… I said earli-
er that one of the things that’s not so good and presses us is when you come 
and they tell you that we do not have that drug yet you decided to go come 
to this centre where you can pay 1,000 shillings and you receive the drugs. 
Now imagine you get here pay the 1000 shillings you just get some of the 
drugs and you are told to go and buy the other drugs from a pharmacy. So 
you have to add more to that 1000 to buy the other drugs from pharmacy 
else where. So that is pressing it would be good to pay if the 1,000 could 
cater for everything, that would be more beneficial.” —P001 256
“There are sometimes when you are told to buy a few non essential drugs 
from the open market or clinics when they don’t have them and at times 
we fail to get them from these clinics and pharmacies.” —P003 259
This problem with drug availability was also noted, 
along with an occasional poor staff attitude:
“Some times when you come here the health workers are harsh to people, 
they are rude and some times its like when you come late you have to stay 
in the line up to 2:00 p.m. and some times you are hungry what, what! So 
if you want to go the medicines like you want to go back home earlier you 
have to come also earlier so that you don’t get any problems. But people 
are many so you have to come here by 7:00 a.m.” —P005 252 
“We have kids, sometimes we even fail to get what to eat for a balanced 
diet so when like me a widow you tell me to go and buy the medication 
because you are busy and you say we are busy and tired. We know and 
appreciate but that rude tongue is sometimes not good. And In such a 
situation I am not happy but other nurses and social workers do but not all 
of them.” —P006 259
While the provision of information on prescribed 
medications was noted earlier as a highly valued re-
ceived component of care, it was not universally ad-
equately received: 
“We need more information on our medications for me I feel we are not get-
ting enough information, why is it important to take it as prescribed, what 
may happen later, why they change regimens such things.” —P002 260
7.5.2—Facility Strengths and Challenges
Facility strengths: When asked about the particu-
lar strengths of a facility, these mirrored the positive 
experiences of care, particularly staff attitudes towards 
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patients and availability of drugs and services. Staff at-
titude appears to be key to the patient experience:
“I have liked the way patients are cared for receiving drugs I feel I want to 
change and come here.” —C001 260 
“Other things are okay, the staff here are friendly, they know how to handle 
us not like in other hospitals were nurses roughens you up and down. I 
have never been roughened here!” —P002 259
“The services here are not bad because we patients are given respect when 
we come here they make sure they well come us talk to us kindly and give 
services as we want.” —P005 260
The ability to have all needs met appropriately (in-
cluding medications) onsite and in a timely fashion was 
seen as essential in defining a positive experience: 
“According to me everything is fine because whenever I come I always get 
what I want and more so in time.” —C004 258
“Yes it takes a short time here to receive the services.” —C005 255
“These is a book they gave us to help us check for dates, to remind us when 
to take drugs and then when to return for check up.” —C002 255
“And when you come here there are no complaints like there is no drug in 
the pharmacy.” —P004 252
Lastly, the ability to give hope and spiritual care 
was described as a positive aspect of care: 
“Words of hope also help on spiritual issues, they encourage us to have 
faith in God and great hope for the future.” —P002 255
Facility challenges: A number of core challenges to 
participating care facilities were identified. Firstly, chal-
lenges were identified by patients in terms of availabil-
ity of counselling staff and challenges to general access 
to care due to lack of home care: 
“Counsellors are few and for home visits our family is too big and we have 
three HIV positive people in the family so they the patients need counselling 
but when you tell the counsellors they look at the clientele number and it 
is big yet the counsellors are few. I am not okay with the services, we have 
three clients in the family and we have so many problems including food, 
money for transport, that is a problem. Even counsellors do not want to 
come over for counselling during home visits so that is not fair.” —C005 255
The view that expanding patient numbers limited 
access to care was echoed by staff:
“Yes this is a big clinic and it is growing day by day yet we have a man-
power problem. I said we have quality manpower but it is not adequate. 
So that is one of the weaknesses that we have as a clinic.” —S001 260 
This problem of increasing numbers places stress on 
clinical space in which to deliver care:
“Our main weakness that probably we have and is about to be solved is 
space because at the beginning the facility was small, it was designed to 
handle a limited number of patients bit since ARVs came and now people 
know we give free ARVs. The numbers are swelling in every time. So the 
space is very limited although we have well trained health workers we are 
overwhelmed by number of patients and limited space.” —S002 259
The human resource challenge was further exacer-
bated by difficulties in retaining staff due to the heavy 
workload and demoralisation:
“People find it that here there is low payment and yet there is a lot of work 
so they jump out. So, I must say that the weakness here is only along the 
line low payment but heavy work load. And demand for life in our local 
area here is very high but you have to work here even on Sundays, you 
don’t have time to do any other business out side, so it is a big challenge to 
the staff.” —S002 252
“Lack of motivation, in fact we have lost very many, they have gone saying 
that they can not withstand and continue with the work we are doing.” 
—S002 258
Onsite lab facility expansion was identified as a 
challenge by staff:
“We need to do something about the lab so that other tests like liver func-
tion tests can be done because in that case we could be in position to scale 
up and do ART.” —S001 256
As mentioned earlier by patients, the ability to 
secure drug supplies is a challenge to dispensing: 
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“In this facility, first of all we get drugs from [supplier], and some times 
we get it direct from [supplier] to the hospital, some times we get it via 
partners like [supplier]. And if we get it direct from [supplier], it reaches 
on time but if some times we get it through partners like [supplier] some 
times delays on the way and during transportation part of it may get dam-
aged on the way. And these are all challenges but I must say that we have 
been getting our medicines/drugs on timely basis because we don’t wait 
until the pharmacy is empty. We just look at the stock if it is going down 
and if it can push the hospital just some few months we immediately 
make the orders.” —S002 252
Lastly, the reliance on donor funds raised concerns 
about sustainability:
“Actually, sustainability is a big challenge because our institution is donor 
dependant. Though we are trying to build and work on IGAs for the 
hospital we still cannot meet the demand.” —S002 252
7.5.3—Suggestions for Improvement
The core areas for improvement reflect the unmet 
needs, strengths/challenges and experiences of care. The 
points raised included reduced waiting times, maintain-
ing drug stocks and replacement of ITNs. Additionally 
home-based care and community visits were suggested, 
including sensitisation of VCT in order to reduce 
stigma, and reaching rural areas:
“They also need more of home visits because you cannot take all family 
members to the centre to receive care it is very expensive and such families 
have unique problems and challenges so it is good for health care workers 
to come right to the home, assess the situation and help accordingly.” —
C005 255.
Respondent: “May be if they can put drugs near people mostly those who 
fear to come to health centres at least they can access them from their 
homes that can be better.”
Interviewer: “You said these people just fear to come or?”
Respondent: “There are some people of that kind who may fear coming 
to health centres because people will see them and say they are sick.” —
P006 255
One facility provided ARVs by referral and patients 
would have preferred to receive them directly:
“On my side I am satisfied but my appeal is about providing us with ARVs 
from this place. Let them not stop on testing, giving septrin and TB drugs 
but also give ARVs to those who want to do so from this place. After testing 
our CD4, they again refer us to other centres yet [facility] is convenient for 
those around [town].” —P003 256
Many patients and carers asked for economic help, 
for themselves or for others:
“I would need support of educating my grandchildren.” —P003 255
“I would suggest that now they became very merciful to help such patients 
like us at least they should contribute some little funds to help such people 
who are coming from different areas. If they could be given some transport 
to take them back.” —P002 255
“So, which means that if possible you should assist us with some things 
even like these home based care kits, they should give us these gloves 
because all these are the problems that we have and on the side of family 
members we see them wash the patient’s body and they do it directly 
using hands and are not protected and because of this the patients can 
infect other people. If possible those people should be assisted materially.” 
—C001 252
7.6—Multiple Identities
In this qualitative component of the study, we aimed to 
collect information from patients, staff and families to 
triangulate data and integrate the datasets on experi-
ences and views on care and support. Interestingly, the 
data demonstrated interrelatedness between these roles, 
reflecting the fact that staff and carers may also be pa-
tients. The presence of openly HIV positive staff/carers 
is seen to facilitate supportive counselling:
“I have stayed long taking the drugs and I am now like a counsellor in the 
home based care programme. So when there is some difficult for patients 
I come and negotiate with them. I also counsel my fellow HIV patients and 
at times they tell me what I should communicate to them.” —P002 252
Interviewer: “What brings you to [facility] normally?”
Respondent: “To get the treatment and care and besides I am working here 
as a hospital employee.” —P001 252
“I first tested in 2001 at [place] hospital, when they found me positive off 
course I disclosed first to my family, friends and community. Then when 
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[facility] started in 2004 I was number 14 in registration because I had 
already known what AIDS. Presently, I am a drama member at [place] and 
I trained as a support agent in [NGO] and now I am a network support 
agent at health centre three level.” —P005 255
Several carers in the study were themselves HIV 
positive and might be caring for multiple family 
members:
“This carer was looking after 3 family members who were [facility] clients 
and he was HIV positive himself. He had to take on the carer’s role because 
it was just him who was still strong enough though infected. Oral consent 
was granted by one of his brothers for him to be interviewed as a carer.” 
—C005 255
Patients are encouraged to take roles as community 
advocates, expert patients and role models: 
“Yes we are encouraged to disclose our sero status and even encourage 
others to go for testing.” —C002 255
“They also go for outreaches and at times they invite me to talk on their 
behalf in the community during the out reach days. Actually, out of these 
outreaches I have gained lots of experiences and I actually replicate the 
lessons learnt among my family members.” —C003 252
“We are encouraged to offer hope to those living in denial and we encour-
age them to open up and receive the care. At times I tell people I am HIV 
positive and some do not believe but what I want them to pick from that is 
that life can continue normally.” —P001 259
“We are told to encourage friends and relatives who get chronic fevers, 
sexually transmitted infections, headaches and general weaknesses to 
go for HIV test and we are told to use persuasive language. In fact the 
people believe when they see this has been the most powerful tool for 
communication in my village, I was badly off but now I am health and I 
can walk so when I talk to other people it is very easy to convince them to 
come over for testing and enrol into the care system if they are found to be 
HIV positive.” —P001 260
Consistent with this overlap of roles, patients 
preferred to be employed by the facility where their 
needs would be understood, and felt the facility should 
support them in this way if possible. 
“We were in need that if they could give us a chance if there are posts here, 
they should also include us in [facility] as we come here and they open up 
our files they also ask us the qualification like me I am diploma holder so I 
can come under [facility] and get something to do Under [facility] because 
I think when I come here I will be working with my own people. It is the 
environment I can fit in well. When I am working with fellow clients and 
there are clinicians around when I get problem or feel sick they give you 
the treatment. But when you are working outside there in the community 
they do not appreciate that you are sick but when we are here as clients, 
let them see us as clients but clients with qualifications and who can come 
and help here when there is need.” —P002 255
The relationship between long-term patients and 
the facility could become strained by the uncertainty 
around the roles of patient, carer and staff member:
Interviewer: “Is there anything that you see that isn’t good whenever you 
go to AIC?”
Respondent: “Most of us are trained but again they can never employ us 
here. In most cases as I told you were are volunteers, we are never con-
sidered much for instance if a condition came by, we are the first ones to 
be shown the exit. When they need you, they will call you like how called 
me here to be interviewed. I wish they could change and know that we 
also part of the organisation and explain to us properly what’s happening. 
For example I have spent 20 years in this organisation but they can never 
employ me as a sweeper they would rather employ someone else yet I can 
also do that job properly.” —P002 256
7.7—Access to Care
7.7.1—Health Seeking Behaviour
Patients described what motivated them to access HIV 
care, which was usually because they had unexplained 
symptoms and poor health that were suggestive of HIV 
infection and advanced disease:
“Basically, a brother of mine had a problem related to HIV and he was 
brought here by relatives and after some two weeks he greatly improved 
and when I developed the same kind of problem my brother had, my rela-
tives and brothers felt wise that I should also give it a try to the same place. 
By then I didn’t know my status but when we came here I had a problem of 
AIDS and that’s how I started.” —P002 259
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“By the time I came to [facility] I was weak. So, I decided to come and test 
my blood for HIV. I found that I was positive and I would like these people 
to assist me if they can with any thing.” —P002 252
“The first health care worker I met asked me about my history and I told 
him and by the time I came to this facility I were extremely weak and not 
feeling well.” —P003 259 
The other, less common, reason given was routine 
testing:
“Okay, I had given birth to a baby. It came to be that this child was born 
positive, now when I brought her to [place] there at the assessment centre, 
we were admitted on the children’s ward and I spent one and half months 
on ward 1C. So this child was tested and I was told that she was infected. 
So from there we went to [place] which is provides care for the children. It 
is those people that gave a referral letter to this place and then I brought 
my husband later. But this child passed away after some time.” —P003 
258
7.7.2—Process of Choosing a Facility
The three principle reasons patients gave for selecting 
a facility were proximity to home, personal recom-
mendation, and the specific nature of care offered. As 
transport costs have been identified as a major barrier 
to care, it is unsurprising that proximity and cost were 
core reasons for choice of facility:
“[Place] is near my place and I don’t want to incur any transport costs.” 
—P003 252
“At the first time, it was very difficult because I thought they use money 
and by then I didn’t have the money and I had a friend who directed me 
here and told me care was free. So, that is how I came to find my self at the 
hospital.” —P002 252
The importance of personal recommendation was 
also key: 
“I first went to a clinic in [place], so as I was there, a friend to my husband 
whose name is [name] , he actually hails from Masindi. So he advised us 
to try [place] and recommended that we see [name].” —P001 259
“Basically, a brother of mine had a problem related to HIV and he was 
brought here by relatives and after some two weeks he greatly improved 
and when I developed the same kind of problem my brother had, my 
relatives and brothers felt wise that I should also give it a try to the same 
place.” —P002 259
Lastly, the nature of the facilities’ services also acted 
as a deciding factor: 
“Now what made me so attached to this centre, when I got to know that 
there was a post test club for those who have tested positive that gave me 
the momentum to keep coming here and it made me more of an [place] 
person. That is why you have managed to find me here.” —P001 256
7.7.3—Eligibility Criteria
Staff at all facilities said that they accept any HIV posi-
tive patient:
“No, under [name] Programme supported by PEPFAR we enroll patients 
as long as they tell us they will be able to come to this facility to pick their 
ARVs. We don’t care about the boundaries. Its other centres which have 
that criteria of radiuses say they will enroll patients with in 20km radius but 
for [name] we don’t have those barriers as long as they are able to assure 
as they will have to come in for their refills.” —S001 259
“For all those who are willing and they are able to continue coming to our 
clinic on a routine basis, we have been able to take care of them with out 
any big problem.” —S002 260
However, caution was exercised in imitating 
therapy and “patient readiness” was appraised:
“But if we are talking of the ART we have the clinical criteria what we 
normally do for some one who is HIV positive should first under go CD4 
count and we follow very much guidelines put by the Ministry of Health 
and when some body goes below 200, the person already qualifies to 
get the treatment. And we also do carry out some other tests like Liver 
Function Tests (LFT). And the social aspect there should be there and some 
body should disclose to the immediate family member and should come 
with a treatment supporter. This is actually a condition that we have put 
and some body should be ready to adhere to the medication and should 
accept to live positively to make the outcome of the treatment to be there. 
So, if the person is ready to abide by that we get the person ready for 
treatment.” —S002 252 
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7.7.4—Retention and Shopping Around
The majority of respondents reported that they did 
not attend multiple care facilities. The exception was 
when facilities sometimes requested that their patients 
to attend non-HIV health centres for minor ailments. 
Feeling that the centre fully meets patient needs was a 
strong motivator to the patients:
“Ever since I joined here for treatment I don’t go anywhere else because I 
feel these are the people who know better and if I go to another facility/
clinic I have to introduce myself but here they know me well.” —P005 259 
 “Now what made me so attached to this centre, when I got to know that 
there was a post test club for those who have tested positive that gave me 
the momentum to keep coming here and it made me more of an [place] 
person. That is why you have managed to find me here. This club brought 
us so close and we became more of children in a home and got a true 
facility belonging.” —P001 256
Even when referral was suggested, the perceived 
stigma at other centres encouraged patients to stay 
where they were:
“Yes, that is why I even refused to be transferred [place]. When you come 
to receive care here, you are not stigmatised at all, no body cares about 
who is sick and who is not. We are all the same but its terrible in the 
villages, when people see you going to the clinic, the entire town will talk 
about you, have you seen she is infected or that one is a land mine, she can 
blow you up. Such things.” —P001 259
Patients were encouraged to attend health centres 
for minor ailments, apparently as a way to deal with the 
large HIV outpatient appointments. However, costs of 
attending these other facilities proved to be a problem
“Because I used them even before [place] came. Now [place] gave us ap-
pointment dates like every after two months so if you get a headache you 
go to those health centres. [Place] has done that because clients are very 
many. So it is negotiation you cannot come to day, tomorrow and the other 
day you may find that other people are not being served.” —P002 255
“I go there for treatment of minor illnesses but it is all a pain just because 
it is very expensive to come here. Those people neglect us they tell us to go 
to our clinics, so I can say their services are very poor in fact now I am not 
happy to go there.” —P002 260 
A final reason for attending elsewhere was to deter-
mine whether additional advice could be given:
“Apart from here there is also a government hospital [place], at other times 
when I have a problem and I go to that hospital and actually they are 
giving us the same advice like this one. I go there looking for help, mainly 
because I think they could give me additional help.” —P002 252
7.7.5—Costs to Patient
Staff generally reported that all interventions and drugs 
were free. The availability of free medications was the 
most commonly reported theme throughout the quali-
tative study. 
“{Place] has really helped me because they are offering me the drugs. It is 
very difficult to get money to buy drugs. For example, my husband used 
to spend shs. 190,000 on my ARVs and that had to be spent on a monthly 
basis whether you like it or not. So I think you can appreciate that [facility] 
is helping me so much.” —P001 259
The only exception to free care was a minimal 
registration/attendance fee that covered all services and 
medications, which was described by staff: 
“We provide services we are donor supported to give the services to the 
clients. but we wanted this element that when clients come to get the 
services they don’t have a feeling of getting free services, actually our 
services are for free but they are contributing to the services also by paying 
five hundred shillings every visit when they come. we think that five 
hundred when its paid and you are given drugs may be will consider these 
drugs as very important because you have given in some little money for 
drugs… we think way of making them contribute there is a way it helps 
them psychologically it helps them to know that this their service and they 
are contributing for it.” —S001 255
“However, I would like to note that there is a small user fee (of UG 2,000 
shillings) paid only once when clients enroll for care.” —S002 252
However, the additional costs of HIV care could be 
substantial in terms of lost income, sale of assets, dif-
ficulty paying school fees, loss of home, dissolution of 
family ties, and reduced working time:
“My biggest problem now is the house, I had my produce and sold it that’s 
where I got the money and started constructing but it is at a poor state. 
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Most of the time I am caring for the patient so I no longer carry out any 
casual labour to earn some money.” —C004 255
“Imagine I have also not worked thus no money yet she is there sick! 
She used to work in a restaurant but she no longer does so due to heat 
problems yet at least we could afford to cook porridge for her which isn’t 
the case now.” —C004 258
“I only know about one problem and it is about money. Like she is no 
longer gainfully employed as she was before. Some times she doesn’t get 
the money yet she has to feed us and so on. Like at times she delays to 
meet our school fees. Ah, such are the ones I know.” —C001 259
“What we need, what I feel we need as HIV patients, it would be good if 
we could be supported because most of us are widows and we have no 
houses. We are living in our father’s homes and that pains us so much.” 
—P007 255
“Well my other challenge because I am teacher I have to go in the morn-
ing and come back in the evening I was even forced to make one of my 
children a day scholar so that she can come after lunch to help him go to 
the toilet.” —C001 255
Respondent: “My biggest problem is my education. I am worried about my 
education whether I will finish or not and the problem I have is between me 
and my parents. One of them was not willing to pay for me tuition fees…”
Interviewer: “What reasons was he giving?”
Respondent: “He told my mum that even if they pay for me tuition, I Will not 
finish, I am going to die soon etc he complained too much.” —P004 256
7.8—Clinical Standards 
7.8.1—Process of Enrollment
Patients generally reported facilities as being easy to 
find, and providing a welcome reception:
“Here, it was very easy because they welcome me, they do not disturb me 
but give me the comfort and because my place is near the hospital they 
easily do the follow up and it is easy for the health workers to reach my 
home.” —P003 252
For those with poorer health, enrolment can be 
made quicker:
“Yes we accept all patients. All who want to access the service apart from 
those who are very weak, those who are very sick and can not wait for 
more than 1hour we will take them to hospital for admission.” —S004 256
7.8.2—Frequency of Contact
Community Health Workers may see patients weekly, 
and ART prescribing was usually monthly. One facility 
reported dispensing every two months for those re-
sponding well to treatment. From the patient perspec-
tive, this had obvious advantages:
“Initially, they used to give and restrict it, giving us for one month but I 
think to their wisdom they thought it wise that they should increase it like 
right now I get drugs for a period of two months that keeps my spending 
a bit better because I don’t have to keep coming here every month, like 
cost of transporting myself, the time you waste here is quite much so if you 
take it for two months this gives you time to at least relax until when it is 
finished and then you come for refill.” —P002 259
7.8.3—Monitoring and Documentation 
The monitoring of patients appeared to be holistic:
“Well when you get there they will first of all ask you how you feel, your 
complaints and challenges in daily life. Then if you have a medical problem 
that requires medication, the medication will be prescribed for you.” —
P001 260
“You come and they weigh your kilos, measure your temperature, you go 
to the doctor and the doctor asks you some questions like how you are 
feeling and asks you any problem you are having and then after that if you 
don’t have any thing which you are feeling like pain. They tell you to go 
and get the medicines.” —P005 252
However, the documentation procedures described 
do not always include the assessment of problems be-
yond basic clinical markers, and therefore a more holis-
tic assessment may depend on the skills and awareness 
of the clinician: 
“So we do have those standard operating procedures but of course they 
don’t say when a patient has a problem send him to the counsellor. So they 
are there but they don’t involve every thing that comes up.” —S002 260 
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7.8.4—Referral Mechanisms
Facilities described the specific circumstances in which 
they referred patients out to other facilities. These 
include medical specialities such as cardiology and for 
surgery as well as for patients who are ready to initiate 
ART but for whom there are inadequate drug supplies;
“Yes, for other conditions apart from HIV, we can refer the clients for some 
services that we don’t have in the hospital. Like may be a heart condition if 
we hear we don’t have enough facilities because our hospital is still under 
developed and for HIV clients we usually refer them because here we have 
a sealing in uptake. Like if we are to start on ART there are times when 
we don’t have ART for new ones so we can refer them to other facilities 
to be enrolled there for ART and those are the kind of referrals we make 
when there is a sealing like only we are going to may be enrol say only 
one hundred (100) clients and no more. So, any other clients who come 
we give them other services but if they want now to be initiated on ART 
we refer them to other facilities were they can get the services like here we 
refer them to government hospital.” —S001 252
For spiritual care:
Interviewer: “If a client is in that line, is need of spiritual counselling, what 
happens?”
Respondent: “We refer to different places may be to the church. At times 
you find out which church she is going to, try to probe and see whether 
there’s a counsellor with in that church because they are of different 
denominations. If he is a Muslim of course there are some sheiks who are 
within that line. The spiritual counselling actually isn’t here. We don’t do 
it.” —S001 256
To ensure that patients can access local care:
“Ok we network with a number of organisations like [place] [place], 
[place], [place], [place] actually in all, all health centres these days have 
those units which give care and support. So you ask the clients which 
places will be convenient for her, which will be near, were he will spend less 
money and the rest, .and those are the places where the doctors refers the 
clients to and its mainly for further management, treatments.” —S001 256
For malignancies:
“The only think may be would be the cancer related illnesses like lym-
phoma which we refer to other centers. Most of the things we can handle 
them here.” —S001 259
And for terminal and palliative care:
“We refer patients to hospice for terminal care, usually pain management 
because we do not have oral morphine here, so pain management really.” 
—S001 260
“For the terminally ill, this facility works with other facilities to make a 
joint effort to manage the patients. Those for example who come with 
cancer are referred to Uganda Cancer Institute and those who come with 
advanced cancer we work with Hospice and are able to be managed at 
home level because we cannot admit them for the whole year. We usually 
work with them because for them they are able to visit them in their home 
and are managed from there.” —S002 259
7.8.5—Staff Education and Training 
As described under staff needs, further specific train-
ing needs were identified in paediatrics, particularly 
counselling, and ART regimens beyond first line. Other 
areas of need were as follows:
“I think I would need skills in marital counselling because apart from 
clients coming for HIV testing, usually you find that they have marital prob-
lems and at times you might find that one is at across word.” —S001 256
“May be a training in special needs. Though they are few but we get them 
people who are deaf, if I can get a training in sign language. They are few, 
but at times we get them and we are at a loss so what actually what we do 
we handle it mechanically if you get a person who can write, you write he 
reads then he writes you read. So, me may be if we can be equipped may 
be with those skills, then we would be able to help those because even 
though they are handicapped but they are also at risk because they also 
have sex.” —S001 256  
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Table 71 and Figure 33 show that there was a wide 
variation in costs per patient per year, ranging from $41 
at Facility 256 to $719 at Facility 252. Annual costs per 
patient at Facility 260 were close to the median of $297 
per patient.
There was also a wide variation in the components 
of the costs per patient as seen in Table 71 and Figure 
34. Per patient staff costs were similar for Facilities 
256, 252 and 259 at between $21 and $24 per patient. 
Facility 256, which did not provide ARVs directly, had 
no ARV costs but staff costs comprised nearly 60% of 
per patient costs. At the other extreme, Facility 260 
had very low per patient staff costs ($2) and high per 
patient ARV costs. At facilities which supplied ARVs, 
ARV per patient costs ranged from $58 at Facility 258 
to $586 at Facility 252. The high overall per patient 
costs at Facility 252 seems to stem from its high per 
patient ARV costs. Other drug costs per patient were 
minimal for most sites except for Facility 255 ($184.) It 
is notable that Facility 259 had relatively high labora-
Table 71: Total and Per Patient Cost of Care (US$ Per Year)
Facility Staff ARVs Other Drugs Lab Cost
Building/Utili-
ties /Rental
Total
252
Total 77,946 585,895 0 140,827 232,372 1,037,040
Per Patient 22 586 4 40 67 719
255
Total 226,211 173,445 1047476 136,555 785,191 2,368,878
Per Patient 40 165 184 24 138 550
256
Total 144,351 0 704 33,485 66,012 244,552
Per Patient 24 0 0 6 11 41
258
Total 753,958 325,226 21050 1,037,060 2,356,364 4,493,658
Per Patient 85 58 2 116 265 526
259
Total 1,435,636 4,428,324 4454 10,973,039 7,416,247 24,257,700
Per Patient 21 149 0 160 108 438
260
Total 12,407 979,655 19839 212 275,615 1,287,729
Per Patient 2 252 3 0 41 297
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tory costs ($160 per patient) and low staff costs ($21.) 
Building-related costs were lowest for Facility 256 
($11) and highest for Facility 255 ($265.)
The composition of staff costs by clinical staff 
(defined as doctors, nurses and pharmacists/dispensers) 
vs. non clinical staff (all other staff types) are shown 
in Figure 35. For most facilities the proportion of staff 
costs accounted for by clinical staff was between 60% 
and 85%. The outlier was Facility 256 where non-clin-
ical staff comprised nearly 70% of staff costs. This may 
reflect the fact that Facility 256 did not provide any 
ARV services.
Patient to staff ratios for clinical and non-clinical 
staff also showed large variation across the facilities 
(Figure 36). Facility 259 had a very high patient:clinical 
staff ratio at 1401:1 as compared to Facility 258 with a 
ratio of 165:1. For non-clinical staff the variations were 
similar: Facility 259 had the highest number of patients 
per non-clinical staff member (1597:1) and Facility 255 
the lowest (211:1).
It was hypothesised that there would be a relation-
ship between staff costs per patient and patient-staff 
ratios, i.e, facilities with high patient loads per staff 
should have lower staff costs. A scatter plot of staff costs 
versus patient-clincial staff ratios (Figure 36) shows an 
inverse relationship, supporting the hypothesis.
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8.1—Economies of Scale and Case Loads: Evidence 
from Uganda and Kenya
The relationship between size of the facilities as mea-
sured by number of patients and costs per patient per 
year was also examined. If there were economies of 
scale it would be expected that there would be a nega-
tive relationship between average costs per patient and 
patient numbers. This would be similar for staff costs 
per patient and patient loads for staff. Because there 
were only six facility per country in this analysis the 
data for Uganda and Kenya were combined. In Figures 
38 and 39 costs per patient were plotted against total 
number of patients registered at a facility, and again 
against number of HIV patients. The figures show 
that for both number of HIV/AIDS patients and total 
number of patients, the cost per patient is lower in 
facilities with more patients.
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Figure 38: Relationship Between Unit Cost and Number of 
Patients
Figure 39: Relationship Between Unit Cost and Number of HIV 
Patients
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9.1—Facility Characteristics, Participant, and 
Interview Numbers
In total 641 participants were recruited into the longi-
tudinal quantitative study, between 102 and 112 per fa-
cility. The aim was to examine whether and how patient 
outcomes changed under care. 
The overall recruitment and completion rates were 
very good for a longitudinal study of an outpatient pop-
ulation. The loss to follow-up during the three months 
of data collection was 16.1%, usually for unknown 
reasons. The highest loss to follow-up was at Facility 
256, where the study manager was seconded to another 
branch for several months. On her return she followed 
up participants who had been lost and managed to 
interview most of them at least once more. Facility 256 
was also a specialised VCT centre with an open door 
policy. One consequence of its accessibility to newcom-
ers was that it was also easy to leave.
Results from Phase 1 showed that clinical and 
preventive care were reported as being offered at all 
facilities, while social and spiritual care were most com-
monly offered at Facility 252, followed by Facilities 255 
and 256 (2). Very few components were reported to be 
delivered by referral; care was either provided onsite or 
not available. All facilities employed nurses and doctors 
but only three had a nutritionist, three a spiritual leader 
and two employed social workers. The number of com-
munity health workers was very low at most facilities. 
Three facilities were based in Kampala, two in other 
towns and one in a mostly rural area.
9.2—Participant Characteristics
9.2.1—Demography
In the sample, women were on average younger than 
men, and outnumbered them by more than two to one. 
This reflects the distribution of HIV in Uganda and 
most African countries, where prevalence is higher 
among women than men, particularly in younger age 
groups (33, 34). The reason for this disparity may be 
due to sexual relationships between younger women 
and older men (35). 
The maximum age of participants was 70. The 
most common indicator of HIV in official figures for 
countries with a generalised epidemic (like Uganda) is 
the prevalence in the 15–49 age group, termed “adult” 
(33). HIV in older people is a neglected issue (36), and 
although they represent a minority of people with HIV, 
older people are likely to experience more severe health 
problems. 
The results for distance to travel from home to the 
facility appear to have a wide range but both extremes 
are reasonable. One person reported taking one minute 
to travel from home to Facility 258, which is in central 
Kampala surrounded by residential areas. The only peo-
ple to travel more than six hours were two participants 
at Facility 252, the referral hospital for a very large area 
with poor transport. 
9.2.2—HIV Diagnosis and Reason for Attending
The most common reason for attending the facility was 
a new presenting problem, followed closely by a new 
HIV test result. The median time since HIV diagnosis 
was 196 days but the median time since registration at 
the facility was seven days, indicating that large num-
bers of people had been diagnosed some time earlier 
and had either recently changed their care facility, or 
had not previously been registered at all. Changing the 
source of care creates problems because of a lack of 
patient history and the inadequate referrals framework 
identified in Phase 1 (2).
The fact that almost a third of participants had 
been diagnosed within the previous two weeks suggests 
a high and increasing patient burden for staff, although 
it is important to remember that the inclusion crite-
ria specified participants with a new diagnosis or new 
problem, thus the results should not be interpreted to 
mean that every third patient at the facility was newly 
diagnosed. 
The new problems reported by some individuals 
9
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were not representative of the study population, as the 
question had a very low response rate. The answers are 
included in the results because they are indicative of 
the range of problems that participants experienced, 
including psychological issues and comorbidities such 
as stroke, not because they represent the prevalence.
9.2.3—Relative Wealth
The demographic information shows that 26% of the 
sample used public or shared latrines, or none at all. 
This represents a substantial risk to health. Access to 
only shared or public latrines is considered inadequate 
sanitation by the WHO (37) and halving the number 
of people with inadequate sanitation is one of the Mil-
lennium Development Goals. Diarrhoea is a frequent 
symptom of HIV (and ART), causes high morbidity 
and mortality (38), and can also be deeply distressing if 
toilet facilities are not appropriate. 
In this sample, the wealth quintile in which most 
people used a public or shared latrine was the second 
wealthiest, which was unexpected. The finding may be 
caused by the intersection of wealth with urban living. 
Participants in the cities, especially Kampala, were more 
likely to live in brick-built houses with cement floors, 
which were indicators of relatively greater wealth. In 
East Africa the number of users per latrine is higher in 
the city where population density is greater (39); thus, 
although relatively better off, city dwellers can have 
worse sanitation than people in rural areas.
The vast majority of participants used biomass fuel 
(charcoal, firewood or straw), which cause indoor air 
pollution and are a risk factor for respiratory tract in-
fections, cancer, stroke, eye problems, chronic obstruc-
tive lung disease and TB in adults, particularly women, 
as well as a host of other health problems in children 
(40, 41). The main health effects of HIV in Africa are 
increased susceptibility to pneumonia, TB and bacterial 
infections, often causing airway obstruction and pulmo-
nary inflammation. 
The wealth quintiles were calculated using the stan-
dard method developed by the DHS and World Bank 
(14) to give a better representation of relative wealth 
appropriate to the setting than could be achieved by in-
dividual measures. The items having the most effect on 
wealth factor were having an earth-floored home, using 
firewood or straw for cooking fuel and having a house 
with a thatched roof (Appendix I). These traits are as-
sociated with rurality as well as poverty. Ownership of 
a mobile phone loaded positively onto the factor; 10% 
of the poorest households and 100% of the wealthiest 
households owned one.
9.2.4—Illness Severity
CD4 counts ranged from 1 to 1569 with a mean of 331 
and median of 297, which is below the normal range 
for a person without HIV. A CD4 count below 50 at 
admission is a predictor of greatly increased mortality 
risk (42). A CD4 count of 200 is the most widely used 
level at which to begin ART (27), although ART has 
also shown benefits between 350 and 200, and current 
European guidelines suggest 350 as the threshold (43).
The people who had two measures of CD4 count 
had a lower than average mean count at baseline, 
though the difference was not statistically significant. 
It is reasonable to think that people with a lower CD4 
count might be monitored more closely and tested 
more frequently. The difference between mean and me-
dian demonstrates that the distribution of CD4 count 
was not parametric, being skewed to the right. How-
ever, as the variances of CD4 count at T1 and T3 were 
similar, and the sample size was large, a paired t-test 
was robust enough to use.
It is not surprising that although physical and 
mental health scores increased, ECOG scores did 
not change over time. The categories of function were 
large and unlikely to alter from one month to the next. 
People with more progressed disease had a lower CD4 
count and were more likely to have impaired physical 
function.
The study population consisted only of outpa-
tients, the great majority of whom attended the facility 
without an accompanying carer. This group is therefore 
biased towards better health than is experienced by 
the entire population of people receiving care for HIV, 
some of whom would have been admitted. It is also 
possible that some people with HIV were unable to 
attend due to ill health and lack of carer support. The 
association between low physical health and loss to 
follow-up suggests further bias towards better health in 
the studied population.
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9.3—Care Participants Received
A small number of participants reported that they did 
not know whether they had received a component 
of care. The only component for which these were 
particularly prevalent was weak opioids. Health care 
workers were trained to define components of care if 
the participant did not understand what they were. The 
large number of ‘don’t know responses for a single item 
(weak opioids) at a single facility (Facility 258) suggests 
that the staff at Facility 258 may themselves have been 
unsure what weak opioids were. 
Even though certain areas of care, such as social 
care, were not provided by all facilities, only 7% of care 
components were obtained by referral. This confirms 
the Phase 1 finding that referral systems were not well 
established.
9.3.1—All Care Components
Participants received a mean of 12.8 components per 
month, which remained stable over time, and a mean 
of 21.5 different components during the study with a 
range from none to 43 out of a possible 52. This repre-
sents a substantial burden of care, including constant 
changes in care regimes. That participants received so 
many different care components within a relatively 
short time implies they experienced a range of complex 
multidimensional problems. 
The six components received by the largest number 
of people were all elements of preventive care, and the 
seventh was ART, which is arguably preventive in that 
it reduces infectiousness and is a long-term treatment. 
It is good clinical practice that preventive care should 
be delivered to the majority of patients and curative 
care only when this first line has failed. The single most 
commonly received care component was daily CTX, 
which increased rapidly over time from 69.8% at T0 
to 88.9% at T1 and finally 92.9% at T3. CTX is easy 
to deliver, is of proven effectiveness and supported by 
policy guidelines for prescription to everyone with HIV 
(24). 
Many symptom control care components became 
less frequently provided over time. This may indicate 
that the symptoms had been effectively controlled. For 
example, provision of antifungals dropped from 16.4% 
at T0 to 5.6% at T3. The provision of anxiety and 
depression treatment did not decline over time, perhaps 
suggesting that these symptoms were more difficult to 
manage. Social interventions such as IGA and provi-
sion of food were more likely to increase over time, 
indicating a possible delay in provision of these compo-
nents of care. 
9.3.2—Care Received Away from the Facility
In Phase 1 of the PHE, several respondents reported 
that it was an advantage to receive all their HIV care 
in one place. Nonetheless, participants in this phase 
frequently supplemented their care from the research 
facility. Apart from obvious differences such as visiting 
a traditional healer, the prevalence of care components 
at the facility and elsewhere was remarkably similar. 
HIV-specific care, general clinical care and social care 
were about twice as likely to be received from the re-
search facility as from somewhere else.
Anthropological studies have shown that when 
several paradigms of healthcare are available to them, 
people take advantage of care from all possible sources, 
even if the underlying philosophies of these healthcare 
systems are in conflict (44). Thus, many people use tra-
ditional healers and modern medicine simultaneously.
9.3.3—PEPFAR Care and Support Categories
Over 99% of participants received clinical care, 98% 
preventive, 78% spiritual, 68% psychological and 35% 
social. As in Phase 1, social care was the least com-
monly available service of the five.
9.3.4—Basic Care Package
The elements of the Preventive Care Package should 
be provided to everyone with HIV who needs them 
(32). They are a minimum level of immediate care for 
people with HIV. The five elements are evidence-based, 
focusing on prevention of some of the major causes of 
morbidity for people with HIV [malaria (45), water-
borne infections (46) and bacterial infections (25)], 
and secondary HIV prevention through two methods; 
condoms to stop infections and family VCT to provide 
services to those at higher risk. 
In this study, the high burden of treatment for 
malaria and other infections (including STIs such as 
herpes) demonstrate the importance of BCP interven-
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tions. The fact that 12% of participants had an unsafe 
drinking water supply is further evidence of their 
necessity. The BCP does not include interventions to 
prevent TB, the main cause of mortality in people with 
HIV, or malnutrition, identified as the major contribu-
tory cause of death for people with HIV in a Tanzanian 
study (47). 
9.3.5—Care for the Newly Diagnosed
People who have just been diagnosed with HIV in sub-
Saharan Africa are known to have a have high preva-
lence of symptoms including fever and weight loss (48), 
depression (49), chest infections, diarrhoea and herpes 
zoster (50). In this study, 76% of participants received 
painkillers during the first three months after diagnosis, 
47% malaria treatment (indicating experience of fever 
though not necessarily malaria infection), 36% treat-
ment for skin rash, 26% treatment for thrush and 16% 
treatment for nausea and vomiting. This represents a 
considerable burden of symptoms. 
Treatment for anxiety and depression was received 
by a small minority of patients (under 10%), even 
though HIV diagnosis is thought to be a time of high 
distress (51) and the APCA African POS scores indi-
cated psychological need in this group.
Over three months of care, the mean number of 
care components received by newly diagnosed par-
ticipants increased from eight to 12 while the mean 
number for the previously diagnosed decreased slightly. 
The decrease was largely due to a reduction in receipt of 
symptom management care such as treatment for diar-
rhoea and fungal infections, presumably because these 
symptoms had been controlled. For newly diagnosed 
participants, on the other hand, there was little reduc-
tion in the prevalence of symptom management care, 
while preventive care such as multivitamins and HIV 
support groups increased over time. Receipt of food 
trebled between T2 and T3, suggesting that the process 
of assessment and allocating food to participants took 
some time to put in place.
The distribution of care component receipt was 
approximately Gaussian, i.e., the mean and median 
were close together, meaning that half of participants 
received more than ten separate components of health 
care in the month following HIV diagnosis. This 
burden of health care indicates a substantial and abrupt 
change to normal life following diagnosis. Even when 
care is free at point of delivery, there are associated 
costs for transport, obtaining drugs from pharmacies, 
and so on. The burden of transport costs may also cause 
anxiety to newly diagnosed patients who see themselves 
having to make sacrifices in future to maintain regu-
lar appointments (52). In qualitative studies of HIV 
diagnosis, uncertainty was one of the defining features 
(53;54); patients do not know how their disease will 
progress and what will be demanded of them.
9.4—Care Themes
9.4.1—Spiritual
The number of people visiting a traditional healer re-
duced rapidly after T0. Possibly it was felt unnecessary 
or inappropriate after the HIV test result was known. 
Traditional healers provide more healthcare in Uganda 
than clinical medicine (55), and are often the first port 
of call for people who suspect they might have HIV 
infection. Therefore it is important to build connections 
between traditional healers and the health system, to 
encourage referral and increase access to care.
9.4.2—Counselling and Advice
The most commonly received components of counsel-
ling were adherence counselling, family planning coun-
selling, and nutritional advice. The evidence from focus 
group discussions in Phase 1 (2) and qualitative inter-
views in Phase 2 suggests that these three components 
were largely educational in nature, based on informing 
patients of benefits and risks. This kind of counselling 
may not address psychological issues such as anxiety, 
loneliness or lack of peace, which study outcomes 
showed to be a burden for participants. These needs 
may be met through patient support groups, which 73% 
of participants attended.
Depression is a predictor of reduced survival with 
HIV, although it is not clear whether this association is 
due to neurological effects or mediated through behav-
iour change (56). It is difficult to separate the direct 
and indirect effects of depression on HIV, as depression 
reduces health-seeking behaviour and adherence (57). 
Since depression is often a recurring condition, and 
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mild depressive symptoms are a risk factor for HIV in-
fection, separating cause from effect is also complicated. 
Very little is known about the burden of mental illness 
in Africa. A study in Uganda found depressive symp-
toms in 47% of people with HIV (58). This and a small 
number of similar studies (49, 59) suggest the possibil-
ity of a very high burden of mental illness, suppressing 
the ability and will to seek healthcare while advancing 
HIV disease progression.
9.4.3—Nursing
It is interesting to note that 25% of participants re-
ceived wound care at baseline and this prevalence 
increased over time. Wounds could have been caused 
by skin infections, bedsores or other skin breakdown, 
or injuries. Wounds are a possible route for bacterial 
or other infection to which a compromised immune 
system will be vulnerable, and in addition could pose an 
HIV transmission risk for household carers. Sixty-nine 
percent of people who received wound care had infec-
tion control training during the study, compared to 31% 
of people who did not have wound care, which suggests 
that these risks were recognised and dealt with.
9.4.4—Pain Management
Pain is a very common symptom in HIV (60), particu-
larly in later stages (61), and ART has little effect on 
the prevalence of pain (62). Analgesics should be given 
by the mouth, by the clock, and by the Pain Ladder 
(WHO), progressing from non-opioids to weak opioids 
to morphine until pain is controlled. Apart from the 
evidence from the APCA African POS and MOS-HIV 
of lasting pain, the very low use of opioids in this study, 
with two facilities not providing morphine to any partic-
ipant and one not providing weak opioids either, would 
have made adequate pain management impossible.
Uganda has one of the best records in Africa for 
opioid use (63), but nonetheless myths about its ad-
dictiveness and danger persist. More people received 
treatment for neuropathic pain than opioids, although 
neuropathic treatment is more expensive. At the same 
time, 83% of participants were given non-opioid anal-
gesics during the study period, indicating a very high 
prevalence of pain. These 83% received on average eight 
more components of care during the study than the 
rest, suggesting that pain was associated with a range of 
other problems.
The prevalence of pain assessment increased from 
T0 938%) to T1 (50%). A possible reason is that the 
use of the study tools, with questions on pain, reminded 
health care workers to carry out an assessment. During 
the development of the APCA African POS, health 
workers reported that using the tool improved their 
practice (13).
9.4.5—Symptom Management
If need can be inferred from treatment, then at the 
beginning of the study 21% of participants had geni-
tal thrush, 21% had skin problems, 15% had diar-
rhoea, 15% had oral candidiasis and 14% had nausea 
and vomiting. Over the three months, almost half the 
sample suffered from skin problems and over a quarter 
from diarrhoea, at a severity that required treatment. 
Added to that the level of symptoms which would go 
unreported or be considered not needing treatment, the 
symptom burden in daily life is very high. Similarly, a 
study of HIV outpatients in Tanzania found that 52% 
were appropriate for palliative care intervention regard-
less of ART use (64). 
The receipt of most of these components of care 
dropped off over time, with treatment for skin rash 
being an exception. This probably indicates that symp-
toms were controlled while skin rash was an ongoing 
complaint. Thirty-nine percent of participants had ma-
laria treatment in the month before T0. In this context, 
any fever-like symptoms are often treated as malaria 
until proven otherwise, particularly if participants self-
diagnosed and bought their own medicines. However, 
malaria treatment rate remained high at about a third 
of participants every timepoint. The majority of data 
collection took place outside the peak malaria sea-
son ( January and February), and this level of malarial 
symptoms in an adult population is much higher than 
normal and indicates a significant burden of disease.
9.4.6—Nutrition
Lack of food is one of the main barriers to ART adher-
ence, as the drugs are difficult to take on an empty 
stomach (47). In the study, 13% of participants received 
emergency therapeutic feeding and 39% received food. 
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Food provision increased at T3, particularly for the 
newly diagnosed. Water-borne infections are a common 
cause of morbidity and mortality for people with HIV 
(46). A randomised controlled trial of a safe water sys-
tem in Uganda found that an intervention of hygiene 
promotion, simple equipment to purify water, and daily 
CTX halved the number of work and school days lost 
due to diarrhoea for people with HIV (65). Apart from 
the health benefits, lost work time (plus the opportu-
nity costs of caring for the sick family member) fre-
quently causes a decrease in income with corresponding 
difficulty meeting the expenses of adequate food, health 
care, and other household costs (66).
In the Tanzanian study of depression in women 
with HIV referred to earlier, vitamin supplementation 
for pregnant women reduced the prevalence of depres-
sive symptoms (2). Multivitamins have also been shown 
to reduce mortality and morbidity (67). 
9.4.7—Social
Social care was by some distance the care theme with 
the lowest prevalence, apart from TB treatment which 
was only applicable to a minority of participants. In 
the Phase 1 focus group discussions, participants were 
generally happy with the clinical care they received but 
when asked about care they would like to have, IGA 
and microfinance were the most common. The difficulty 
of paying for the three essential costs of food, transport 
and school fees was a major theme of the qualitative 
data. Food and money were scarcely separated; the most 
common schemes involved providing chicks or seeds 
so participants could grow their own food and sell the 
surplus. In addition, IGA was held to have the further 
benefit of improving self-esteem and self-efficacy, prov-
ing that people with HIV were capable of work (45).
Home help and provision of household items were 
rarely received, either from the health facilities or from 
any other source. That said, some components of pre-
ventive care such as water treatment and ITNs could be 
considered household items as well as preventive items, 
and these were more commonly received. 
9.4.8—Prevention
People with HIV are at increased risk of clinical ma-
laria (68). The fact that 21–33% of participants received 
an ITN at each of four timepoints (usually from the 
facility) yet 36% never received one at all implies that 
some participants received more than one. This may not 
be the most efficient use of resources if the aim is to 
ensure that everyone with HIV sleeps under an ITN. 
Prevention with positives (PWP) is a package of inter-
ventions aimed at prevention further transmission of 
HIV and protecting the HIV positive individual from 
coinfection with other strains. It was one of the most 
widely received components of care. 
9.4.9—ART
Almost 70% of participants received ART during the 
study period. It is possible that the sample was biased 
towards those receiving ART, as they may have had 
more frequent appointments than those not receiving 
ART and therefore more opportunities to be recruited 
into the study. Over time, there were some irregularities 
in reported receipt. Participants might have collected 
two months’ worth of ART and not reported receipt in 
the second month. An alternative explanation is that 
some participants could have interrupted their schedule 
for different reasons, e.g., changing regimen due to tox-
icity, or taking ART for prevention of mother to child 
transmission (PMTCT).
Some facilities had inadequate levels of ART mon-
itoring and support. Proper monitoring is essential to 
control side effects and prevent resistance. One possible 
consequence of beginning ART is immune reconstitu-
tion inflammation syndrome (IRIS), with symptoms 
such as fever arising from the restored immune system’s 
response to a pre-existing infection (69).
9.4.10—CTX
CTX was the most widely accessed component of care, 
received at least once during the study period by 97% 
of participants. In Uganda, daily CTX has been shown 
to reduce morbidity and mortality of people with 
HIV(70). At every timepoint, about 5% of the sample 
reported taking CTX on the previous day despite not 
receiving it for daily use. This occurred with similar fre-
quency at all facilities and so it is unlikely to be an error 
of understanding. More probably they were receiving a 
short course of CTX, for example to treat an infection. 
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9.4.11—TB
Tuberculosis is a very common cause of death for 
people with HIV (71) and HIV is the biggest risk fac-
tor for activating latent TB (5, 72). In hospital-based 
studies in Africa, 45–60% of people with HIV were 
coinfected with TB, and autopsy studies showed that 
TB was underdiagnosed by 50% even when it was the 
cause of death (73). In Uganda, 7.2% of people about 
to begin ART were diagnosed with TB (26), which is 
comparable to the point prevalence of TB treatment at 
each timepoint in this study. Isoniazid was rarely used 
as a prophylactic in this study, possibly because with a 
high population prevalence of TB it could be difficult 
to identify individuals at greater than average risk. 
9.5—Health at the Beginning of the Study
The APCA African POS and MOS-HIV used to col-
lect longitudinal data have both been validated for use 
with HIV positive patients in sub-Saharan Africa (5, 
74) and have been used longitudinally (75), demon-
strating their suitability for use in this study. The MOS-
HIV and APCA African POS were well completed at 
all time points, apart from the three carer questions of 
the APCA African POS which were rarely completed 
due to the absence of a carer.
The MOS-HIV physical and mental health sum-
mary scores of the population at baseline were com-
parable to those found in other studies of HIV disease 
in the sub-Saharan African setting (8, 11). There is a 
strange pattern to the distribution of scores. They are 
designed to be Normally distributed around a mean 
of 50 with a standard deviation of ten (12) but in this 
population the upper part of the curve drops away very 
steeply, as though cut off. The reason for this is not 
known. 
The APCA African POS measures multidimen-
sional problems: pain and symptoms (physical); worry 
and being able to share feelings (psychological); finding 
life worthwhile and being at peace (spiritual); and hav-
ing enough help and advice fro the family to cope (so-
cial). Each question is representative of clinical need and 
the items were not designed to be united into domains. 
APCA African POS scores showed that the psychologi-
cal, social and spiritual dimensions of HIV infection 
caused more distress than the physical elements.
9.5.1—Problems Facing Caregivers
Only a minority of patients were accompanied by an 
informal carer, and they were biased towards worse 
physical health, so the findings related to carer-reported 
problems cannot be representative of those informal 
carers who (presumably) did not attend. The worst mul-
tidimensional problems reported by participants were 
not being able to share how they felt, and not having 
enough help and advice for the family to plan for the 
future.
At the same time, very few participants were ac-
companied by a friend or family carer. Most people felt 
that they were alone in dealing with their HIV and 
they came for treatment alone. The costs of getting to 
the care facility can be substantial in terms of transport 
fares and lost working time (76). An accompanying 
carer would double these costs. Another possible reason 
why some participants came alone is that they had not 
informed their family of their HIV diagnosis.
9.6—How Participants Differ by Facility
9.6.1—Participant Characteristics at Different 
Facilities
Facility 252 was a mission hospital which offered 
spiritual care to all its participants and social care to 
most. Participants there had the lowest wealth quintile 
average, the highest mean number of dependants, the 
lowest education level and the highest ratio of women 
to men. In general Facility 252 was the outlier while the 
other five facilities were comparable in most participant 
demographic characteristics. The three Kampala facili-
ties (256, 258, and 259) all had a similar wealth quintile 
distribution and included the great majority of people 
in the wealthiest quintile.
Facility 252 was also the exception in that it did 
not recruit (or register) new patients during the study. 
This was because a decision was taken by the facility 
management to suspend recruitment of new patients 
as they had insufficient funds to deliver ART. Facility 
256 specialised in voluntary counselling and testing, 
and recruited large numbers of patients via that route. 
Almost three quarters of participants enrolled at this 
facility had been diagnosed with HIV in the previous 
14 days. The high proportion of participants at Facil-
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ity 258 whose reason was an HIV test more than 14 
days ago suggests that this facility often had a delay of 
several weeks between the positive test result and the 
first appointment. 
9.6.2—Illness Severity at Different Facilities
Participants at Facilities 255 and 256 had the highest 
physical functioning. These were NGOs which encour-
aged voluntary counselling and testing. 
The individuals with two CD4 counts may not be 
representative of everyone receiving care. They could 
have been newly initiated on ART and therefore more 
closely monitored, or they could have been particularly 
sick with a lower CD4 count. In addition, the time 
period between the two counts was different for each 
participant with a possible range of one month to 21 
months. Thus the fact that the change in mean CD4 
count was positive at three facilities and negative at the 
other three should not be taken to represent the level of 
care or participant health at these facilities. 
9.6.3—Care Received at Different Facilities
Provision of spiritual, social and nursing care varied a 
great deal by facility. Almost everyone received some 
degree of prevention care, clinical care and pain man-
agement.
Facility 256 delivered care to the lowest proportion 
of its patients in every theme except for nursing care. 
The main reason for this is probably the higher levels of 
physical health enjoyed by Facility 256 participants at 
recruitment. The Phase 1 results do not suggest Facility 
256 was greatly different to the others in terms of care 
offered, apart from providing ART by referral instead 
of onsite. Also, there was only one component (IGA) 
which it did not provide to any participant. Facility 259 
also lacked one component (treatment for cryptococcal 
meningitis), Facility 260 did not provide seven of the 
components examined, including treatment for anxiety 
and depression, and facility 256 did not provide eight.
The maximum number of care components deliv-
ered may have depended on the resources available to 
the facility. The minimum number appears to have been 
more a matter of policy. Facilities 259 and 252 provided 
all their participants with a minimum of 11 and 14 
components of care, respectively, suggesting that the fa-
cilities had a standard package of care they provided to 
all patients. Facilities 256 and 258 could not have had 
a similar policy because their minimum level of care 
delivery was, respectively, zero components and one.
Strangely, Facilities 252 and 256, which reported 
offering the most social care in Phase 1, actually deliv-
ered social care to less than 2% of participants. Facility 
255 had the highest provision of the social care theme 
(76%), mainly due to the large number of people receiv-
ing IGA services. 
9.6.4—Health at Baseline at Different Facilities
Participants at the different facilities did not begin with 
equal health scores. Facility 252, the facility with the 
poorest patients, unsurprisingly had the lowest mean 
physical health. The synergy between ill health and 
poverty is well known. Perhaps unexpectedly, given 
that physical and mental health were closely associ-
ated (Appendix I), Facility 252 did not have the lowest 
mean mental health score. Facility 256, which had the 
highest physical health score at 11 points above that 
of Facility 252, was only 1.3 points above it in mental 
health. The explanation may be that Facility 252 offered 
spiritual and social care to a higher proportion of its 
participants. As explained earlier, Facility 256 mainly 
recruited through VCT and its participants may have 
been physically healthier for this reason. 
9.7—Participant Characteristics and Health
9.7.1—Gender, Age, Education
Older people experienced worse physical health, which 
is to be expected in a population aged from 18 to 70. 
Additionally, there is evidence that older age is associ-
ated with more rapid HIV disease progression(11, 77). 
Mental health was not associated with age even though 
mental and physical health scores were closely linked 
(Appendix I). Women and men had the same mean 
physical and mental health scores at baseline, which 
was also observed in other studies of people with HIV 
in Uganda (75).
9.7.2—Relative Wealth
Greater relative wealth was associated with better 
physical and mental health at baseline. These results are 
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consistent with the literature on the effects of poverty 
and health in HIV, and may be caused by the wealthier 
having better nutritional intake and thus a more robust 
immune system, health-promoting infrastructure such 
as a latrine to reduce the risk of infections, more access 
to transport and medication which are major barriers 
to care (78). Meanwhile, poorer people may tolerate 
a higher burden of symptoms before spending money 
and lost work time on visiting a health centre. 
It is important to remember that though this study 
showed the poorest people to have worse health, there 
is evidence that proportionate wealth is a risk factor for 
HIV infection (79). Poverty may exacerbate the effects 
of HIV while simultaneously decreasing the probabil-
ity of infection. The wealth quintiles used in this study 
were generated from the dataset and can only be used 
to describe individuals relative to each other, not in 
absolute terms, thus it is not possible to link wealth to 
probability of recruitment, as it is with gender.
9.7.3—Illness Severity
All three health outcomes were more severe in the 
groups with lower CD4 count, agreeing with the evi-
dence for reduced outcomes and quality of life for those 
with a lower CD4 count (29). Physical health score 
was particularly affected, shown by the high value of F 
(11.9). 
Appendix I shows that when analysed as a continu-
ous variable, mental health was not associated with 
CD4 count after controlling for physical health. This 
is not a case of overcontrolling, as physical health was 
still associated with CD4 after controlling for mental 
health. It is a real indication that mental health could 
not be predicted by the progression of disease. Those in 
the early stages were just as likely to suffer from anxiety, 
worry or depression as people with AIDS, after ac-
counting for physical health. 
The reason that CD4 was analysed categorically in 
the main body of the report and continuously in the 
Appendix is that the former was for clinical use and the 
latter for statistical use. It is the case that people with a 
CD4 count below 200 are likely, based on these results, 
to have impaired mental health. The further analysis 
demonstrates the mechanism, which is that this impair-
ment is probably caused by poor physical health alone.
9.7.4—Individual Care Components
People who received ART or TB treatment in the 
month between T0 and T1 had worse physical and 
mental health summary scores than those who had not. 
In the case of TB it is not known whether the differ-
ence is caused by the symptoms of TB or whether TB 
is a proxy for more advanced HIV. The fact that people 
receiving TB treatment had a lower CD4 count sug-
gests the latter is partly responsible.
This analysis is not a test of the effectiveness of 
ART at improving health outcomes. The study was 
observational and non-random, and ART recipients 
would have differed systematically from non-recipients. 
Those who did not receive it comprised a mixture 
of people already registered at the facility who did not 
need ART, newly diagnosed individuals who did not 
yet need ART, and newly diagnosed individuals who 
did need it. The first two groups would be likely to have 
a higher physical score, the last group to have a lower 
score. The proportions of these groups to each other 
would determine mean physical score. The findings 
demonstrate the difficulty of linking care with out-
comes.
9.7.5—Association of Outcomes with Loss to 
Follow-Up
Unlike traditional techniques for analysing longitudi-
nal data, multilevel modelling can make efficient use 
of data with missing timepoints (11). The limitation 
is that at least two points must be present in order to 
calculate change. In this study, participants with fewer 
than four data points showed worse mental health than 
participants who completed all four. Traditional tech-
niques would have removed these non-responders from 
analysis and created a bias towards better health. 
On the other hand, there were no differences in 
health outcomes between those who completed only 
the first interview and those who completed more than 
one. Therefore, excluding the participants who com-
pleted only T0, as is required for longitudinal analysis, 
does not bias the population.
It is interesting to note that low mental health was 
significantly associated with loss to follow-up (p=0.003) 
but low physical health much less so (p=0.072), al-
though both scores at baseline were equally predictive 
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of change over time. In the study, participants were 
reimbursed their travel expenses, which may have 
biased follow-up rates away from the normal pattern of 
attendance. It is possible to speculate that depression, 
anxiety or discouragement were more likely than physi-
cal problems to deter health facility visits, and further 
analysis using attendance as an outcome variable might 
be able to explore this.
9.8—Changes in Health Over Time
The results show that participants who were newly 
diagnosed with HIV or had developed a new problem, 
attending PEPFAR-funded HIV care and treatment 
clinics, showed statistically and clinically significant im-
provements in their self-reported physical and mental 
health during the first three months of care. It is not 
possible to determine from these results whether the 
improvement was caused by the care they received or 
whether it would have happened in any case. However, 
improvement in health outcomes over time is contrary 
to the progressive trend of HIV disease.
The use of the MOS-HIV in longitudinal stud-
ies has been demonstrated in Uganda (74, 80, 81) and 
internationally (1). Some studies have been analysed 
using traditional methods and others using longitudinal 
analysis similar to that presented here. Unusually, this 
study was multicentred and the analysis included an 
adjustment for clustering by facility.
Over the three months of the study, five of the sev-
en patient APCA African POS items showed improved 
mean scores, and the breakdown into more clinically 
relevant categories showed that there was a reduction 
in the proportion experiencing severe problems for all 
items. It appears that the physical problems of pain and 
symptoms were managed more successfully than the 
other dimensions of health. 
Lack of help and advice, and inability to share feel-
ings, the two items with the highest average scores at 
baseline, were the only two in which substantial num-
bers of participants still had severe needs after three 
months of care. Possibly the problems represented by 
these items take more time to resolve. 
9.8.1—Changes in Health Over Time for Those 
in Most Need 
It was of particular concern that individuals with 
the most severe problems as recorded on the APCA 
African POS should receive appropriate care. It was 
possible that the most intractable problems were not 
dealt with sufficiently, and that an average improve-
ment in scores hid this. In fact, people with the worst 
baseline scores showed the most improvement. There is 
a tendency for outliers to converge to the mean, which 
increases the probability of improvement for those with 
low scores. The results should only be interpreted to 
mean that there is no evidence of unresponsive pain 
and symptoms, rather than positive evidence that the 
worst sufferers gained most.
9.8.2—Change in Health Over Time at 
Different Facilities
Facilities 259 and 252 showed greater change in physi-
cal health score than the others, particularly in later 
timepoints where they showed increasing improvement 
and the other four facility scores flattened out.. For 
mental health, Facilities 252, 259 and 256 experienced 
steady increase in mean scores while the other three 
levelled off. (It should be remembered that these curves 
are essentially made up of three points and so a small 
alteration to any data point is sufficient to change the 
entire shape of the graph.) 
A possible explanation runs as follows. Facilities 
252 and 259 provided more spiritual and psychologi-
cal care than average. The results of the APCA African 
POS analysis suggest that these dimensions of health 
take longer to respond to care. Facilities which spe-
cialised in physical care generated an improvement in 
outcomes but the effect was not sustained after pain 
and symptoms had been controlled (shown by the de-
cline in delivery of symptom management components 
after T1). Facilities 252 and 259 maintained the effect 
of increasing improvement in scores because they also 
delivered long-term psychological and spiritual care. 
Facility 256 did not demonstrate much improvement 
in physical health score because mean score was already 
high at T0 and unlikely to improve, potentially leaving 
staff the time to concentrate on mental health concerns.
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9.9—Changes in Health Over Time in Detail 
9.9.1—Participant Characteristics
Mental health score improved over time and was not 
associated with any demographic characteristics, while 
participants with more education or relative wealth 
benefited from increased gains in physical health. 
Mental health appeared to be more individual and less 
predictable both in its relationship with disease pro-
gression and its responsiveness to care. 
9.9.2—ART and TB Treatment
Not only did participants receiving ART at the begin-
ning of the study have lower than average physical and 
mental health, they also made smaller improvements 
over time. CD4 count was not sufficient to explain 
these findings. People on ART had poorer physical and 
mental health than their CD4 count alone might sug-
gest. In other words, self-reported health did not keep 
pace with clinical outcomes.
The findings show that ART alone does not create 
optimal physical and mental health, and complemen-
tary multidimensional care and support is important to 
maximise self-reported health. Outcomes improved for 
ART recipients over time, showing that there is more 
opportunity for progress. 
Participants receiving TB treatment had lower 
physical and mental health at the beginning of the 
study but they gained in mental health at the same 
rate as the rest of the study population, while physical 
health improvement was reduced. Indeed, the negative 
coefficient for TB was larger than the positive coeffi-
cient for time, suggesting that participants on TB treat-
ment actually got worse over time in terms of physical 
health score. 
9.9.3—Care Availability
Change in mental health score was not statistically 
associated with any care themes over time. This finding 
reflects the evidence from different stages of the analy-
sis that mental health score at baseline and change over 
time were both individual and unpredictable, either by 
care receipt, CD4 count, or demographic character-
istics. Physical health score was associated with pain 
management, symptom management and nutrition. 
Strangely, the associations were negative; receipt of care 
appeared to lessen improvement in physical health over 
time. However, the best predictor for health scores at 
T1, T2 or T3 was health score at baseline; the likely 
explanation for the results is that facilities with lower 
mean health scores at baseline were more likely to 
deliver these care themes to their patients. Multivariate 
modelling attempted to test this theory. 
9.9.4—Multivariate Modelling and Further 
Exploration
Pain management, symptom management, nutrition, 
relative wealth and education level were included in a 
multivariate model of physical health, and after a pro-
cess of reduction, nutrition was the only time-varying 
factor to remain. The result showed that at facilities 
where a larger proportion of participants received nutri-
tion support, there was less improvement in physical 
health over time. Further analysis was necessary to 
understand this concerning result. 
The graphs of nutrition care against outcome, and 
the collinearity of the care themes nutrition and symp-
tom management, revealed the reason why nutrition 
appeared to reduce physical health gain. Essentially, 
the model was driven by unmet care need. It found an 
association between the extra care delivered to those in 
greater need and the gap that still remained between 
their scores and everyone else’s. Therefore the associa-
tions were negative. 
In the Kenya Phase 2 study, multivariate model-
ling did not identify care themes associated with health 
score outcomes, and the primary reason for this was a 
lack of variability between the facilities in both out-
comes and care delivery. All six facilities offered similar 
care and gained equal improvement in health over time. 
In the Uganda study, the problem was different. 
There was facility-level variation in both the needs of 
patients and the care they received. Appendix I shows 
highly significant ANOVA results comparing mean 
baseline outcome scores by facility. Some facilities had 
patients with greater mean physical health needs, and 
they provided them with more symptom management, 
nutrition and pain control. However, the additional 
care was still not sufficient to compensate for the lower 
starting point. Although they were more likely to 
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receive nutrition, symptom management and pain con-
trol, their lower physical health scores on recruitment 
prevented them from attaining the health scores of 
participants at other facilities. Thus the results showed 
a negative correlation between care and outcomes. The 
disadvantages of low physical health at baseline were 
not outweighed by the greater probability of receiving 
appropriate care during the study period. 
Appendix I also shows that the between-facility 
variation in physical health scores was twice that for 
mental health. Physical health was more closely as-
sociated with facility, one reason why the models for 
mental health score failed to show any association with 
care themes. It is useful to consider why facilities varied 
in the mean physical health of their recruited patients. 
The three Kampala facilities had higher scores than the 
rural ones. The reasons may be to do with access, avail-
ability of services, and poverty. Even when services are 
free, the transport to the facility and loss of work time 
impose costs on healthcare. HIV disease progression 
may also have been associated with greater need for 
symptom management and nutrition care.
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In this sample, a patient’s carer might be their mother, 
sibling, daughter, spouse, friend or paternal aunt. Apart 
from married couples, the carer was usually of the 
same gender as the patient; brothers cared for broth-
ers, daughters for mothers. Six women were caring 
for their husbands (sometimes sharing this duty with 
a co-wife), and only one man was caring for his wife. 
Studies in Africa show that people with HIV are most 
likely to first disclose their status to a relative or friend 
of the same gender, and that men are more likely than 
women to disclose to their sexual partner (82), match-
ing the relationships of carers to patients. This suggests 
that carers could have been the first (or only) person to 
whom the patient disclosed their status.
The majority of patients, carers and staff reported 
positive experiences of PEPFAR-funded Care and 
Support. Patients felt very much part of the facility 
community, especially at those facilities which aimed 
for a holistic care approach. One facility has a policy 
of referring to its patients as ‘friends’, to encourage this 
sense. 
There was virtually no limit to the help which 
might be asked of a care facility, including school fees, 
employment, funding for small businesses, IT train-
ing, sponsorship to record an album, construction of a 
house, adoption of children, and matchmaking. Where 
the effects of HIV have exhausted the reserves of com-
munity and family network resources (83), the care 
facility was expected to step in.
The repeated pleas for assistance also suggest a 
loss of self-efficacy and the demotivating effects of 
depression. The periods of illness and dependency in 
HIV disease damage self-esteem and lead to feelings 
of disempowerment (84). Patients and carers encour-
aged others to work, not to be discouraged; indeed, very 
often patients said that the care they received had given 
them “courage,” which in context seems to mean will 
and spirit, the literal opposite of discouragement, rather 
than bravery. One of the reasons patients gave for 
requesting IGA and loans was to prove that with a little 
initial help they were still capable of earning a living. 
This finding was also observed in Phase 1. 
The fact that financial needs were mentioned more 
often than clinical, emotional, social or psychological 
needs (which were all prevalent) indicated that for this 
group of patients and carers, health concerns were not 
the greatest source of need. In extreme poverty financial 
need equates to the need for food, according to Engel’s 
law that proportion spent on food is inversely related to 
income (85). 
Discrimination from the community was a prob-
lem. Some participants recommended an increase in 
HIV education and VCT promotion in order to reduce 
stigmatisation and abuse from the community.
Several patients reported that they had been 
advised to use condoms but that they now no longer 
wanted to have sex. Lack of interest in sex is a possible 
symptom of depression and is associated with impaired 
physical and mental health in a Ugandan HIV study 
(77).
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Discussion of Costing Study
The main cost drivers for provision of care at the six 
facilities were ARVs, other drugs, staff, lab costs, and 
building rental. There were economies of scale, with 
larger facilities having lower costs per patient.
Providing care and support for HIV positive 
patients constitutes a significant part of national HIV/
AIDS programs in general, and care and support is a 
focus of PEPFAR with its commitment to reach 12 
million people with care services. In considering scale 
up and expansion of care and support services it is 
helpful to know the costs of such services. With almost 
40 million people testing positive for HIV and nearly 
three million people already on ARVs (77), the finan-
cial sustainability of maintaining and expanding care is 
a challenge for the public health community.
The cost of providing comprehensive HIV care and 
support may vary significantly across country settings 
and program delivery approaches. Calculating care 
and support costs in a range of settings will provide 
estimates of annual per-patient care costs that are 
representative of Emergency Plan-supported programs. 
Understanding the contextual factors that affect the 
cost of providing comprehensive HIV care and support 
is important in interpreting comparative costs analysis 
across country and program settings.
The overall purpose of the costing component of 
this study was to estimate the average costs of provid-
ing care and support to a patient over a one year period. 
This could then be used to calculate life time care for 
patients as a function of their life expectancy, or be used 
to estimate scale-up requirements of program expan-
sion. However, such modelling was not part of the 
present study.
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Integration and Conclusions
Longitudinal quantitative study participants taking 
ART had lower physical and mental health than other 
patients, not only because of their CD4 count but 
because of other problems. Some of these were reported 
in the qualitative interviews. Issues such as the side ef-
fects and toxicity of ART, unmanaged pain, worry over 
the regular expenditure on transport, health impairment 
due to reduced spending in other areas such as food, 
and depression and isolation resulting from stigma, 
could all have contributed to the lower than expected 
health and slower improvement experienced by patients 
taking ART. 
It is important to recognise that these findings do 
not imply patients would have been better off without 
ART. The analysis compared ART users to non-users, 
but in reality these groups were very different from 
each other in more ways than their medication. The 
non-ART group would largely have been those not yet 
eligible for ART, with less advanced disease, thus fewer 
health problems and better physical and mental health. 
The results show that ART recipients experience di-
minished self-reported health compared to people with 
early-stage HIV. They indicate that care and support 
are needed alongside ART to maximise its potential.
The descriptions of the outcomes of psychological 
and emotional care demonstrate the importance of this 
dimension of care. Despair, suicidal ideation and child 
abuse were all caused by psychological reactions to HIV 
diagnosis. In these circumstances, treatment such as 
ART would be of very limited benefit without address-
ing patients’ mental health needs. There is evidence of 
high levels of depression (57) and post traumatic stress 
disorder (86) after HIV diagnosis.
There is some evidence that what was being 
observed in the qualitative interviews was the conse-
quences of social breakdown due to HIV. It has been 
argued that the effects of HIV on society are quali-
tatively different from other stressors (83), and that 
HIV is associated with societal breakdown as the usual 
strategies for dealing with crisis fail to work (87). The 
person with HIV becomes sick, is less able to work and 
requires care, leaving the carer less able to earn income 
or grow food. As a result (83) “Given the nature of its 
impact, households severely affected by AIDS invari-
ably need support in caring for those who are ill, food 
for the entire household, and assistance to keep chil-
dren in school” (p. 628). Efforts to mitigate the financial 
stress include removing children from school, giving 
children caring responsibility, eating less, and sale of 
assets, representing short-term saving with long-term 
negative consequences. All of these responses were 
identified in the qualitative interviews. 
A further problem in HIV is the uncertain trajec-
tory and fluctuating health, coupled with the presence 
of invisible symptoms such as pain, fatigue, and depres-
sion, which were common in the study population. The 
traditional nature of the sick role, which is a tempo-
rary state when work duties are suspended and which 
depends on the patient making efforts to recover, does 
not apply in long-term illness (54). Patients can be 
seen as malingering, and denied care, or carers can find 
themselves dealing with emotional antagonism towards 
patients (84). Both of these effects were reported in 
qualitative interviews. In the long term, the supportive 
family network breaks down and patients are neglected 
(87). This is expressed as stigma.
The majority of participants in the longitudinal 
quantitative study did not receive socioeconomic care 
components such as food, employment training or 
microfinance schemes, but these components were 
very frequent concerns in the qualitative interviews. It 
was apparent that people hoped, or expected, the care 
facility would support them and their families in many 
ways. Staff also felt that financial support was necessary, 
especially for poorer families, those living in remote 
areas, and orphans.
The average longitudinal quantitative study partici-
pant was taking daily medication, receiving a mean of 
12 other care components per month and visiting the 
health centre (a median of an hour’s travel away) every 
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month. The stress of attempting to adhere to this life-
style, and pay for it, while keeping secret the reason for 
it had consequences described in the qualitative inter-
views as sleeplessness, worry, isolation, and fear. The con-
sequences were also visible in participants’ most com-
monly reported problems on the APCA African POS: 
being unable to share feelings (still a severe problem for 
25% after three months of care), lack of help and advice 
to help the family cope, and not feeling at peace.
Staff in the qualitative interviews reported the 
difficulty of contacting family members, particularly 
men, and the problem of patients not disclosing their 
status to family. Carers found it difficult to take time 
away from their responsibilities and requested home 
visits. As a result of these problems, family information 
on VCT was the least often received component of the 
Preventive Care Package, at 49%. Patients who have not 
disclosed their status do not have access to the sup-
port of family networks, both emotional and practical 
(88), which improves their quality of life (77). Disclo-
sure also has health benefits; maintaining a secret and 
holding back feelings causes stress which impacts on 
physical health (89). The advantage of non-disclosure is 
that patients and their families do not face the stigma-
tisation and rejection experienced by some interview 
participants and reported in the literature (90, 91).
Patients were encouraged to act as role models and 
they believed that this tactic was the most effective at 
persuading others to test. There is some evidence that 
people who have a friend with HIV are more likely to 
accept VCT (92) although the evidence for effect on 
behaviour change is mixed. For qualitative interview 
participants, a common reason for taking an HIV test 
was the experience of symptoms combined with know-
ing someone else who had tested positive. Rather than 
laying the responsibility for changing social attitudes on 
the shoulders of individual patients, community-level 
interventions are necessary to allow patients to disclose 
without fear of the consequences, and their families to 
receive the care they need. 
Most people in the longitudinal quantitative study 
did not have a carer who came with them to the facility. 
Staff in the qualitative interviews believed the lack of 
carers was due to non-disclosure by patients, so that 
nobody was aware the patient needed help. 
HIV prevention strategy has shifted since the 1990s 
from primary prevention (protecting the HIV-negative 
from infection by increasing knowledge, relying on the 
Health Belief Model) to secondary prevention (protect-
ing the HIV-positive from transmission by empower-
ment and engagement) (89). As well as being a public 
health measure, PWP is designed to improve patients’ 
quality of life (89) by releasing from stress caused by 
the burden of secrecy and improving feelings of self-
worth and morale. Prevention with positives was one 
of the most widely received components of care in the 
longitudinal quantitative study and qualitative interview 
participants described their receipt of it, centring on 
encouragement to disclose their status to others and act 
as role models for VCT, and the ABC strategy. People 
with HIV show altruistic motives for prevention (93) as 
well as self-preserving motives of avoiding reinfection, 
and both were observed in the interviews. 
Facility 252, which had the highest per-patient 
costs, had been unable to admit newly diagnosed pa-
tients because of lack of resources; specifically, because 
it would not be able to enrol any more patients onto 
ARVs. The largest cost driver at Facility 252 was ARVs, 
but these were donated and the real cost was not borne 
by the facility. The next highest cost driver is for build-
ing costs and utilities, possible due to its remoteness, 
few suppliers and the necessity of high transport costs. 
12.1—Strengths and Limitations
The mixed-methods design was a strength of the evalu-
ation, allowing triangulation between the different 
elements. The quantitative interviews illuminated what 
was meant by care and support, longitudinal quantita-
tive study showed the number of people to receive it, 
and the costing study showed the various ways in which 
it could be delivered. Far more data were collected than 
can be explored here and the dataset will continue to 
reveal insights into the experience of people receiving 
HIV care in Uganda.
Use of two well-validated tools, a multidimensional 
outcome measure as well as the more traditional quality 
of life questionnaire, allowed more understanding of 
the issues causing most concern to patients. Qualitative 
interviews supported this evidence that pyschological 
problems such as loneliness and anxiety were a cause of 
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distress in the population. The longitudinal study design 
was appropriate to the study, allowing observation of 
how quickly problems were managed over time and 
whether care was sporadic or maintained.
The tightly controlled methods of data collection, 
management and validation ensured a high quality of 
data in the longitudinal quantitative study. Completion 
was very high at all facilities and over time. Qualitative 
interviews were conducted by external researchers but 
they often took place on facility property and partici-
pants may have felt constrained in speaking negatively 
about the facility, even though they were assured that 
the recording would be confidential. 
The longitudinal quantitative study was observa-
tional, not randomised. It was not a comparison be-
tween those in and out of care, nor was it designed to 
measure the effectiveness of ART, which as a covariate 
was inextricably associated with disease progression. 
Given the circumstances of the evaluation, a compari-
son group was not available and so it is not possible to 
determine what fraction of the results demonstrated 
in this study were the result of PEPFAR funding and 
what would have happened without it. No data exist 
from before the beginning of the PEPFAR investment 
which could be used as a baseline. 
The facilities were selected purposively from a 
randomly selected sample, and thus are not representa-
tive of all PEPFAR-funded programmes. An evaluation 
of this kind, which required resources in terms of staff 
time, space and basic infrastructure from its facili-
ties could not have been carried out in a truly random 
sample as the majority of PEPFAR-funded Care and 
Support facilities are very small. 
The study measured care received, not care needed. 
There is no certainty that all the care components a pa-
tient received were necessary, nor that patients received 
all the care they required. As a result of this and the fact 
that facilities were different from each other in the care 
their patients needed, the analysis of the longitudinal 
quantitative study were driven by the gap between care 
need and care delivery.
12.1.1—Longitudinal Quantitative Study
Strengths: The facilities involved in Phase 1 were 
selected at random (29), thus reducing response bias 
(facilities confident in the outcomes of their care being 
more likely to respond to an invitation to participate 
than others). In phase 2 facilities were selected purpo-
sively (by size), and no facilities refused to participate. 
The longitudinal nature of the study design enabled the 
change in patient outcomes to be monitored over time, 
thus overcoming the limitation of a before and after 
study design (13).
Eligible patients were those who were new to the 
facility or who were presenting with a new problem. 
These criteria were applied to maximise the potential of 
detecting any influences of care on patient outcomes in 
the short follow up time available for this study. Given 
the chronic illnesses associated with HIV infection, 
it seemed there was a high possibility of recruiting a 
great proportion of patients to the study who had had 
the same illness for a long time, and so were unlikely to 
change their health outcomes in three months. There 
was a high response rate and low level of patients leav-
ing the study over the three months.
The difficulty identifying whether patients had re-
ceived weak opioids at Facility 258 seems to have been 
the only problem with comprehension. This suggests a 
gap in knowledge, but its existence adds support to the 
rest of the data because it suggests social desirability 
bias did not hinder participants from admitting igno-
rance. Subsequent patients were asked to participate if 
they met the inclusion criteria, until the desired number 
had been recruited. This minimised the possibility of 
healthcare workers recruiting patients who they thought 
likely to have favourable outcomes. There were no facili-
ties which struggled to recruit sufficient numbers.
The concise and multi-dimensional nature of the 
APCA African POS means this study provides valuable 
data on the multi-dimensional wellbeing of HIV posi-
tive patients accessing outpatient clinics in sub-Saharan 
Africa, and this has potential for future clinical and 
research uses.
Limitations: The facilities involved in Phase 2 do 
not necessarily represent the diversity of geography, 
relative wealth of the facility catchment areas, facility 
funders, service provision or other aspects that may af-
fect service provision, quality of care, facility attendance 
or response to treatment. Some of these factors (e.g. rel-
ative wealth of the patients, care received at the facility) 
Phase 2 uganda 103
integration and conclusions 103
were measured for individuals and so were accounted 
for in the analysis. The chance event of selecting three 
facilities in Kampala, two in other major towns and one 
very rural, biased the results in (with hindsight) pre-
dictable ways. 
Facility 256 had a higher dropout rate than others, 
for reasons discussed above. A high loss to follow-up 
is a cause of bias. It is unknown which individuals are 
most likely to remain in the study. Most people left the 
study for unknown reasons, which means they probably 
did not return to the facility at all and so the reason 
could not be ascertained. Thus they did not receive 
care from the facility. It seems likely that people with 
greater physical needs might be more likely to attend 
for care. On the other hand, people with psychological 
needs might be more likely not to attend, being unable 
to accept the diagnosis, or concerned about their status 
being discovered. 
One source of bias for the study is the fact that 
all six facilities cared for outpatients only. People who 
needed inpatient care were referred to the main hospital 
and were not referred back to the HIV centre until they 
were discharged. Thus the people who probably had the 
most severe symptoms, lowest CD4 count and were 
most in need of care do not appear in this study. The 
APCA African POS total score has not previously been 
calculated and the tool was not designed to be so sum-
marised, although the separate items have been assessed 
in a validation study of reliability and sensitivity (33).
A large number of statistical tests increases the 
probability of falsely identifying connections. In this 
study, five demographic covariates plus eight care 
themes were each modelled separately with two out-
come variables, making 26 models. Stepwise downward 
regression was later used to rule out any covariates 
which might have been included due to Type II error.
The CSRI recorded the receipt of 52 items of care. 
It is possible that the tool excluded some items of 
care, the receipt of which could potentially have been 
influencing health outcomes. The act of undertaking the 
study may have influenced the care given, and thus may 
have affected participant outcomes in a way that normal 
care would not have shown. Furthermore, even the pro-
cess of asking a series of questions about how patients 
feel could be viewed as a form of care in itself, or it 
might have revealed problems to the health provider 
that a normal consultation would not have detected. 
Analysis of the lowest-scoring individuals to 
observe change over time is vulnerable to bias caused 
by regression to the mean. People with a lower score 
have a greater probability of improved score over time. 
Therefore, the fact that the people scoring zero on 
APCA African POS items experienced a greater rise 
in score than the mean for the entire group should be 
treated with some caution. 
12.1.2—Qualitative Iinterviews
There are several strengths and limitations to the 
qualitative data. Firstly, although the views of patients, 
carers and staff were captured in this study, which gave 
views from the key individuals involved in patient care, 
respondents were identified by the participating facili-
ties, which may have introduced bias. Second, as the 
interviews were conducted in a range of languages they 
had to be analysed in the common language of English. 
Although this raised issues of translation and 
interpretation it allowed respondents to express them-
selves freely without the constraints of translating their 
thoughts to a less familiar language. Furthermore, the 
protocol ensured that interpretation of the local mean-
ing was established. The interviews were coded twice 
by independent researchers in the UK and Kenya. This 
process gave rigour to the coding process by reducing 
individual bias in interpretation. In addition, the cross-
country coding allowed the possibility of culturally 
different interpretations to arise and be discussed.
12.1.3—Costing Study
Care and support is the aggregate of many services, 
(psychological support, ART, pain management, etc.) 
The average cost of care for patients will therefore be 
the aggregate of the costs of providing these individual 
components. Although this study examined drug, staff, 
laboratory and facility running costs, the costs per 
patient for individual components of care could not be 
calculated. The cost of drugs other than ARVs was a 
particularly difficult area. A small selection of drugs rel-
evant to HIV care were identified, but the proportion of 
total drug costs spent on these would depend partly on 
the extent of the range of drugs offered by the facility. 
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For other components of care where the cost 
drivers were higher for staff time than for drugs, such 
as counseling services, it was not possible to allocate 
proportional staff time to the specific components of 
care sufficiently well.
The facilities received funding from the Ministry of 
Health and in some cases from other donors as well as 
PEPFAR funding which came through partner organi-
sations. The amount of funding received from PEPFAR 
and the proportion of its budget that this represented is 
not known, thus costs at the facility, rather than direct 
costs to PEPFAR, are the aim of analysis.
Care and support is provided not only at facilities 
but also in many cases by communities, at the family or 
household level or by FBOs/NGOs all of which incur 
costs and contribute to the overall costs of care for a pa-
tient. Individual patients may also incur costs in terms 
of time off of work (lost income) or the opportunity 
costs of their time in productive work and for trans-
portation. Due to funding limitations, this study only 
looked at facility-based costs. Other areas of cost which 
were not represented include those incurred by program 
managers at the donor level, administration of donor-
funded programmes, and training of specialized care 
and support for HIV positive patients. 
Lastly, the study did not take account of cost 
savings associated with averted illnesses or reduced in-
patient costs as a result of effective care and support.
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13.1—For Health Professionals
 » People with HIV have physical and mental health 
needs throughout the trajectory of illness, and 
mental health in particular is not related to HIV 
progression but can be a problem at any stage. Care 
and support should be available to all patients ir-
respective of HIV disease severity.
 » Care must respond to non-virological dimensions 
of HIV infection. All patients referred with HIV 
should be assessed for multidimensional need on a 
regular basis.
 » Participants taking ART experienced worse self-
reported physical and mental health at baseline and 
they made less improvement over time, even after 
accounting for CD4 count. Health staff should be 
aware of the needs of this group, and all patients 
taking ART should have regular monitoring, to 
include assessment and management of emotional 
and physical wellbeing as core clinical activities.
 » Counselling services should include the opportuni-
ty for patients to raise concerns and discuss prob-
lems, rather than focusing solely on educational 
intervention
 » The needs of carers should be included in the 
patient care encounter. Including carers early in the 
disease trajectory would improve social care for pa-
tients and could help to identify patient needs that 
are not acknowledged by the patients themselves. 
 » All patients should be assessed for pain, which 
should be managed according to the WHO Pain 
Ladder.
13.2—For Health Facility Managers
 » Home-based care should be encouraged, so that 
family carers can receive support and services such 
as VCT, and to reduce the costs to patients. 
 » There should be sufficient numbers of non-clinical 
staff to ensure a manageable patient load for coun-
sellors, nutritionists, social workers and community 
health workers, and high quality patient care. The 
areas addressed by these professions were identified 
as areas of high need for people in this study.
13.3—For Policymakers
 » No problems were reported with the supply of 
ARVs but supplies of other drugs were frequently 
unreliable, causing expense to patients and delays 
to care. Supply chain systems should adopt the best 
practices of the ART delivery system.
 » Chronic hunger is not adequately managed by 
short-term interventions. Food shortage caused 
by poverty is a significant problem which inhibits 
delivery of HIV care. Health facilities should work 
towards sustainable, adequate food supply for all 
patients to help maintain health and adherence.
 » Patients reported living in an atmosphere of stigma 
and discrimination which adversely affected their 
mental health. They recommended increased VCT 
promotion, in order to change public perceptions 
of HIV, make it easier for patients to disclose their 
status, and relieve the stress of secrecy. Increased 
prevention services would benefit HIV care and 
support. 
 » To achieve the best possible physical and mental 
health outcomes, HIV care and support should 
include:
•	 helping family members care for patients, 
through training and health care for carers;
•	 services to allow families to achieve adequate nu-
trition, ventilation and sanitation for basic health;
•	 a programme of psychological care, including 
‘talking therapies’ and medication, with referral 
for those with psychiatric problems; and
•	 support for patients whose financial situation 
inhibits their adherence, either directly through 
inability to pay or indirectly through worry.
13
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13.4—For Researchers
 » Facility staff who had hosted research projects for 
years expressed a wish to learn skills and conduct 
their own research. Future research programmes 
should include continued building of knowledge 
and capacity in host settings.
 » A study of care and outcomes for children should 
be undertaken to explore the multidimensional 
problems of this important population, particularly 
the expanding group of HIV positive older children 
for whom optimal care is still being developed
 » Shortage of drugs delayed patient care and was a 
common complaint, but the cause of these short-
ages is unclear. Examination of the barriers to drug 
delivery and a more detailed investigation of how 
drugs are supplied would be beneficial in terms of 
care delivery and patient satisfaction. 
 » A longer follow-up period would be beneficial to 
explore whether care and outcomes are maintained 
over a period greater than three months.
 » A study of how different staff working in care and 
support of HIV patients spend their working hours 
would enable an examination of how care costs 
relate to patient outcomes.
 » Further study of referral networks from individual 
facilities would help understand where and why 
patients obtain care that is not provided at the 
principal facility of study.
 » The evaluation model used here could be replicated 
in other countries.
 » Interventions to meet these recommendations 
should be developed, implemented and robustly 
evaluated in a sample of sites using experimental 
designs.
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Demography questionnaire
P1 Please indicate the patient's gender male=1, female=2
I would like to ask you a few questions about your background:
P2 How old are you (years)?
P3 What is the highest level none=1
of education you attended? attended primary=2
attended secondary=3
diploma=4
degree or higher=5
P4 What is the main material natural earth, mud, sand=1
used to make the floors finished cement=2
of your house? linoleum=3
parquet/polished wood=4
tile=5
carpet=6
stone=7
P5 What is the main material natural thatched/straw=1
used to make the  walls rudimentary mud and poles=2
of your house? un-burnt bricks=3
burnt bricks with mud=4
finished cement blocks=5
stone=6
Wood timber=7
burnt bricks with cement=8
P6 What is the main material used natural thatched=1
to make the roof of your house? finished wood/planks=2
corrugated iron sheets=3
asbestos=4
tiles=5
tin=6
cement/concrete=7
P7 What type of toilet do you use at home? private flush=1
private VIP latrine =2
private traditional pit (covered)=3
private traditional pit (uncovered)=4
public/shared=5
bush/field/other=6
P8 How far from the facility do you 
live? (kilometres) If not known, don't know=888 km
 ask for means of travel and  time taken to estimate distance.
A Demography
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P9 What is the main source of safe bottled=0
drinking water for your house? piped inside house=1
piped outside house (yard, public tap)=2
protected well=3
borehole=4
spring/rain water=5
unsafe unprotected well=6
river/stream/pond=7
tanker truck=8
P10 What type of fuel does your electricity=01, lpg/natural gas=02
household mainly use biogas=03, paraffin/kerosene=04
for cooking? coal=05, charcoal from wood=06
firewood=07, straw/shrubs/grass=08
dung=10, no food cooked in household=11
P11.1 Does anyone in the car yes = 1, no = 2
P11.2 household own a …? bicycle
P11.3 refrigerator
P11.4 television
P11.5 mobile phone
P11.6 radio
Now I would like to ask you a few questions about your HIV diagnosis:
P12 What date did you enrol into this facility? dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P13 why did you visit this facility today? new illness/well-being issue = 1
referred = 2 (from where)
obtain medication = 3 Place from which referred (2), 
HIV test result = 4 or other reason for attending (5):
other = 5 (specify) ________________
P14 date diagnosed HIV+ dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P15 date started on ARV treatment dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
777777=not on ARV
P16 Current WHO clinical stage (1-4) 8=don't know
P17 Most recent CD4 count don't know=8888
P18 date of most recent CD4 count dd/mm/yy
unknown day= 15, unknown month= 06, unknown year =888888
P19 How many dependants do you have?
(family members who are dependent on you including children)
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The APCA African POS & ECOG 
Question
number
ASK THE PATIENT
Questions 1-7
POSSIBLE RESPONSES ANSWER
Q1
Please rate your pain 
(from 0 = no pain to 5 = 
worst/overwhelming
pain) during the last 3 
days
0 = No pain at all 
1 = Slight pain 
2 = Moderate pain 
3 = Severe pain (interferes with activities of daily 
life)
4 = Very severe pain 
5 = Overwhelming. The worst pain you can 
imagine

Q2
Have any other 
symptoms (e.g. nausea, 
coughing or constipation) 
been affecting how you 
feel in the last 3 days? 
0 = no, not at all 
1 = slightly 
2 = moderately 
3 = severely 
4 = very severely 
5 = overwhelmingly 

Q3
Have you been feeling 
worried about your 
illness in the past 3 
days?
0 = Not at all worried 
1 = Worried very occasionally 
2 = Worried some of time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 

Q4
Over the past 3 days, 
have you been able to 
share how you are 
feeling with your family or 
friends?
0 = Not at all 
1 = Only once 
2 = Occasionally 
3 = Fairly frequently 
4 = Often 
5 = Yes, I’ve talked freely 

Q5
Over the past 3 days 
have you felt that life was 
worthwhile?
0 = Not at all 
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 

Q6
Over the past 3 days, 
have you felt at peace? 
0 = Not at all 
1 = Not very often 
2 = Occasionally 
3 = Some of the time 
4 = Most of the time 
5 = Yes, all the time 

Q7
Have you had enough 
help and advice for your 
family to plan for the 
future?
0 = None 
1 = Very little 
2 = For a few things 
3 = For several things 
4 = For most things 
5 = As much as wanted 

Thank the patient 
B APCA African POS and ECOG
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.
ASK THE CARER Questions 8, 9 and 10 ONLY if consent 
given by patient and carer
Q8
How much information 
have you and your family 
been given? 
0 = None 
1 = Very little 
2 = Some 
3 = Quite a lot 
4 = A great deal 
5 = As much as wanted 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 

Q9
How confident does the 
family feel caring for 
____?
0 = Not at all 
1 = Not confident about many things 
2 = Confident about a few things 
3 = Confident about some things 
4 = Confident about most things 
5 = Very confident 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview 

Q10
Has the family been 
feeling worried about the 
patient over the last 3 
days?
0 = Not at all worried 
1 = Worried very occasionally 
2 = Worried some of time 
3 = Worried a lot of the time 
4 = Worried most of the time 
5 = Worried all of the time 
7 = N/A, no carer/consent not given 
8 = carer not present at time of interview

ECOG (rated by the 
interviewer) 
Q11
Physical function of 
patient
0= fully active, able to carry on all pre-disease 
performance without restriction 
1=Restricted in physically strenuous activity but 
ambulatory and able to carry out light work, 
e.g., light house work, office work 
2=Ambulatory and capable of all selfcare but 
unable to carry out any work activities. Up and 
about more than 50% of waking hours 
3=Capable of only limited selfcare, confined to 
bed or chair more than 50% of waking hours 
4=Completely disabled. Cannot carry on any 
selfcare. Totally confined to bed or chair 

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The MOS-HIV 
Question
number
QUESTION POSSIBLE
RESPONSES 
ANSWER
I would like to ask you a few questions about your health.   
Q1 In general would you say your health is: Excellent=1 
Very good=2 
good=3 
fair=4
poor=5 

Q2 How much bodily pain have you generally 
had during the past thirty days? 
None=1 
Very mild=2 
Mild=3
Moderate=4 
Severe=5 
Very severe=6 

Q3 During the past thirty days, how much did 
pain interfere with your normal work, 
including both work outside the home and 
housework?
Not at all=1 
A little bit=2 
Moderately=3 
Quite a bit=4 
Extremely=5 

The following questions are about activities that a person might do during a typical day. Does your
health now limit you in the following activities? And if so, how much?
Yes, limited a lot=1 
Yes, limited a little=2 
No, not limited at all=3
Q4.1 The kinds or amounts of vigorous activities 
you can do like digging, fetching water from 
a well, carrying a load, splitting firewood, 
running, lifting heavy objects or engaging in 
strenuous sports

Q4.2 The kinds of moderate activities you can do 
like washing clothes, moving a jerrican of 
water or cleaning the house 

Q4.3 Walking up hill, climbing stairs  
Q4.4 Bending, lifting light objects or kneeling  
Q4.5 Walking a moderate distance, like the length 
of a football pitch or taking a village walk 
Q4.6 Feeding, dressing or bathing yourself or 
ability to use the latrine 
C MOS-HIV
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The following questions are about work. Does your health now restrict you in doing the following 
kinds of work?
Q5 Does your health keep you from working at a 
job, doing work around the house or 
attending school? 
Yes=1 
No=2 
Q6 Have you been unable to do certain kinds or 
amounts of work, housework, schoolwork, 
because of your health? 
Yes=1 
No=2 
For each of the following questions, please tell me the answer that comes closest to the way you 
have been feeling. 
(Interviewer must begin by reading this 
introductory question to the patient) 
How much of the time during the past 30 
days:
All of the time=1 
Most of the time=2 
A good bit of the time=3 
Some of the time=4 
A little of the time=5 
None of the time=6 
Q7 Has your health limited your social activities, 
like visiting with friends or family? 
Q8.1 Have you been a very nervous person?  
Q8.2 Have you felt calm and peaceful?  
Q8.3 Have you felt depressed? 
Q8.4 Have you been a happy person?  
Q8.5 Have you felt so depressed that nothing 
could cheer you up? 
Q9.1 Did you feel full of life and energy?  
Q9.2 Did you feel totally without energy?  
Q9.3 Did you feel tired?  
Q9.4 Did you have enough energy to do the things 
you wanted to do? 
Q9.5 Did you feel weighed down by your health 
problems? 
Q9.6 Were you discouraged by your health 
problems? 
Q9.7 Did you feel despair over your health 
problems? 
Q9.8 Were you afraid because of your health?  
(Interviewer must begin by reading this 
introductory question to the patient) 
How much of the time during the past 30 
days:
All of the time=1 
Most of the time=2 
A good bit of the time=3 
Some of the time=4 
A little of the time=5 
None of the time=6 
Q10.1 Did you have difficulty reasoning and making 
decisions, for example, making plans or 
learning new things?

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Q10.2 Did you forget things that happened recently, 
for example, where you put things or when 
you had appointments?

Q10.3 Did you have trouble keeping your attention 
on any activity for long? 
Q10.4 Did you have difficulty doing activities 
involving concentration and thinking? 
Please tell me the answer that comes 
closest to describing whether the 
following statement is true or false for 
you.
Definitely true=1 
Mostly true=2 
Don’t know=3 
Mostly false=4 
Definitely false=5
Q11.1 You are somewhat ill 
Q11.2 You are as healthy as any other person you 
know 
Q11.3 Your health is excellent 
Q11.4 You have been feeling bad recently 
Q12 How has the quality of your life been during 
the past thirty days? That is, how have things 
been going for you? 
Very well, could hardly 
be better=1 
Pretty good=2 
Good and bad parts 
about equal=3 
Pretty bad=4 
Very bad, could hardly 
be worse=5 

Q13 How would you rate your physical health and 
emotional condition now compared to thirty 
days ago? 
Much better=1 
A little better=2 
About the same=3 
A little worse=4 
Much worse=5 

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Ask the patient if they have received the following care in the last 30 days
Category Component of care have you received this If yes, where?
of care care from any facility this facility=1
in the last month? elsewhere=2
1=yes, 2=no, 8=don't know If A=2 or 8, B=7
Question number Question section: A B
C1 Spiritual visit by pastor etc
C2 prayer with staff
C3 contact with traditional healer
C4 Psychological pre and post test counselling
C5 adherence counselling
C6 family planning counselling
C7 patient HIV support groups
C8 family counselling
C9 psychiatric therapy
Clinical Prevention
C10 prevention with positives
General
C11 wound care
C12 other nursing care
C13 ART/ARV
C14 assess ART treatment
Pain
C15 assessment of pain
C16 strong opioids eg morphine
C17 weak opioids eg codeine
C18 non-opioids eg paracetemol
C19 treatment for neuropathic pain
Symptom management
C20 anxiety/depression treatment
C21 treatment for nausea/vomiting
C22 treatment for skin rash/itching
C23
C24 treatment for constipation/laxatives
C25 treatment for genital thrush
C26 treatment for oral thrush/candidiasis
C27 treatment for cryptococcal meningitis
treatment for diarrhoea, including ORS or drip
D CSRI
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Category Component of care have you received this If yes, where?
of care care from any facility this facility=1
in the last month? elsewhere=2
1=yes, 2=no, 8=don't know If A=2 or 8, B=7
Question number Question section: A B
C28 treatment for other fungal infections
C29 treatment for herpes (e.g. acyclovir)
C30 treatment for malaria
C31 TB testing
C32 TB treatment
C33
C34
C35 management of cancer
C36
Prophylaxis
C37 food
C38 multivitamins
C39 nutritional advice
C40 provided access to safe drinking water at home
C41 septrin/cotrimoxazole to take every day
C42 isoniazid (INH) to prevent TB
C43 condoms
C44 mosquito bednets
C45 Social provide household items
C46
C47 employment training/IGA
C48 transport/money for bus to care centre
C49 legal services
C50 memory book work
C51 loans/microfinance
C52 infection control training
C53 Did you sleep under a bednet last night? 1=yes, 2=no
C54 Did you take cotrimoxazole yesterday? 1=yes, 2=no
How much have you spent on your care in past month (inclu transport to facility and drugs)
C55 at this facility? shillings
C56 anywhere else? shillings
 treatment for other opportunistic 
infections
home help e.g. help with bathing, housework, 
cooking
therapeutic feeding for severe malnutrition, i.e. 
drip
physiotherapy i.e. excercises to help improve 
movement
End of interview
Thank patient
Complete front cover
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Patient Qualitative Interview 
Schedule
 » Introduce self and background
 » Introduce project
 » Explain how patient selected 
 » What we will talk about
 » How long it will last 
 » Consent and confidentiality
 » Collect consent now
 » Tape recording and destruction
 » What will happen with data
 » Who to speak to if they have any questions 
 » Complete basic demographic information about patient 
•	 Age 
•	 Gender 
•	 Household size 
•	 Household location (urban, peri-urban, rural)
•	 Currently using ART (yes/no)
•	 History
 - How did you come to find/access the facility? 
 - Why did you come to this facility? 
 - How easy/difficult was it to become a patient here? 
•	 Contact
 - How often do you come to this service? 
 - What do you attend the service for? 
 - How satisfied are you with the service you receive?
* What is good about it?
* What is not so good about it?
 - (If the patient receives medicines) What problems, if any, have you had getting medicines? 
E
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•	 Need
 - What would you say are your biggest problems in relation to your HIV diagnosis? 
* Suggestions to help patient: These could be anything, such as getting to the facility, pain or other symptoms, 
childcare, anxiety, etc. 
 - Do you have any other pressing problems that may not be obviously related to HIV?
* Suggestions to help patient: Again, these could be anything such as family relationships, food, etc. 
 - How does the facility help you with these problems, if it does? 
 - What help do you currently receive (including medications) from this facility? 
 - When you see the health worker, what do you talk about with them? 
 - Do they ever talk with you about:
* Spiritual care?—what specifically do they ask/do?
* Clinical care?—what specifically do they ask/do?
* Ways to prevent infecting others with HIV?—what specifically do they ask/do?
* Emotional/psychological well-being?—what specifically do they ask/do?
* Social or financial issues?—what specifically do they ask/do?
* General advice and communication skills for you?—what specifically do they ask/do?
 - Are there ever any things you need or problems you have that you don’t talk about?  
 - What else does the health worker do for you? 
 - Do you feel that staff ever treat you differently from other patients because you have HIV? 
 - What would you like an HIV care service to do for you, what things would you need? 
 - Which other health services do you go to?
* Why do you go there?
* What things do you get there? 
 - We are coming to the end of the interview. Is there anything we haven’t asked about that is important to 
you? Do you have any questions?
Thank the patient.
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Carer Qualitative Interview Schedule
 » Introduce self and background
 » Introduce project
 » Explain how patients selected 
 » What we will talk about
 » How long it will last 
 » Consent and confidentiality
 » Collect consent now
 » Tape recording and destruction
 » What will happen with data
 » Who to speak to if they have any questions 
 » Complete basic demographic information about carer 
•	 Age
•	 Gender
•	 Household size 
•	 Household location (urban, peri-urban, rural)
•	 Relationship to patient
•	 Contact
 - How often does your relative see the service? 
 - What do they attend the service for? 
 - How satisfied are you with the service they receive?
* What is good about it?
* What is not so good about it? 
 - Do you collect any medicines from the facility for them? 
* If so, what problems, if any, have you had getting medicines for the patient? 
•	 Need
 - What would you say are your biggest problems in relation to the patient’s HIV diagnosis? 
* Are there any other pressing problems you have that may not be obviously related to HIV? 
 - How does the facility help you with these problems, if it does? 
F
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 - Do you ever see a health worker?
* If you see the health worker, what do you talk about with them?
* Do they ever ask you about any problems/questions you have as a carer/relative of the patient with HIV (try to 
use the patient’s name)? 
 - Does the health worker talk to you or your relative about:
* Spiritual care?
* Clinical care?
* How to prevent infecting others with HIV?
* Emotional/psychological wellbeing?
* Social or financial issues?
* General advice and communication skills?
 - What else does the health worker do?
 - What would you like an HIV care service to do (i.e., what things would you, the patient, or your family 
need)?
 - We are coming to the end of the interview. Is there anything we haven’t asked about that is important to 
you? Do you have any questions?
Thank the carer.
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Staff Qualitative Interview Schedule
 » Introduce self and background
 » Introduce project
 » Explain how staff member selected
 » What we will talk about
 » How long it will last 
 » Consent and confidentiality
 » Collect written consent
 » Tape recording and destruction
 » What will happen with data
 » Who to speak to if they have any questions: 
•	 About you
 - What is your job title? 
 - How long have you worked at this facility?
•	 Access
 - What criteria, if any, do you have for patients who want to access your service? 
 - Are you able to accept all the patients that wish to access your service?
* (If not) How do you choose them? 
 - Are there any costs to patients? 
•	 Contact
 - How often/where do you see patients? (i.e. regularity of appointments) 
 - Do you ever see their families?
* If so are you expected to offer support to them also? 
* In what ways?
* Do you? 
 - How do patients get in touch with you? 
 - Can you describe the average patient encounter:
* What standard forms/reporting, if any, do you have?
* What do you ask/record? 
G
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 - What sorts of things do you to talk with the patient about? (For the following areas of care include the 
following areas of enquiry: do you talk about it? What do you ask? What do you do? Is it part of your job? 
If not, whose? Do you refer them on in these cases? Are you confident/do you feel able to offer this care?). 
Prompt:
* Spiritual care 
* Clinical care
* Ways to prevent HIV transmission
* Emotional/psychological wellbeing
* Social/economic wellbeing
* Bereavement 
 - What do you give them?
•	 Care and referrals
 - What is the difference between caring for early and advanced disease patients with HIV? 
 - What happens with dying patients?  
 - Do you ever refer HIV patients on to other facilities?
* For what?
•	 Multiprofessionalism and training
 - Do you work with other health care workers in your facility, and if so, how? 
 - What sort of problems do you not ask patients about as it someone else’s work? 
 - What supervision do you receive/give to workers? 
 - What training have you had? 
 - What extra training would you like? 
 - What do you consider to be your own personal skills and strengths in caring for HIV patients? 
 - Where do you feel you could do better?
•	 Components of care
 - What problems, if any, do you find with supplying medicines to patients? 
* Which ones do you use most/least?
* What medicines don’t you have that you’d like to have?  
 - If you could add extra services to your facility what would you like to provide?  
Phase 2 uganda 122
staff Qualitative interview schedule 122
 - Are there any problems relating to HIV that you can’t manage in your facility (e.g., severe pain, depression, 
poverty)?
* Is there anything you do for patients in these situations? 
 - Do you refer patients to any other services?
* What for?
* Please can you describe the process of referring a patient (i.e., details of any written information, patient follow-
up, communication with the other facility)
•	 Evaluation
 - What are the strengths of your facility? 
 - What are the weaknesses of your facility? 
 - What main challenges do you face in terms of sustainability for your facility?
 - We are coming to the end of the interview. Is there anything else important to you that you would like to 
say?
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Costing InstrumentH
facility number Date
Completed by : Names of those interviewed
Accountant:
Pharmacist:
Clinician (drugs, lab tests etc):
(1) Patient numbers
1 total # individuals cared for in past year (2007):
2 # individuals provided with any HIV care in past year (2007), including ART and non-ART:
3 of those, # individuals provided with ART in past year (2007):
NB: all following questions refer to HIV care only and in the context of patients being HIV positive
(2) staff
ask a range of staff (doctor, nurse, counsellor, CHW)
staff type number of HIV patients # hours spent hours worked
you see in a typical day with HIV patients per week per week
4.1.1 doctor 1
4.1.2 doctor 2
4.2.1 nurse 1
4.2.2 nurse 2
4.3.1 counsellor 1
4.3.2 counsellor 2
4.4.1 community health worker 1
4.4.2 community health worker 2
4.5 clinical officer
4.6 pharmacist
4.7 lab staff member
4.8 nutritionist
4.9 social worker
4.10 physiotherapist
Mackuline Atieno
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facility number Date
(3) medicines ask pharmacist Option A OR ask clinician/pharmacist option B
medicine Actual quantity dispensed Estimated quantity used by typical pt in 3 mths (tabs)
in Feb-April 2008(tabs) on ART pre-ART
5 Abacavir (ABC)
6 Didanosine (ddI)
7 Efavirenz (EFV)
8 Indinavir (IDV)
9 Lamivudine (3TC)
10 Lopinavir (LPV)  + Ritonavir (RTV)
11 Nelfinavir (NFV)
12 Nevirapine (NVP)
13 Stavudine (d4T)
14 Stavudine + Lamivudine
15 Stavudine + Lamivudine + Nevirapine
16 Tenofovir (TDF)
17 Tenofovir + Emtricitabine (FTC)
18 Zidovudine (ZDV)
19 Zidovudine + Lamivudine
20 Zidovudine + Lamivudine + Nevirapine
21 strong opioids eg morphine
22 Septrin/cotrimoxazole
23 weak opioids eg codeine
non-opioid painkillers (name 3 most common)
24.1 1
24.2 2
24.3 3
25                                TB Treatment
600mg
400mg
200/50mg
150mg
300mg
Aspirin
300mg
Brufen
300/150mg
200mg
30+40mg
Paracetamol
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facility number Date
(3) medicines continued ask pharmacist Option A OR ask clinician/pharmacist option B
medicine Actual quantity dispensed Estimated quantity used by typical pt in 3 mths (tabs)
in Feb-April2008 (tabs) on ART pre-ART
other antibiotics for opportunistic infections (name 3 most common)
26.1 1 0
26.2 2 0
26.3 3 0
Name 2 most common first line ART regimens: Estimated number of patients on this regimen
27.1 1.___
27.2 2.___
Name 2 most common second line ART regimens:
28.1 1.___Zidovudine+lamivudine+lopinavir/ritonavir
28.2 2.___
(4) lab tests
ask lab staff and doctor Option A or Option B
Actual number of tests this facility Estimated number of tests a typical patient
test conducted in Feb-April 2008 receives in 3 months
on ART pre-ART
29 liver function test (LFT)
30 AFB smear (TB)
31 CD4 count
32 haemotology test (FHG)
33 viral load
Abacavir+didnosine+lopinavir/ritonavir
Amoxil (500mg+250mg)
Doxycycline
Stavudine+lamivudine+nevirapine
Zidovudine+lamivudine+nevirapine
Cefzil (500mg)
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(5) building infrastructure and utilities (all, not only HIV) ask accountant/manager
34 Utility costs per month (shillings)
Include water, electricity, generator fuel, 0
 communications, waste disposal etc
35 Transport costs, fuel, drivers, maintenance (shillings) 0
36 Clinical consumable costs per month (shillings)
Include gloves, syringes, cotton wool 0
swabs, plasters, soap, sterilising solution etc
37 amount spent on volunteer staff (inclu training, 0
travel reimbursements, payment in kind) in past 3 months (shillings)
(6) capital costs ask accountant
38 approximate total facility space (sq m)
39 approximate facility space for HIV care (sq m)
40 rent per month, or estimated rental value
41 number of four-wheeled vehicles
42 number of two-wheeled vehicles
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I Further Quantitative Analysis
Loadings onto Wealth Factor
Table 72 shows the contribution of each variable to the 
single factor, with the exception of six variables which 
did not contribute at all. The variables loading most 
heavily onto the factor were having an earth floor, using 
firewood or straw as cooking fuel and having a thatched 
roof, loading negatively, and having piped water (ei-
ther inside or outside the house) and owning a mobile 
phone or television, loading positively. 
Association of Mental Health Score with Physical 
Health Score
Linear regression was used, with CD4 count as a con-
tinuous variable, to explore the effect of CD4 on mental 
health score adjusting for physical health score. The 
hypothesis was that the observed association of mental 
health score and CD4 count was explained by the effect 
of CD4 on physical health score. 
It was also hypothesised that participants with 
lower physical health would be more likely to be ac-
companied by a carer, but the same would not be true 
of mental health. To test this hypothesis, linear regres-
sion was used to separate the associations of carer pres-
ence with physical and mental summary scores at T0. 
Table 73 shows that physical health score was as-
sociated with CD4 count when analysed alone (Model 
A) and when mental health score was included (Model 
B). However, in Table 74, the results show that while 
mental health score was included with CD4 count in 
univariate analysis (Model C), the addition of physi-
cal health score wiped out the association (Model D). 
Physical health score was a total cofounder for the 
apparent relationship between CD4 count and mental 
health, being related to both. 
Table 75 shows that participants with a carer pres-
ent at T0 had on average a physical health score six 
points lower than those without a carer (Model A), 
and if mental health was included in the model (Model 
B), the difference in physical health remained statisti-
cally significant at 4.6 points. Mental health, on the 
Table 72: Loadings onto Wealth Factor
Variable Loading
Earth floor -0.266
Firewood, grass or straw for cooking fuel -0.264
Thatched roof -0.208
Water piped outside the house 0.182
Water piped inside the house 0.152
Own a mobile phone 0.112
Own a television 0.106
Walls of thatch, mud and poles, or mud and unburnt brick -0.091
Own a refrigerator 0.087
Private flush toilet 0.084
Public or shared latrine 0.071
Own a radio 0.058
Own a car 0.044
Kerosene, paraffin, lignite or coal for cooking fuel -0.035
Unsafe water source (river, stream, lake, uprotected well) 0.025
Own a bicycle 0.023
Finished floor (linoleum, tile, carpet, stone) -0.015
Electricity or gas for cooking fuel -0.009
Roof of asbestos, tile, tin or cement -0.008
other hand, was two points lower for those with a carer 
(Table 76, Model C) but there was no significant differ-
ence in mental health after adjusting for physical health 
score (Model D). 
Details of Longitudinal Analysis Method
Multilevel modelling was carried out using the Stata 
xtmixed command function. Outcomes were physical 
health score and mental health score, measured up to 
three times at monthly intervals. Baseline score was in-
corporated as a covariate and not as an outcome. Mod-
els included levels for facility and individual. The only 
random effects was timepoint (interview number, rather 
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than actual time interval), which was allowed to have a 
random coefficient at the individual level. Other covari-
ates were fixed. Demographic and care theme covariates 
were constant over time, receipt of ART and TB treat-
ment varied. The default independent covariance struc-
ture was used. Variance and standard error of variance 
were reported for random-effects parameter estimates. 
Exploring the Variance at Different Levels
Table 77 shows that there was as much variation in 
summary scores between facilities as within individu-
als over time. Facility was significantly associated with 
both outcome scores on an ANOVA test but the 
F-value was twice as high for physical health score, 
Table 75: Linear Regression of Physical Health Score by Carer Presence at T0
Model Covariate Coefficient Standard Error T P 95% CI
A Carer present -6.066 1.072 -5.66 <0.001 -8.171 to -3.960
B Carer present -4.557 0.864 -5.27 <0.001 -6.254 to -2.860
B mental health score 0.736 0.039 18.80 <0.001 0.659 to 0.813
showing greater variation between facilities for mean 
physical than mental scores.
Additionally, a multi-level model without covari-
ates was developed to ascertain the contribution of the 
facility level to change over time (Table 78). There was 
more variance at the individual level than facility level, 
showing that participants within facilities were more 
different to each other than was explained by the differ-
ence between facilities. 
However, the variance scores were within the same 
order of magnitude, whereas in the Kenya Phase 2 
longitudinal quantitative study, within-facility differ-
ence outweighed between-facility difference more than 
tenfold.
Table 73: Linear regression of physical health score by CD4 count at T0
Model Covariate Coefficient Standard Error T P 95% CI
A CD4 count 0.011 0.003 4.49 <0.001 0.006–0.016
B mental health score 0.768 0.052 14.89 <0.001 0.666–0.869
B CD4 count 0.007 0.002 3.60 <0.001 0.003–0.011
Table 74: Linear Regression of Mental Health Score by CD4 Count at T0
Model Covariate Coefficient Standard Error T P 95% CI
C CD4 count 0.005 0.002 2.63 0.009 0.001–0.009
D Physical health score 0.480 0.032 14.89 <0.001 0.417–0.543
D CD4 count -0.001 0.002 -0.11 0.910 -0.003–0.003
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Table 76: Linear Regression of Mental Health Score by Carer Presence at T0
Model Covariate Coefficient Standard Error T P 95% CI
C Carer present -2.051 0.871 -2.35 0.019 -3.761 to -0.340
D Carer present 0.893 0.716 1.25 0.213 -0.513 to 2.300
D physical health score 0.485 0.026 18.80 <0.001 0.435 to 0.536
Table 77: Results of ANOVA Using Facility at T0
N R Squared
Adjusted  
R Squared
F P
physical 
health score
639 0.121 0.114 17.36 <0.001
mental 
health score
639 0.069 0.062 9.36 <0.001
Table 78: Results of Multi-level Model with Random Intercept 
Facility Level Individual Level
Variance Standard Error Variance Standard Error
physical 
health score
20.739 13.543 56.508 4.224
mental 
health score
10.006 6.626 35.861 2.796
Phase 2 uganda 130
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Table 79: PEPFAR Categories of Care
Area of Care and Support Care Components included from CSRI Area of Care and Support Care Components included from CSRI
Clinical Pre and post test counselling
Adherence counselling
Nursing care
Adult diagnostic HIV testing
Weighing
Assessment of pain
Strong opioids
Weak opioids
Non-opioid analgesics
Treatment for neuropathic pain
Treatment for nausea/vomiting
Treatment for skin rash/itching
Treatment for diarrhoea
Laxatives
Treatment for thrush
Treatment for oral candidiasis
Treatment for cryptococcus
Treatment for other fungal infections
Treatment for herpes
Treatment for malaria
TB detection and treatment
Therapeutic feeding for malnutrition
Treatment for other opportunistic infections
Management of cancer
Multivitamins
Nutritional advice
Access to safe drinking water at home
CTX
Isoniazid to prevent TB
ITNs
Wound care
Physiotherapy
Psychological Family counselling
Psychiatric therapy
Anxiety/depression treatment
Spiritual Visit by faith leader
Staff prayer with patients
Contact with traditional healer/herbalist
Memory book work
Social Home help
Employment training
Legal services
Loans/microfinance
Prevention Family planning counselling
Patient HIV support groups
Support for family testing
Prevention with positives
Condoms
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Country-Level Coding FramesK
Coding Frame Developed by APCA Researchers 
 » Components of care/care provision
•	 Curative, preventive and on going monitoring 
•	 VCT, RCT and Diagnostic counselling
•	 Adherence counselling
•	 Spiritual care
•	 Bereavement care 
•	 Socio-economic support
•	 Laboratory services 
•	 Psychological/emotional  care 
 » Health seeking behaviour
•	 Associated with self initiation into care
 - Sickly
 - Suggestive symptoms 
 - Community advice 
•	 Reasons for choice of facility
 - Proximity
 - Available services 
 - Affordability
 » Patient and carer’s needs
•	 Clinical 
•	 Preventive
•	 Social and financial
•	 Emotional/psychological
 » Structure of HIV/AIDS care services
•	 Criteria for accessing care
•	 Enrollment process
•	 Frequency of care
•	 Documentation in care
•	 Differences in care needs for patients at different 
stages of disease
•	 Referrals 
•	 Costs to patients
•	 Education and training
•	 Supervision
 » Strengths, challenges, and service gaps
•	 Services facilities /patients would like to have 
•	 Challenges faced
•	 Patients perceptions of services received
Coding Frame Developed by KCL
 » Carer roles, relationship to patient and facility
•	 Patient as care provider and educator
 » Content of service receipt
•	 Advanced and bereavement care
•	 Carer
•	 Clinical and medicine
•	 Monitoring and process
•	 Preventive
•	 Psychological, counselling and advice
•	 Referral
•	 Social
•	 Spiritual
 » Experiences of care provision and receipt
•	 Negative experiences
•	 Positive experiences
•	 Facility self-reported strengths
•	 Patient and carer self report
•	 Suggested improvements
•	 Clinical and facility challenges
 » Initiating care
•	 Criteria for service entry and care
•	 Patient choice of facility
•	 Process of enrollment
•	 Retention and shopping around
•	 Service identification of needs
 » Needs
•	 Carers
•	 Clinical
•	 Preventive
•	 Psychological
•	 Social
•	 Staff
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Table 80: MOS-HIV Responses at T0
Subscale No. Question Responses
poor fair good very good excellent
Health Perception
Q1 Health is 20.5 50.5 22.0 5.9 1.1
true mostly true don’t know mostly false false
Q11.1 Somewhat ill 28.6 45.9 1.6 18.1 5.8
Q11.4 Feeling bad recently 19.7 48.7 1.6 23.6 6.4
false mostly false don’t know mostly true true
Q11.2
As healthy as anyone 
you know
22.7 42.8 3.1 22.8 8.6
Q11.3 Health is excellent 30.6 45.3 3.4 14.2 6.4
very severe severe moderate mild Very mild None
Pain
Q2 Bodily pain 4.4 23.0 26.1 14.8 12.3 19.4
extremely quite a bit moderately a little bit not at all
Q3
Pain interfering with 
daily life
10.0 22.5 18.0 19.4 30.2
limited a lot
limited a 
little
not limited 
at all
Physical Function
Q4.1 Vigorous activities 36.9 34.4 28.8
Q4.2 Moderate activities 18.1 30.5 51.4
Q4.3 Walking up hill 19.1 41.7 39.2
Q4.4 Bending, kneeling 8.6 26.7 64.7
Q4.5 Walking 7.0 18.6 74.4
Q4.6 Self care 2.3 6.9 90.8
Yes No
Role Function Q5 Cannot work 38.9 61.1
Q6
Cannot do certain 
kinds of work
42.2 57.8
Proportion of Time
all most a good bit some a little none
Social Function Q7
Limited social 
activities
4.7 11.4 11.1 18.1 15.3 39.4
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Table 80: MOS-HIV Responses at T0
Subscale No. Question Responses
Mental Health
Q8.1 Nervous 1.7 9.4 7.7 34.8 20.3 26.1
Q8.3 Depressed 2.5 9.7 9.2 35.5 20.6 22.5
Q8.5 Very depressed 1.9 5.9 6.9 20.2 27.0 38.1
Vitality
Q9.2 Without energy 2.8 10.5 8.0 25.0 28.6 25.2
Q9.3 Tired 3.3 13.9 9.8 40.2 19.2 13.6
Health Distress
Q9.5 Weighed down 2.3 11.4 8.0 28.9 22.8 26.6
Q9.6 Discouraged 3.1 8.0 7.0 25.2 18.0 38.8
Q9.7 Despair 2.8 7.5 6.6 22.7 21.4 39.1
Q9.8 Afraid 3.6 9.5 6.9 25.0 22.0 33.0
none a little some a good bit most all
Mental Health
Q8.2 Calm and peaceful 8.6 16.9 33.0 12.8 21.3 7.5
Q8.4 Happy 5.9 13.8 27.7 13.8 30.0 8.9
Vitality
Q9.1 Full of life 14.5 18.8 27.7 10.2 21.3 7.7
Q9.4 Enough energy 14.1 15.2 27.7 8.9 25.2 9.1
all most a good bit some a little none
Cognitive Function Q10.1 Difficulty reasoning 0.5 5.8 7.3 21.9 17.5 47.0
Q10.2 Forgetful 0.9 8.3 5.9 22.0 18.9 43.9
Q10.3 Attention problem 0.6 5.6 6.4 22.8 19.4 45.2
Q10.4
Concentration 
problem
0.2 6.3 5.9 20.9 21.1 45.6
very bad pretty bad about equal pretty good very good
QoL Q12 Quality of life 8.3 32.0 35.9 20.0 3.8
much worse a little worse the same a little better much better
Health Transition Q13
Compared to 30 days 
ago
5.9 29.4 26.6 31.7 6.4
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Feedback from DisseminationM
Introduction
Part of the objective of this evaluation is, in conjunction 
with MEASURE Evaluation, to build commitment to 
utilising the findings and lessons learnt from the study. 
As a step towards meeting this objective a meeting was 
held in Kampala in July 2009 with the research team 
and participating facilities. The purposes of this meet-
ing were (a) to share the results of Phase 2 with partici-
pants; (b) to gain insight into the findings from those 
involved in service delivery to improve the presentation 
of the findings in the report; and (c) to discuss the 
recommendations made, with the option of facilities 
making additional recommendations if desired
Representatives from all six facilities, the country 
team and the Ministry of Health attended the work-
shop.
Meeting Outline
Participants were given a summary of the findings. 
Presentations from the research team explained (a) the 
parties involved and the aims, objectives, and design 
of the evaluation; (b) the methods and data collection 
experiences; and (c) the results.
Participants were then divided into five groups in 
order to explore key themes that arose from the data in 
more detail. In addition to the summary report already 
received, each group was given relevant supplementary 
data (i.e., report tables and excerpts from qualitative 
interviews) to aid discussions. Group participants were 
asked to discuss the main findings relating to the theme 
allocated. 
Prompts to aid discussion included: Were any find-
ings surprising? What are the areas where things are 
doing well or are on track and why? What areas need 
improvement and why? Participants were then asked 
to review and discuss the recommendations contained 
in the summary report, and finally to draft their own 
set of recommendations for action in this thematic area 
using the attached format. Discussion summaries were 
shared with all.
Meeting Feedback—General
Participants expressed their appreciation at being 
informed of the findings. In general participants found 
that the findings were borne out by their own experi-
ence. Specifically, they agreed with the conclusions 
regarding the burden of poverty for patients, staff work-
load and the importance of motivation, the value of 
carer involvement, drug supply issues, resource limita-
tions, and the pressure on counsellors. 
The Country Team reported that the evaluation 
showed that ART alone was not sufficient to solve all 
problems in HIV, with further care and support being 
necessary. They also agreed that the needs of patients 
on ART, which are highlighted in the evaluation, are 
an essential area. The evaluation provided the evidence 
needed to plan services and distribute funds.
Participants discussed the possible reasons for lower 
self-reported health among people receiving ART, and 
speculated that over a period longer than three months, 
this group might ‘catch up’ with ART-naïve patients. 
There was a strong feeling that facilities must offer 
more than ART management, vital though that was, in 
the presence of great social, psychological and economic 
need. Participants were also concerned about over-reli-
ance on donor funds, as reported in Phase 1. 
Meeting Feedback—Groups
ART, BCP, Pain Management, Symptom and 
Infection Management, Prevention
The proportion of participants in the longitudinal 
quantitative study receiving ART increased from 41.4% 
to 57.3%, a change which the group found surprising in 
the relatively short time of three months. The possible 
reasons for this included increased awareness of HIV, 
accessibility of services and availability of ART. The 
group commented on how much the environment of 
HIV care had changed in the past few years, with the 
rollout of ART.
The group felt it was important to understand why 
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CD4 counts were not recorded, especially for those on 
ART, and pointed out that machines were bought for 
the facilities yet the tests were not done.
The factors impeding performance for facilities 
were identified as overwhelming patient numbers, lack 
of palliative care skills, infrastructure deficiencies, drug 
supply problems, low staff morale, and the underlying 
issue of poverty. The group emphasised that research 
recommendations in themselves were not enough, and 
action needed to be taken to put them into effect.
Nutrition, Social Care, Psychological Care, 
Spiritual Care
The group commented that social care was particularly 
important because social status had a bearing on the 
mental and physical health of participants, but social 
support was seen as expensive. The goal was to empow-
er patients, to enable them to improve. Spiritual care 
was believed to change behaviour, and to be connected 
with a decline in visits to traditional healers. In Kenya, 
the relationship between medical services and tradi-
tional healers is very poor. 
This care required skilled staff. The group com-
mented that the skills and knowledge to provide 
nutritional counselling, adherence counselling, and 
family planning counselling were widespread, so these 
components were well delivered, but social and spiritual 
care training was less developed. 
Facility Strengths and Weaknesses
The group reported that the strengths of the six facili-
ties were (a) a positive staff attitude; good collaboration 
between clients and counsellors, staff motivation; (b)
availability of drugs; (c) holistic patient management, 
including the ability to give hope and spiritual care; and 
(d) time management and scheduling.
The areas where improvement was needed were 
staff training, particularly counselling, development of 
community home based care, stigma reduction, and 
staff motivation. Staff motivation was a strength as well 
as an area of concern because it was such a challenging 
issue and constantly needed to be addressed. Over-
whelming patient numbers, lack of space and shortage 
of time impeded staff performance and caused disillu-
sion and demotivation, as well as limiting care.
Patient Issues and Perspectives
The group felt that the most important issue was to 
empower patients to produce their own food and make 
the family self-sufficient. They had many recommenda-
tions to improve patient care (summarised in the table 
below). These centred around community participation 
and peer support. The issue of whether to renumerate 
community volunteers was highlighted, as doing so 
would make the project non-self-supporting but moti-
vation could be difficult without it.
Carer Issues and Perspectives
The group agreed that the findings of the evaluation 
reflected their own experiences. They emphasised that 
carers often had numerous other responsibilities includ-
ing supporting dependants and caring for other family 
members, and might also be HIV positive and have 
health problems. This made long waiting times frustrat-
ing as carers had other needs to attend to. Communi-
cation was identified as the essential issue for carers. 
Carers had psychological challenges from feeling left 
out, having no-one to talk to, and wanting to share the 
challenges faced in trying to care. They were underval-
ued, although the group recognised that the work they 
did was vital. Increasing poverty, as both patients and 
carers became less able to work and bring in income, 
added to the burdens of caring.
Each group produced recommendations based on 
the data. These are presented in the table below, togeth-
er with the principal supports for them and the main 
beneficiaries. Some recommendations were made by 
more than one group and have been merged together.
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Table 81
Recommended Actions Data supporting recommendation Beneficiaries
Longitudinal Qualitative Cost/survey
Make staff motivation a priority. Facilities use 
stress management activities to avoid burnout 
and reduce turnover
•	 Facility challenges, staff 
needs
•	 Staff burden, risk of 
burnout
•	 Value of positive staff 
attitude to patients
•	 High staff: patient ratio •	 Staff
•	 Patients 
Facilities should have strategy of training staff in 
palliative care
•	 Low provision of opioids 
and palliative care
•	 Staff training needs, care 
provided
Facilities should have a well documented human 
resources plan to match demand
•	 Facility challenges, 
experience of receiving 
care
•	 High patient burden for 
non-clinical staff
Empower patients to be self-supporting and 
increase social status—avoid dependency
•	 skills training, e.g. knitting, farm techniques
•	 loan schemes for starting capital
•	 seed projects, e.g. seedlings, chicks
•	 sensitisation towards food security
•	 Social status as predictor 
of self-reported health 
score
•	 High proportion receiving 
food and therapeutic 
feeding
•	 Burden of hunger and 
food insecurity
•	 Patients
•	 Carers
•	 Dependants
Enable stable patients to access pharmacy 
quickly, reduce queuing time
•	 Range of treatment 
regimes, some patients 
receiving complex care 
and counselling, others 
only medication
•	 Waiting time as barrier, 
carer burden
•	 Cost of staff time •	 Patients
•	 Carers
•	 Staff 
Provide components addressing all dimensions of 
care on one site
•	 Multidimensional 
problems, wide range of 
care components received
•	 Transport costs, preference 
for single centre of care
•	 Economies of scale •	 Patients
•	 Carers
•	 Funders 
Increase spiritual and psychological care to 
families. Train staff in spiritual and psychological 
care to complement the skills and knowledge in 
counselling
•	 Multidimensional 
problems, mental health 
needs 
•	 Low delivery of spiritual 
care theme
•	 Psychological needs, 
anxiety, worry.
•	 Value of spiritual care 
•	 Patients
•	 Carers
Extend VCT to rural areas •	 Late presentation, high 
symptom burden, rapid 
uptake of ART
•	 Facility challenges—lack 
of space, late presentation, 
difficulty of outreach
•	 New 
patients
Provide satellite clinics in rural areas, equipped 
with drugs and HCWs
•	 Staff overload, problem 
of queues, transport 
difficulties
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Table 81
Recommended Actions Data supporting recommendation Beneficiaries
Longitudinal Qualitative Cost/survey
Expand HBC, give HCWs time to talk to carers 
and assess family needs. Increase home visits by 
nurses
•	 Proportion of patients 
with carer, proportion 
not able to share feelings, 
lack of help and advice for 
family
•	 Patient needs 
•	 staff interviews
•	 Patients
•	 Carers
CHWs to provide adequate pain relief in the 
community and assess regularly when pain is 
present. Adapt pain management and palliative 
care skills to their settings
•	 Proportion receiving pain 
relief, high prevalence 
of pain
•	 Pain reported •	 Phase 1: low use of 
opioids
•	 Patients
Medicine companions to collect pain medication 
for patients
•	 Higher dropout for 
patients with low physical 
health
•	 Decreasing pain 
medication over time
•	 Some carers report 
collecting medication for 
patients
•	 Patients 
Involve religious leaders in the community, 
encourage patients to visit them
•	 High proportion not 
feeling at peace
•	 Patients reporting no 
spiritual care at facility
Regularise appointments •	 Complex care regimes •	 Queuing and long waiting 
time
•	 Phase 1: lack of fixed 
appointments
•	 Staff
•	 Patients
•	 Carers 
Continuous health education and encouraging 
hygiene to prevent infections
•	 Proportion receiving 
wound care, treatment 
for OIs
•	 Patients
Involve carers in planning care. Run workshops 
in communication skills,  information, IGA, and 
prevention. Encourage disclosure and education.
•	 Lack of help and advice 
for carers
•	 Carers report few services
•	 Burden of poverty, work 
time lost through caring
•	 Carers
•	 Patients
Instil a culture of appreciation for carers, give 
them motivation
•	 High proportion without 
a carer
•	 Carer burden •	 Carers
•	 Patients 
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